Andersen, F. A. éd. 1998. Final report on the safety assessment of Mink oil. Int. J. Toxicol. 17:71-82.
2.
Bower, D. 1999. Unpublished information on hair spray particle sizes provided at the September 9, 1999 CIR Expert Panel meeting.
3.
Clark, E. W.1980.A brief history of lanolin.Pharm. Hist. (Lond).10:5–6.
4.
Cooper, T. P.2002.Use of EMLA cream with vasectomy.Urology60:135–137.
5.
CTFA. 2003. Concentration of use data for lanolin and related compounds. Unpublished data submitted by CTFA, February 6, 2003. 7 pages.
6.
Culviner, W. T., D. W. Leonard, C. L. Wilhelmsen, and W. E. Bolger.2000.Experimental myospherulosis of the paranasal sinuses: A histologie rabbit study.Am. J. Rhinol.14:131–137.
7.
DeLeo, V. A., S. C. Taylor, D. V . Belsito, J. F Fowler, Jr., A. F Fransway, H. I. Maibach, J. G. Marks, Jr., C. G. Mathias, J. R. Nethercott, M. D. Pratt, R. R. Reitschel, E. F Sherertz, F J. Storrs, and J. S. Taylor.2002.The effect of race and ethnicity on patch test results.J. Am. Acad Dermatol.46:S107–S112.
8.
Elder, R. L., ed. 1980. Final report on safety assessment of Acetylated Lanolin, Acetylated Lanolin Alcohol, Hydrogenated Lanolin, Hydroxylated Lanolin, Lanolin (anhydrous), Lanolin Acid, Lanolin Alcohol, Lanolin Oil, and Lanolin Wax. J. Environ. Pathol. Toxicol. 4:63-92.
9.
Giordano-Labadie, F, F Ranee, F Pellegrin, J. Bazex, G. Dutau, and H. P. Schwarze.1999.Frequency of contact allergy in children with atopic dermatitis: Results of a prospective study of 137 cases.Contact Dermatitis40:192–195.
10.
Heikes, D. L., and J. C. Craun.1992.Rapid multiresidue procedure for the determination of pesticides in anhydrous lanolin and lanolin-containing pharmaceutical preparations utilizing gel permeation chromatography cleanup with gas Chromatographie and mass spectrometric techniques.J. Agrie. Food Chem.40:1588–1590.
Jensen P. A., and D. O'Brien.1993.Industrial Hygiene. In Aerosol measurement. Principles techniques and applications, ed. K. Willeke, P. A. Baron, 538–540. New York: John Wiley and Sons.
13.
Jover, E., and J. M. Bayona.2002.Trace level determination of organochlorine, organophosphorus and pyrethroid pesticides in lanolin using gel permeation chromatography followed by dual gas chromatography and gas chromatography-negative chemical ionization mass spectrometric confirmation. J.Chromatogr. A950:213–220.
14.
Jover, E., Z. Moldovan, and J. M. Bayona.2002.Complete characterisation of lanolin steryl esters by sub-ambient pressure gas chromatography-mass spectrometry in the electron impact and chemical ionisation modes.J. Chromatogr. A970:249–258.
15.
Kligman, A. M.1998.The myth of lanolin allergy.Contact Dermatitis39:103–107.
16.
Lopez-Mesas, M., M. Crespi, J. Brach, and J. P. Mullender.2000.Clean-up of a pesticide-lanolin mixture by gel permeation chromatography.J. Chromatogr. Sei.38:551–555.
17.
Marks, J. M., D. V. Belsito, V. A. DeLeo, J. F Fowler, A. F Fransway, H. I. Maibach, C. G. Toby Mathias, M. D. Pratt, R. L. Reitschel, E. F. Sherertz, F. J. Storrs, and J. S. Taylor.2000.North American contact dermatitis group patch-test results, 1996-1998.Arch Dermatol.136:272–273.
18.
Marks, J. M., D. V. Belsito, V. A. DeLeo, et al. 2003.North American Contact Dermatitis group patch-test results, 1998-2000.Am. J. Contact Dermat.14:59–62.
19.
Polese, L., M. Sannomiya, A. P. de Olivera Sader, and M. Lucia Ribeiro.2000.Extraction and clean-up procedure for analysis of organochlorine pesticide residues in ethoxylated lanolin.Farmacologie55:637–640.
20.
Stone, L.2000.Medilan: A hypoallergenic lanolin for emollient therapy.Br. J. Nurs.9:54–57.
21.
Suleyman, F2000.Role of lanolin in managing eczema and dry skin conditions.Community Nurse6:30–31.
22.
Takano, S., M. Yamanaka, K. Okamoto, and F. Saito.1983.Allergens of lanolin. Part 1. Isolation and identification of the allergens of hydrogenated lanolin. Part 2. Allergenicity of synthetic alkane-alpha-beta-diols and alkane-alpha, omega-diols.J. Soc. Cosmet. Chem.34:99–125.
23.
Trümmer, M., W. Aberer, and B. Kranke.2002.Clinical relevance of + patch test reactions to lanolin alcohol.Contact Dermatitis46:118.
24.
Uter, W, J. Geier, M. Land, A. Pfahlberg, O. Gefeller, and A. Schnuch.2001.Another look at seasonal variation in patch test results. A multifactorial analysis of surveillance data of the IVDK. Information Network of Departments of Dermatology.Contact Dermatitis44:146–152.
25.
Uter, W, J. Geier, A. Pfahlberg, and I. Effendy.2002.The spectrum of contact allergy in elderly patients with and without lower leg dermatitis.Dermatology204:266–272.
26.
Wakelin, S. H., H. Smith, I. R. White, R. J. Rycroft, and J. P. McFadden.2001.A retrospective analysis of contact allergy to lanolin.Br. J. Dermatol.145:28–31.
27.
Zhai, H., P. Willard, and H. I. Maibach.1998. Evaluating skin-protective materials against contact irritants and allergens. An in vivo screening human model.Contact Dermatitis38:155–158.
28.
Bogdanffy, M. S., and M. L. Taylor.1993.Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate.Drug Metab. Dispos.21:1107–1111.
29.
Bogdanffy, M. S., H. C. Dreef-Van Der Meulen, R. B. Beems, V. J. Feron, T. C. Tascieri, T. R. Taylor, M. B. Vinegar, and R. W. Rickard.1994a.Chronic toxicity and oncogenicity inhalation study with vinyl acetate in the rat and mouse.Fundam. Appl. Toxicol.23:215–229.
30.
Bogdanffy, M. S., T. R. Tyler, M. B. Vinegar, R. W. Rickard, F. M. Carpanini, and T. Cascieri.1994b.Chronic toxicity and oncogenicity study with vinyl acetate in the rat: In utero exposure in drinking water.Fundam. Appl. Toxicol.23:206–214.
31.
Bower, D. 1999. Unpublished information on hair spray particle size provided at the September 9, 1999, CIR Expert Panel meeting.
32.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002a. Information regarding VA/Crotonates Copolymer. Unpublished data submitted by CTFA October 31, 2002. 1 page.
33.
CTFA. 2002b. Concentrations of use VA/Crotonates Copolymer. Unpublished data submitted by CTFA November 1, 2002. 1 page.
34.
Deese, D. E., and R. E. Joyner.1969.Vinyl acetate: A study of chronic human exposure.American Industrial Hygiene Assoc. Journal.30:449–457.
35.
Elder, R. L.1983.Final report on the safety assessment of vinyl acetate/crotonic acid copolymer.J. Am. Col. Toxicol.2:125–140.
36.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington: FDA.
37.
Fromming, K. H., K. R Krahl, and F Fischer.1983.Enteric coated film tablets from an aqueous solution of a copolymer of vinyl acetate and crotonic acid. Part 3. Roentgenographical experiments.Pharm. Ind.45:199–202.
38.
Hurtt, M. E., M. B. Vinegar, R. W. Rickard, T. C. Cascieri, and T. R. Tyler.1995.Developmental toxicity of oral and inhaled vinyl acetate in themt. Fundam. Appl. Toxicol.24:198–205.
39.
International Agency on Risk of Cancer (IARC). 1995. Vinyl acetate. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 63:443-466.
40.
Jensen PA, O'Brien D.1993.Industrial Hygiene. In: Willeke K, Baron PA eds. Aerosol Measurement. Principles Techniques and Applications.New York: John Wiley and Sons, Inc., 538–540.
41.
Krahl, K. P., and K. H. Fromming.1982.Enteric coated film tablets from an aqueous of a copolymer of vinylacetate and crotonic acid. Part 2. In vivo drug release from enteric coated tablets with méthylène blue.Pharm. Ind.44:1084–1087.
42.
Kuykendall, J. R., and M. S. Bogdanffy.1992.Reaction kinetics of DNA-histone crosslinking by vinyl acetate and acetaldehyde.Carcinogenesis.13:2095–2100.
43.
Lahdetie, J.1988.Effects of vinyl acetate and acetaldehyde on sperm morphology and meiotic micronuclei in mice.Mutat. Res.202:171–178.
44.
Lijinsky, W., and M. D. Reuber.1983.Chronic toxicity studies of vinyl acetate in Fischer rats.Toxicol. Appl. Pharm.68:43–53.
45.
Maki-Paakkanen, J., and H. Norppa.1987.Induction of Micronuclei by Vinyl Acetate in Mouse Bone Marrow Cells and Cultured Human Lymphocytes.Mutat. Res.190:41–45.
46.
Maltoni, C A., Ciliberti, G. Lefemine, and M. Soffritti.1997.Results of along-term experimental study on the carcinogenicity of vinyl acetate monomer in mice.Ann. NYAccad. Sei.837:209–238.
47.
Mebus, C. A., F M. Carpanini, R. W. Rickard, T. C. Cascieri, T. R. Tyler, and M. B. Vinegar.1995.A two-generation reproduction study in rats receiving drinking water containing vinyl acetate.Fundam. Appl. Toxicol.24:206–216.
48.
Miñardí, F, F. Belpoggi, M. Soffritti, A. Ciliberti, M. Lauriola, E. Cattin, and C. Maltoni.2002.Results of long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley rats.Ann. N. Y. Acad. Sei.982:106–122.
49.
Norppa, H., F Tursi, P. Pfaffli, J. Maki-Paakkanen, and H. Jarventaus.1985. Chromosome damage induced by vinyl acetate through formation of acetaldehyde in human lymphocytes and Chinese ovary cells.Cancer Res.45:4816–4821.
50.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen.2002.International Cosmetic Ingredient Dictionary and Handbook. 9th ed.Washington, D. C.: CTFA.
51.
Simon, P., J. G. Filser, and H. M. Bolt.1985.Metabolism and pharmacokinetics of vinyl acetate.Arch. Toxicol.57:191–195.
52.
Sipi, P., H. Jarventaus and H. Norppa.1992.Sister-chromatid exchanges induced by vinyl esters and respective carboxylic acids in cultured human lymphocytes.Mutat Res.279:75–82.
53.
Abdel-Nabi, I. M., A. M. Kadry, R. A. Davis, and M. S. Abdel-Rahman.1992.Development and validation of a high-performance liquid Chromatographie method for the determination of benzophenone-3 in rats.J. Appl. Toxicol.12:255–259.
54.
Alanko, K., R. Jolanki, T. Estlander, and L. Kanerva.2001.Occupational allergic contact dermatitis from benzophenone-4 in hair-care products.Contact Dermatitis44:188.
55.
Berne, B., and A. M. Ros.1998.7 years of photopatch testing with sunscreen allergens in Sweden.Contact Dermatitis38:61–64.
Bilsland, D., and J. Ferguson.1993.Contact allergy to sunscreen chemicals in photosensitivity dermatitis/actinic reticuloid syndrome (PD/AR) and polymorphic light eruption (PLE).Contact Dermatitis29:70–73.
58.
Boehncke, W. H., M. Schmitt, T. M. Zollner, and O. Hensel.1997.Nail varnish allergy. An important differential diagnosis in contact dermatitis.Dtsch. Med. Wochenschr.122:849–852.
59.
Bosca, F., and M. A. Miranda.1998.Photosensitizing drugs containing the benzophenone chromophore.J. Photochem. Photobiol.43:1–26.
60.
Bronaugh, R. L., R. C. Wester, D. Bucks, H. I. Maibach, and R. Sarason.1990.In vivo percutaneous absorption of fragrance ingredients in rhesus monkey and humans.Food Chem. Toxicol.28:369–373.
61.
Burdock, G. A., D. H. Pence, and R. A. Ford.1991.Safety evaluation of benzophenone.Food Chem. Toxicol.29:741–750.
62.
Chew, S., V. A. DeLeo, and L. C. Harber.1987.An animal model for evaluation of topical photoprotection against ultraviolet A (320-380 nm) radiation.J. Invest. Dermatol.89:410–414.
63.
Collins, P., and J. Ferguson.1994.Photoallergic contact dermatitis to oxyben-zone.B. J. Dermatol.131:124–129.
64.
Cook, N., and S. Freeman.2001.Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the Skin and Cancer Foundation.Australas J. Dermatol.42:257–259.
65.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Use concentration data on benzophenones from industry survey. Unpublished data submitted by CTFA, June 26, 2002. 7 pages.
66.
Couteau, C, N. Perez Cullel, A. E. Connan, and L. J. Coiffard.2001.Stripping method to quantify absorption of two sunscreens in human.Int. J. Pharm.322:153–157.
67.
Darvay, A., I. R. White, R. J. Rycroft, A. B. Jones, J. L. Hawk, and J. P. McFadden.2001.Photoallergic contact dermatitis is uncommon.Br. J. Dermatol.145:597–601.
68.
DeLeo, V. A., S. M. Suarez, and M. J. Maso.1992.Photoallergic contact dermatitis.Arch. Dermatol.128:1513–1518.
69.
Douki, T, and J. Cadet.1999.Modification of DNA bases by photo sensitized one-electron oxidation.Int. J. Radiât. Biol.75:571–581.
70.
Duguid, C, D. O'Sullivan, and G. M. Murphy.1993.Determination of threshold UV-A elicitation dose in photopatch testing.Contact Dermatitis29:192–194.
71.
Dutta, K., M. Das, and T. Rahman.1993.Toxicological impacts of benzophenone on the liver of guinea pig (Cavia porcellus).Bull. Environ. Contam. Toxicol.50:282–285.
72.
Elder, R. L. ed. 1983a. Final report on the safety assessment of Benzophenones-1,-3,-4,-5,-9, and-11. J. Am. Col. Toxicol. 2:35-77.
73.
Elder, R. L. ed. 1983b. Addendum to the final report on the safety assessment of Benzophenones-1,-3,-4,-5,-9, and-11 to include Benzophenones-2,-6, and-8. J. Am. Col. Toxicol. 2:79-84.
74.
Elmets, C. A., A. Vargas, and C. Oresajo.1992.Photoprotective effects of sunscreens in cosmetics on sunburn and Langerhans cell photodamage.Photo-dermatol. Photoimmunol. Photomed.9:113–120.
75.
English, J. S., I. R. White, and E. Cronin.1987.Sensitivity to sunscreens.Contact Dermatitis17:159–162.
76.
Environmental Protection Agency (EPA). (1976) Initial submission: Letter from Upjohn Co to USEPA Re: Production, processing, safety & handling, and toxicity of benzophenone with attachments. Acute oral toxicity (rats), and ocular irritation and dermal irritation studies (rabbits). EPA/OTS Report No. FYI-OTS-0794-0987.
77.
EPA. 1978. Initial submission: Letter from Upjohn Co to USEPA Re: Production, processing, safety & handling, and toxicity of benzophenone with attachments. Bacterial mutagenicity testing. EPA/OTS Report No. FYI-OTS-0794-0987.
78.
EPA. 1990. Preliminary assessment for an epidemiologic study on employees at the North Haven Fine Chemicals Plant (Final Report) with cover letter dated 060790. EPA/OTS Report No. 89-0000042.
79.
EPA. 1980a. Initial submission: Salmonella/Mammalian Microsome plate incorporation assay with cover letter dated 081492. EPA/OTS Report No. 88-920007764.
80.
EPA. 1980b. Initial submission: Test for chemical induction of mutation in mammalian cells in culture. The 2,2′-dihydroxy-4 methoxy benzophenone mouse lymphoma assay with cover letter dated 081492. EPA/OTS Report No. OTS 88-920006804.
81.
EPA. 2001. Initial submission: TK 10050 (Chimassorb 81). Contact hyper-sensitivity in albino guinea pigs. Maximization-test, with cover letter dated 6/4/2001. EPA/OTS Report Number 88-010000159.
82.
European Economic Community. 1999. EEC Cosmetics Directive 76/768/EEC, as amended through the 26th Adapting Commission Directive 2002/34/EC, Annexes I-VII. Brussels: EEC.
83.
Felix, T, B. J. Hall, and J. S. Brodbelt.1998.Determination of benzophenone-3 metabolites in water and human urine by solid-phase microextraction and quadruple ion trap GC-MS.Anal. Chim. Acta371:195–203.
84.
Fernandez, C, G. Marti-Mestres, J. P. Mestres, and H. Maillols.2000.LC analysis of benzophenone-3 in pigskin and in saline solution: Application to determination of in vitro skin penetration.J. Pharm. Biomed. Anal.22:393–402.
85.
Fernandez, C, F Nielloud, R. Fortune, L. Vian, and G. Marti-Mestres.2002.Benzophenone-3 : Rapid prediction and evaluation using non-invasive method of in vivo human penetration.J. Pharm. Biomed. Anal.28:57–63.
86.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
87.
FDA. 2002. Sunscreens, tanning products, and sun safety, http://vm.cfsan.fda. gov/dms/cos-220.html.
88.
Goncalo, M., E. Ruas, A. Figueiredo, and S. Goncalo.1995.Contact and photocontact sensitivity to sunscreens.Contact Dermatitis33:278–280.
89.
Goswami, S. K., and J. E. Kinsella.1985.Inhibitory effects of tannic acid and benzophenone on soybean lipoxygenase and ram seminal vesicle cyclooxygenase.Prostaglandins Leukot. Med.17:223–228.
90.
Guin, J. D.2000.Eyelid dermatitis from benzophenone used in nail enhancement.Contact Dermatitis43:308–309.
91.
Gurish, M. F, L. K. Roberts, C. G. Krueger, and R. A. Daynes.1981.The effect of various sunscreen agents on skin damage and the induction of tumor susceptibility in mice subjected to ultraviolet irradiation.J. Invest. Dermatol.76:246–251.
92.
Horn, H. M., F Humphreys, and R. D. Aldridge.1998.Contact dermatitis and prolonged photosensitivity induced by ketoprofen and associated with sensitivity to benzophenone-3.Contact Dermatitis38:353–354.
93.
Jacobs, M. C.1998.Contact allergy to benzophenone-2 in toilet water.Contact Dermatitis39:42.
94.
Jiang, R., H. A. Benson, S. E. Cross, and M. S. Roberts.1998.In vitro human epidermal and polyethylene membrane penetration and retention of the sunscreen benzophenone-3 from arange of solvents.Pharm. Res.15:1863–1868.
95.
Jiang, R., M. S. Roberts, D. M. Collins, and H. A. Benson.1999.Absorption of sunscreens across human skin: An evaluation of commercial products for children and adults.Br. J. Clin. Pharmacol.48:635–637.
96.
Joint FAO/WHO Expert Committee on Food Additives (JECFA) 2001. Fifty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives.
97.
Summary and conclusions. Flavoring agents evaluated using the Procedure for the Safety Evaluation of Flavoring Agents. Geneva: World Health Organization.
98.
Kadry, A. M., C. S. Okereke, M. S. Abdel-Rahman, M. A. Friedman, and R. A. Davis.1995.Pharmacokinetics of benzophenone-3 after oral exposure in male rats. J.Appl. Toxicol.15:97–102.
99.
Knobler, E., L. Almeida, A. M. Ruzkowski, J. Held, L. Harber, and V. DeLeo.1989.Photoallergy to benzophenone.Arch. Dermatol.125:801–804.
100.
Krainev, A. K., R. I. Viner, and D. J. Bigelow.1997.Benzophen one-sensitized photooxidation of sarcoplasmic reticulum membranes: Site-specific modification of the Ca(2+)-ATPase.Free Radie. Biol. Med.23:1009–1020.
101.
Le Coz, C. J., A. Bottlaender, J. N. Scrivener, F Santinelli, B. J. Cribier, E. Heid, and E. M. Grosshans.1998.Photocontact dermatitis from ketoprofen and tiaprofenic acid: Cross-reactivity study in 12 consecutive patients.Contact Dermatitis38:245–252.
102.
Leroy, D., A. Dompmartin, C. Sczurko, M. Michel, and S. Louvet.1997.Photo-dermatitis from ketoprofen with cross-reactivity to fenofibrate and benzophe-nones.Photodermatol Photoimmunol Photomed13:93–97.
103.
Lhiaubet, V., N. Paillous, and N. Chouini-Lalanne.2001.Comparison of DNA damage photoinduced by ketoprofen, fenofibric acid and benzophenone via electron and energy transfer.Photochem. Photobiol.74:670–678.
104.
Maquad, M., A. B. Fleischer, Jr., E. F Sherertz, and S. R. Feldman.1999.Significance prevalence index number: A reinterpretation and enhancement of data from the North American Contact Dermatitis Group.J. Am. Acad. Dermatol41:573–576.
105.
Marks, J. G. Jr., D. V. Belsito, V. A. DeLeo, J. F Fowler, Jr., A. F Fransway, H. I. Maibach, C. G. Toby Mathias, M. D. Pratt, R. L. Rietschel, E. F. Sherertz, F. J. Storrs, and J. S. Taylor.2000.North American Contact Dermatitis Group patch-test results, 1996-1998.Arch. Dermatol136:272–273.
106.
Marks, J. G. Jr., P. Eisner, and V. A. Deleo. eds. 2002.Contact and occupational dermatology, 3rd ed., 239, 240, 260. St. Louis: Mosby.
107.
Ministry of Health, Labor and Welfare (MHLW). (June 29, 2001a). MHW Ordinance No. 331, Attached Table 4 [UV Filters]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
108.
Ministry of Health, Labor and Welfare (MHLW). (June 29, 2001b). MHW Ordinance No. 332. Ingredients of quasi-drugs. Products to be used directly on the body. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
109.
Morin, B., and J. Cadet.1995.Type I benzophenone-mediated nucleophilic reaction of 5′-Amino-2′,5′-dideoxyguanosine. A model system for the investigation of photosensitized formation of DNA-protein cross-links.Chem. Res. Toxicol.8:792–799.
110.
Mortelmans, K., S. Haworth, T. Lawlor, W Speck, B. Tainer, and E. Zeiger.1986.Salmonella mutagenicity tests. 2. Results from the testing of 270 chemicals.Environ. Mutagen.8:1–119.
111.
Nakagawa, Y, T. Suzuki, and S. Tayama.2000.Metabolism and toxicity of benzophenone in isolated rat hepatocytes and estrogenic activity of its metabolites in MCF-7 cells.Toxicology156:27–36.
112.
Nakagawa, Y., and K. Tayama.2001.Estrogenic potency of benzophenone and its metabolites in juvenile female rats.Arch. Toxicol.75:74–79.
113.
National Toxicology Program (NTP). 1990. Final report on the reproductive toxicity of 2-hydroxy-4-methoxybenzophenone (CAS No. 131-57-7). NTIS Report No. PB91-158477.
114.
NTP. 1992. NTP technical report on toxicity studies of 2-hydroxy-4-methoxybenzophenone (CAS Number: 131-57-7). NTIS Report No. PB93-126498.
115.
NTP. 2000. Report on the toxicity studies of benzophenone administered in feed to F344/N rats and B6C3F1 mice. NTIS Report No. PB2000-106659.
116.
NTP. July 9, 2002a. Personal communication with NTP's Central Data Management. Year of initiation of 2-year carcinogenicity study on benzophenone (CAS No. 119-61-9). Research Triangle Park: NTP.
117.
NTP. 2002b. NTP management status report, http://ntp-server.niehs.nih.gov/htdocs/Results.Status/Msr/ReflO.html
118.
NTP. (2002c) NTP management status report, http://ntpserver.niehs.nih.gov/ht-docs/Results.Status/Msr/Ref04.html
119.
Okereke, C. S., M. S. Abdel-Rhaman, and M. A. Friedman.1994.Disposition of benzophenone-3 after dermal administration in male rats.Toxicol. Lett.73:113–122.
120.
Okereke, C. S., S. A. Barat, and M. S. Abdel-Rahman.1995.Safety evaluation of benzophenone-3 after dermal administration in rats.Toxicol. Lett.80:61–67.
121.
Okereke, C. S., A. M. Kadry, M. S. Abdel-Rahman, R. A. Davis, and M. A. Friedman.1993.Metabolism of benzophenone-3 in rats.Drug Metab. Dispos.21:788–791.
122.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen, Jr., eds. 2002.International cosmetic ingredient dictionary and handbook.9th ed., 171–174. Washington, DC: CTFA.
123.
Potard, G., C. Laugel, A. Baillet, H. Schaefer, and J. P. Marty.1999.Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies.Int. J. Pharm.189:246–260.
124.
Potard, G., C. Laugel, H. Schäfer, and J. P. Marty.2000.The stripping technique: In vitro absorption and penetration of five UV filters on excised fresh human skin.Skin Pharmacol. Appl. Skin Physiol.13:336–344.
125.
Robison, S. H., M. R. Odio, E. D. Thompson, M. J. Aardema, and A. L. Kraus.1994.Assessment of the in vivo genotoxicity of 2-hydroxy 4-methoxybenzophenone.Environ. Mol Mutagen.23:312–317.
126.
Schauder, S., and H. Ippen.1997.Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature.Contact Dermatitis37:221–232.
127.
Schlumpf, M., B. Cotton, M. Conscience, V. Haller, B. Steinmann, and W Lichtensteiger.2001.In vitro and in vivo estrogenicity of UV screens.Environ. Health Perspect.109:239–244.
128.
Schmidt, T, J. Ring, and D. Abeck.1998.Photoallergic contact dermatitis due to combined UVB (4-methylbenzylidene camphor/octyl methoxycinnamate) and UVA (benzoph enone-3/butylmethoxydibenzoylmethane) absorber sensitization.Dermatology196:354–357.
129.
Sheng, P. G., J. Feix, and B. Kalyanaraman.1990.Characterization of radical adducts formed during photochemical spin trapping in liposomes.Photochem. Photobiol.52:323–331.
130.
Stocklinski, A. W, O. B. Ware, and T. J. Oberst.1980.Benzophenone metabolism. I. Isolation of p-hydroxybenzophenone from rat urine.Life Sei.26:365–369.
131.
Vanquerp, V, C. Rodriguez, C. Coiffard, L. J. Coiffard, and Y De Roeck-Holtzhauer.1999.High-performance liquid Chromatographie method for the comparison of the photostability of five sunscreen agents.J. Chromatogr.832:273–277.
132.
Yamasaki, K., M. Takeyoshi, Y Yakabe, M. Sakaki, N. Imatanaka, and M. Takatsuki.2002.Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals.Toxicology170:21–30.
133.
Yesudian, P. D., and C. M. King.2002.Severe contact urticaria and anaphylaxis from benzophenone-3 (2-hydroxy 4-methoxy benzophenone).Contact Dermatitis46:55–56.
134.
Aasmoe, L., J. O. Winberg, and J. Aarbakke.1998.The role of liver alcohol dehydrogenase isoenzymes in the oxidation of gly col ethers in male and female rats.Toxicol. Appl. Pharmacol.150:86–90.
135.
Agency for Toxic Substances and Disease Registry (ATSDR). 1998. Toxicological profile for 2-butoxyethanol and 2-butoxyethanol acetate. NTIS Report No. PB99-102527.
136.
Alarie, Y., G. D. Nielsen, and J. Andonian-Haftvan.1995.Physicochemical properties of nonreactive volatile organic chemicals to estimate RD50: Alternatives to animal studies.Toxicol. Appl. Pharmacol.134:92–99.
137.
American Chemistry Council. 2001. Review of ongoing studies concerning the tumorigenicity of EGBE in rodents-Research Update/Draft. Arlington VI: American Chemistry Council.
138.
Andersen, F. A. ed. 1996. Final report on the safety assessment of butoxyethanol. J. Am. Col. Toxicol. 15:462-526.
139.
Battelle Memorial Institute. 1999a. Final Report. Species-, gender-, and age-related differences in the pharmacokinetics of 2-butoxyethanol and 2-butoxycetic acid. II. In vitro renal active transport of 2-butoxyacetic acid. NTIS Report No. OTS06001387.
140.
Battelle Memorial Institute. 1999b. Final Report. Short-term studies to evaluate the dosimetry and modes of action of 2-butoxyethanol in B6C3F1 mice, with cover letter dated 8-6-99. NTIS Report No. OTS0001363.
141.
Boatman, R. J., and J. B. Knaak.2001.Ethers of Ethylene Glycol and Derivatives. In Patty's toxicology, ed. E. Bingham, B. Cohrssen, and C. H. Powell, 73–270. New York: lohn Wiley & Sons.
142.
Bowden, H. C, O. K. Wilby, C. A. Botham, P. J. Adam, and F. W. Ross.1995.Assessment of the toxic and potential teratogenic effects of four glycol ethers and two derivatives using the hydra regeneration assay and rat whole embryo culture.Toxicol. In Vitro9:773–781.
143.
Chou, C.-H. S. J., J. Holler, and C. T. De Rosa.1998.Minimal risk levels (MRLs) for hazardous substances.J. Clean Tech. Environ. Toxicol. Occup. Med.7:1–24.
144.
Corley, R. A.1996.Assessing the risk of hemolysis in humans exposed to 2-butoxyethanol using a physiologically-based pharmacokinetic model.Occup. Hyg.2:45–55.
145.
Corley, R. A., D. A. Markham, C. Banks, R Delorme, A. Masterman, and J. M. Houle.1997.Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans.Fundam. Appl. Toxicol.39:120–130.
146.
Corning Hazleton, Inc. 1995. Draft Report. Clonal transformation assay on RO434.01 DRD:HESE 415, ethylene glycol monobutyl ether, using Syrian golden hamster embryo (SHE) cells w/cover letter dated 8-11-95. NTIS No. OTS0557-846.
147.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2001. Concentration of use-Butoxyethanol. Unpu Wished data submitted by CTFA.
148.
Dartsch, P. C, S. Hildenbrand, W. Gfroerer, R. Kimmel, and F W. Schmahl.1999.Cytotoxic effects of 2-butoxyethanol in vitro are related to butoxyac-etaldehyde, an intermediate oxidation product.Environ. Toxicol. Pharmacol.7:135–142.
149.
Dill, J. A., M. L. Kyeonghee, D. J. Bates, D. J. Anderson, R. E. Johnson, B. J. Chou, L. T. Burka, and J. H. Roycroft.1998.Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice.Toxicol. Appl. Pharmacol.153:227–242.
150.
Dow Chemical Company. (Published in 1958; made available in 2000a. Results of range finding eye and skin irritation tests on Dowanol EBCrude (ethyleneglycol, butyl ether). NTIS No. OTS0520314.
151.
Eastman Kodak Company. 1994. Ethylene glycol monobutyl ether: Acute oral toxicity study in the guinea pig with cover letter dated 7-21-94. NTIS No. OTS0572612.
152.
Elliott, B. M., and J. Ashby1997.Review of the genotoxicity of 2-butoxyethanol.Mutat. Res.387:89–96.
153.
European Centre for Ecotoxicology and Toxicology of Chemicals (ECE-TOC). 1994. Butoxyethanol criteria document, including a supplement for 2-butoxyethyl acetate. Special Report No. 7 (71 pages). Brussels: ECETOC.
154.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
155.
Ghanayem, B. I., P. H. Long, S. M. Ward, B. Chañas, M. Nyska, and A. Nyska.2001.Hemolytic anemia, thrombosis, and infarction in male and female F344 rats following gavage exposure to 2-butoxethaanol.Exp. Toxicol. Pathol.53:97–105.
156.
Ghanayem, B. I., S. M. Ward, B. Chañas, and A. Nyska.2000.Comparison of the acute hematotoxicity of 2-butoxyethanol in male and female F344 rats.Hum. Exp. Toxicol.19:185–192.
157.
Gingell, R., R. J. Boatman, and S. Lewis.1998.Acute toxicity of ethylene glycol mono-n-butyl ether in the guinea pig.Food Chem. Toxicol.36:825–829.
158.
Giraudi, G., and C. Baggiani.1993.Solvent effect on testosterone-antitestosterone interaction.Biochim. Biophys. Acta.1157:211–216.
159.
Gollapudi, B. B., E. D. Barber, T. E. Lawlor, and S. A. Lewis.1996.Re-examination of the mutagenicity of ethylene glycol monobutyl ether to Salmonella tester strain TA97a.Mutat. Res.370:61–64.
160.
Green, C. E., G. R. Gordon, P. M. Cohen, H. W. Nolen, J. H. Peters, and C. A. Tyson.1996.In vitro metabolism of glycol ethers by human and rat hepato-cytes.Occup. Hygiene2:67–75.
161.
Haufroid, V., F Thirion, P. Mertens, J. P. Buchet, and D. Lison.1997.Biological monitoring of workers exposed to low levels of 2-butoxyethanol.Int. Arch. Occup. Environ. Health.70:232–236.
162.
Hoflack, J. C, L. Lambolez, Z. Elias, and P. Vasseur.1995.Mutagenicity of ethylene glycol ethers and of their metabolites inSalmonella typhimurium his-. Mutat. Res.341:281–287.
163.
Hoflack, J. C, P. Vasseur, and G. G. Poirier.1997.Glycol ethers induce death and necrosis in human leukemia cells.Biochem. Cell. Biol.75:415–425.
164.
International Programme on Chemical Safety (IPCS). 1997. Concise International Assessment Document 10. 2-Butoxyethanol. http://www.inchem.org/ documents/cicads/cicads/cicad10.htm.
165.
Judson, I. R., and M. D. Threadgill.1993.Poly(ADP-ribosyl)ation as target for cancer chemotherapy.Lancet342:632.
166.
Kaphalia, B. S., B. I. Ghanayem, and G. A. Ansari.1996.Nonoxidative metabolism of 2-butoxyethanol via fatty acid conjugation in Fischer 344 rats. J.Toxicol. Environ. Health.49:463–479.
167.
Kerchaert, G. A., R. Brauninger, R. A. Leboeuf, and R. J. Isfort.1996.Use of the Syrian hamster embryo cell transformation assay for carcinogenic-ity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.Environ. Health Perspect.104:1075–1084.
168.
L. A. B. Bio-Res International, Inc. 1996. Dermal bioavailability study of 2-butoxyethanol in fasted volunteers with cover letter dated 12-6-96. NTIS No. OTS0573540.
169.
Lautier, D., J. Lagueux, J. Thibodeau, L. Ménard, and G. G. Poirier.1993.Molecular and biochemical features of poly(ADP-ribose) polymerase metabolism.Biochem. Cell. Biol.68:602–608.
170.
Lindahl, T., M. S. Satoh, G. G. Poirier, and A. Klungland.1995.Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks.Trends Biol. Sei.20:405–411.
171.
Long, P. H., R. R. Maronpot, B. I. Ghanayem, J. H. Roycroft, and A. Nyska.2000.Dental pulp infarction in female rats following inhalation exposure to 2-butoxyethanol.Toxicol. Pathol.28:246–252.
172.
Moslen, M. T, L. Kaphalia, H. Balasubramanian, Y. M. Yin, and W. W. Au.1995.Species differences in testicular and hepatic biotransformation of 2-methoxyethanol.Toxicology96:217–224.
173.
National Toxicology Program (NTP). 2000. Toxicology and carcinogenesis studies of 2-butoxyethanol (CAS No. 111-76-2) in F344/N Rats and B6C3F1 mice (Inhalation Studies). NTIS Report No. PB2000-105865.
174.
Nyska, A., R. R. Maronpot, and B. I. Ghanayem.1999a.Ocular thrombosis and retinal degeneration induced in female F344 rats by 2-butoxyethanolHum. Exp. Toxicol.18:577–582.
175.
Nyska, A., R. R. Maronpot, P. H. Long, J. H. Roycroft, J. R. Hailey, G. S. Travlos, and B. I. Ghanayem.1999a.Disseminated thrombosis and bone infarction in female rats following inhalation exposure to 2-butoxyethanol.Toxicol. Pathol.27:287–294.
176.
Raymond L. W, L. S. Williford, and W. A. Burke.1998.Eruptive cherry angiomas and irritant symptoms after one acute exposure to the glycol ether solvent 2-butoxyethanol.J. Occup. Environ. Med.40:1059–1064.
177.
Sivarao, D. V., and H. M. Mehendale.1995.2-Butoxyethanol autoprotection is due to resiliency of newly formed erythrocytes to hemolysis.Arch. Toxicol.69:526–532.
178.
Udden, M. M.2000.Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: A comparison with the in vitro effects of bu-toxyacetic acid on rat and human erythrocytes.J. Appl. Toxicol.20:381–387.
179.
Udden M. M., and C. S. Patton.1994.Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans.J. Appl. Toxicol.14:91–96.
180.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen, Jr., eds. 2000.International cosmetic ingredient dictionary and handbook.8th ed.162. Washington, DC: CTFA.
181.
Woo, Y.-T, D. Lai, J. Arcos, M. Argus, M. Cimino, S. DeVito, and L. Keifer.1997.Mechanism-based structure-activity relationship (SAR) analysis of carcinogenic potential of 30 NTP test chemicals.J. Environ. Sei. Health C Environ. Carcinogen. Ecotoxicol. Rev.05:139–160.
182.
Zissu, D.1995.Experimental study of cutaneous tolerance to glycol ethers.Contact Dermatitis32:74–77.
183.
Andersen, F. A., éd. 1997.Final report on the safety assessment of cetyl esters.Int. J. Toxicol.16:123–130.
184.
Anonymous. 1994. Henkel KgaA: Submission of IUCLID data set on fatty acids, C16-18, 2-ethylhexylester to the European Chemical Bureau, unpublished documents. D-Düsseldorf and I-Ispra.
185.
Aulmann, W., W. Sterzel, and Henkel KgaA. 1994. Assessment of maternal-, fetotoxic-and teratogenic effects of fatty acids, C 16-18, 2-ethylhexyl ester and its breakdown products 2-ethylhexyl alcohol and 2-ethylhexyl acid. Report-No. 9400096.
186.
Aulman, W., W. Pittermann, F. Bartnik, W. Sterzel, W. Kastner, and M. Potokar.2000.Developmental toxicity of 2-ethylhexyl Stearate.Food Chem. Toxicol.38:57–63.
187.
ChemIDplus. 2003. ChemIDplus database. Bethesda: National Library of Medicine.
188.
Chiba, K., and K. Tohyama.1989.Safety evaluation of oil ingredients for cosmetics using cell culture system.J. Jpn. Cosmet. Sei. Soc.13:194–202.
189.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2003. Use concentration data on Butyl Stearate, Cetyl Stearate, Ethylhexyl Stearate, Isobutyl Stearate, Isocetyl Stearate, Isopropyl Stearate, and Myristyl Stearate from industry survey. Unpublished data submitted by CTFA, April 21, 2003. i 5 3 pages.
190.
Eastman Kodak Co. 1992. Submission summary: Synopsis of teratology study in rats (final report) using di(2-ethylhexyl)adipate with cover letter dated 091391. NTIS Report No. OTS0533689-1.
191.
Elder, R. L. ed. 1985 . Final report on the safety assessment of butyl Stearate, cetyl Stearate, isobutyl Stearate, isocetyl Stearate, isopropyl Stearate, myristyl Stearate, and octyl Stearate. J. Am. Col. Toxicol. 4:107-146.
192.
Environmental Protection Agency (EPA). No date. Toxic substances control act inventory representation for chemical substances of unknown or variable composition, complex reaction products and biological materials. UVCB substances. http://www.epa.gov/opptintr/newchems/uvcb.txt.
193.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
194.
Fulton, J. E., Jr., S. R. Pay, and J. E. Fulton, III.1984.Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear.J. Am. Acad. Dermatol.10:96–105.
195.
Hachiya, N.1987.Evaluation of chemical genotoxicity by a series of short-term tests.Akita J. Med.14:269–292.
196.
Hisashi, T, and R. Hagakaya.1991.A study on the relation between the result of guinea pig skin irritation test and human patch test with cosmetic ingredients.Hifu33:31–38.
197.
Munro, I. C, and E. Kennepohl.2001.Comparison of estimated daily capita intakes of flavouring substances with no-observed-effect levels from animal studies.Food Chem. Toxicol.39:331–354.
198.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen, Jr., eds. 2002.International cosmetic ingredient dictionary and handbook, 9th ed., 223, 310, 616, 809, 812, 828, 1017. Washington, DC: CTFA.
199.
Vermüe, M., J. Sikkema, A. Verheul, R. Bakker, and J. Tramper.1993.Toxicity of homologous series of organic solvents for the gram-positive bacteria Arthrobacter sp. and Nocardia sp. and the gram-negative bacteria Acinetobacter sp. and Pseudomonas sp.Biotechnol. Bioeng.42:747–758.
200.
World Health Organization (WHO). 1998. Safety evaluation of certain food additives and contaminants. Prepared by The forty-ninth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 272, 305, 324. WHO Food Additives Series 40. Geneva: WHO.
201.
WHO. 1999. Evaluation of certain food additives and contaminants. Forty-ninth report of the Joint FAO/WHO Expert Committee on Food Additives, 25, 62. WHO Technical Report Series 884. Geneva: WHO.
202.
Anonymous. 1993a. Phototoxicity. Unpublished data submitted by the Cosmetic, Toiletry, and Fragrance Association (CTFA). May 8, 2002.
203.
Anonymous. 1993b. Photoallergenicity. Unpublished data submitted by CTFA. May 8 2002.
204.
Anonymous. 1994a. Single Application Patch Test. Unpublished data submitted by CTFA. May 8 2002.
205.
Anonymous. 1994b. Human Repeat Insult Patch Test. Unpublished data submitted by CTFA. May 8 2002.
206.
Anonymous. 1995. Human Repeat Insult Patch Test. Unpublished data submitted by CTFA. May 8 2002.
207.
Bui, L. M., M. W. Taubeneck, J. F Commiso, J. Y. Uriu-Hare, W. D. Faber, and C. L. Keen.1998.Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid.Toxicology126:9–21.
208.
Chemical Manufacturers Association (CMA). 1987a. Acute toxicity study of 2-ethylhexanoic acid in the rat (Final Report) with attachments and cover letter dated 061 787. NTIS Report No. OTS0525538.
209.
CMA. 1987b. Letter from Chemical Manufacturers Association to USEPA submitting enclosed interim and final reports on the testing of 2-ethylhexanoic acid with attachments. NTIS Report No. OTS0525547.
210.
Consumer Product Testing Co. 1985. Repeated Insult Patch Test Final Report. Unpublished data submitted by CTFA. March 14, 2002. 13 pages.
211.
Consumer Product Testing Co. 1996a. Acute oral toxicity in rats. Unpublished data submitted by CTFA August 5, 2002. 3 pages.
212.
Consumer Product Testing Co. 1996b. Primary ocular irritation in rabbits. Unpublished data submitted by CTFA August 5, 2002. 7 pages.
213.
Consumer Product Testing Co. 1996c. Primary dermal irritation in rabbits. Unpublished data submitted by CTFA August 5, 2002. 6 pages.
214.
Consumer Product Testing Co. 1996d. Comedogenicity assay in rabbits. Unpublished data submitted by CTFA August 5, 2002. 10 pages.
215.
Consumer Product Testing Co. 1998. 48 hour patch test in humans (dermal irritation study). Unpublished data submitted by CTFA. March 22, 2002. 8 pages.
216.
Consumer Product Testing Co. 1999a. Skin irritation by MatTex Epiderm Skin Model. Unpublished data submitted by CTFA. March 22, 2002. 14 pages.
217.
Consumer Product Testing Co. 1999b. Eye irritation by Mat Tek Epiocu-lar Model. Unpublished data submitted by CTFA. March 22, 2002. 14 pages.
218.
Cosmetic, Toiletry, and Fragrance Association. 1990a. Report regarding the primary eye irritation of neopentyl glycol diethylhexano ate; COSMOL 525. Unpublished data provided by CTFA September 14, 1990. 6 pages.
219.
CTFA. 1990b. Report regarding the primary dermal irritation of neopentyl glycol diethylhexanoate; COSMOL 525. Unpublished data provided by CTFA August 24, 1990. 4 pages.
220.
Unpublished data available from the Director, Cosmetic Ingredient Review, 1101 17th Street, NW, Washington, DC 20036, USA.
221.
CTFA. 1990c. Report assay of comedogenicity in the rabbit ear of neopentyl glycol diethylhexanoate; COSMOL 525. Unpublished data provided by CTFA December 16, 1990. 8 pages.
222.
CTFA. 2001a. Report rearding the primary eye irritation of pentaerythrityl tetraethylhexanoate; Salacos 5408. Unpublished data provided by CTFA October 22, 2001. 7 pages.
223.
CTFA. 2001b. Report rearding the primary dermal irritation of pentaerythrityl tetraethylhexanoate; Salacos 5408. Unpublished data provided by CTFA October 30, 2001. 5 pages.
224.
CTFA. 2002a. Concentration of use of ethylhexanoateingredients. Unpublished data provided by CTFA. Updated October 21, 2002. 6 pages.
225.
CTFA. 2002b. Concentration of 2-E thylhexanoic Acid in Cetearyl Ethylhexanoate. Unpublished data provided by CICD committee of CTFA Sept. 6, 2002.
226.
Eastman Kodak Company. 1992. Initial submission: Dermal corrosivity test of 2-ethylhexanoic acid in rabbits with cover letter dated 09/28/92. NTIS Report No. OTS0555383.
227.
Elder, R. L., ed. 1982. Final report on the safety assessment of Cetearyl Octanoate. J. Am. Col. Toxicol. 1:81-90.
228.
English, J. C, R J. Deisinger, and D. Guest.1998.Metabolism of 2-ethylhexanoic acid administered orally or dermally to the female Fischer 344 rat.Xenobiotica28: 699–714.
229.
European Commission. 1999. EEC Cosmetics Directive 76/768/EEC, as amended through the 26th Adapting Commission Directive 2002/34/EC, Annexes I-VII. Brussels: EEC. http://europa.eu.int/scadplus/leg/en/lvb/121191. htm
230.
Faber, W.2003.Presentation made at the February, 2003 meeting of the CIR Expert Panel.6
231.
Food and Drug Administration (FDA). 1984. Cosmetic product formulation and frequency of use data. FDA database. Washington, DC: FDA.
232.
FDA. 1992. Modification in Voluntary Filing of Cosmetic Product Ingredient and Cosmetic Raw Composition Statements. Final Rule. Fed. Register 57:3128-3130.
233.
FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
234.
Hauck, R. S., C. Wegner, P. Blumtritt, J. H. Fuhrhop, and H. Nau.1990.Asymmetric synthesis and teratogenic activity of (R)-and (S)-2-ehtylhexanoic acid, a metabolite of the plasticizer di-(2-ethylhexyl) phthalate.Life Sei.46:513–518.
235.
Hendrickx, A. G., P. E. Peterson, R. W Tyl, L. C. Fisher, L. J. Fosnight, M. F Kubena, M. A. Vrabanic, and G. V Katz.1993.Assessment of the develp-mental toxicity of 2-ethylhexanoic acid in rats and rabbits.Fundam. Appl. Toxicol.20:199–209.
236.
Huntingdon Research Centre. 1977a. Acute oral toxicity to rats of Crodamol CAP. Unpublished data submitted by CTFA. March 14, 2002. 3 pages.
237.
Huntingdon Research Centre. 1977b. Irritant effects of Crodamol CAP on rabbit eye mucosa. Unpublished data submitted by CTFA. March 14,2002.5 pages.
238.
Huntingdon Research Centre. 1979. Irritant effects of Crodamol CAP on rabbit skin. Unpublished data submitted by CTFA. March 14, 2002. 4 pages.
239.
Huntingdon Research Centre. 1985. Repeated Insult Patch Test. Unpublished data submitted by CTFA. March 14, 2002. 13 pages.
240.
Juberg, D. R., R. M. David, G. V Katz, L. G. Bernard, D. R. Gordon, M. S. Vlaovic, and D. C. Topping.1998.2-ethylhexanoic acid: Subchronic oral toxicity studies in the rat and mouse.Food Chem. Toxicol.36:429–436.
241.
Kröger, S.1989.Gas Chromatographie determination of 2-ethylhexanoic acid in urine as its pentafluorobenzyl ester.Analyst114:1647–1648.
242.
Kröger, S., J. Liesivuori, and A. Manninen.1990.Evaluation of workers' exposure to 2-ethylhexanoic acid (2-EHA) in Finnish sawmills.Int. Arch. Occup. Environ. Health62:213–216.
243.
Laboratoire de Recherche et d'Expérimentation. 1997. Industry data regarding cetearyl ethylhexanoate. Unpublished data submitted by CTFA. March 12, 2002. 7 pages.
244.
Manninen, A., S. Kröger, J. Liesivuori, and H. Savolainen.1989.2-Ethylhexanoic acid inhibits urea synthesis and stimulates carnitine acetyl-transferase activity in rat liver mitochondria.Arch. Toxicol.63:160–161.
245.
Ministry of Health, Labor, and Welfare (MHLW). 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chôme, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
246.
MHLW. 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted List]. Ministry of Health, Labor, and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
247.
Pennanen, S., and A. Manninen.1991.Distribution of 2-ethylhexanoic acid in mice and rats after an intraperitoneal injection.Pharmacol. Toxicol.68: 57–59.
248.
Pennanen, S., A. Manninen, and H. Savolainen.1990.Urinary arginine and ornithine in occupational exposure to 2-ethylhexanoic acid.Arch. Toxicol.64:426–427.
249.
Pennanen, S., K. Tuovinen, H. Huuskonen, and H. Komulainen.1992.The developmental toxicity of 2-ethtylhexanoic acid in Wistar rats.Fundam. Appl. Toxicol.19:505–511.
250.
Pennanen, S., K. Tuovinen, H. Huuskonen, V M., Kosma, and H. Komulainen.1993.Effects of 2-ethylhexanoic acid on reproduction and postnatal development in Wistar rats.Fundam. Appl. Toxicol.21:204–212.
251.
Pradhan, M. 2002. Letter with independent toxicologist's evaluation of toxicological data, exposure levels, and assessment to Dr. F. Alan Andersen, dated April 11, 2002.
252.
Ritter, E. J., W. J. Scott, Jr., J. L. Randall, and J. M. Rittter.1987.Teratogenicity of di(2-ethylhexyl) phthalate, 2-ethylhexanol, 2-ethylhexanoic acid, and valp roic acid, and potentiation by caffeine.Teratology35:41–46.
253.
Scott, W J., Jr., M. S. Collins, and H. Nau.1994.Pharmacokinetic determinants of embryotoxicity in rats associated with organic acids.Environ. Health Perspect.102:97–101.
254.
Shell Oil Company. 1992a. Initial submission: Two-week oral (dietary administration) toxicity study of 2-ethylhexanoic acid in the mouse (Final Report) with cover letter dated 041792. NTIS Report No. OTS0539188.
255.
Shell Oil Company. 1992b. Initial submission: Two-week oral toxicity study of 2-ethylhexanoic acid in the rat (Final Report) with cover letter dated 041792. NTIS Report No. OTS0539183.
256.
Sipi, P., H. Jarventaus, and H. Norppa.1992.Sister-chromatid exchanges induced by vinyl esters and respective carboxylic acids in cultured human lymphocytes.Mutat. Res.279:75–82.
257.
Union Carbide Corporation. 1992a. Initial Submission: Letter from Union Carbide Corp. to USEPA submitting information on the enclosed 90 day (dietary administration) toxicity study of 2-ethylhexanoic acid in the rat and mouse. NTIS Report No. OTS0543763.
258.
Union Carbide Corporation. 1992b. Initial Submission: Letter from Union Carbide Corp. submitting two developmental toxicity studies with 2-ethylhexanoic acid in rats and rabbits with attachments. NTIS Report No. OTS0539327.
259.
Wil Research Laboratories, Inc. 2001. A dietary two-generation reproductive toxicity study of di-2-ethylhexyl terephthalate in rats. Final Report. Unpublished data submitted by the American Chemistry Council. 3250 pages.
260.
Al varado, R., M. Dickens, M. Klausner, K. Renskers, and M. Stern.1998.Evaluation of the EpiOcular(tm) tissue model as an alternative to the Draize eye irritation test.Toxicol. In Vitro12:455–461.
261.
Andersen, F. A., ed. 1997. Final report on the safety assessment of cetylesters. Int.]. Toxicol. 16:123-130.
262.
Bagheri, D., B. W. Blake, K. Enslein, V. K. Gombar, J. J. Hostynek, H. I. Maibach, and C. C. Sigman.1997.A quantitative structure-toxicity relationships model for the dermal sensitization guinea pig maximization assay.Food Chem. Toxicol.35:1091–1098.
263.
Basketter, D. A., M. Chamberlain, H. A. Griffiths, M. Rowson, E. Whittle, and M. York.1997.The classification of skin irritants by human patch test.Food Chem. Toxicol.35:845–852.
264.
Blevins, R. D., and D. E. Taylor.1982.Mutagenicity screening of twenty-five cosmetic ingredients with the Salmoneila/microsome test.J. Environ. Sei. Health A17:217–239.
265.
Blum, R. P., A. Dingier, S. Gohla, R. H. Müller, and H. Niehus.1999.Solidlipid nanoparticles (SLN/Lipopearls)-a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.J. Microencapsul.16:751–767.
266.
Brabec, V., and V. Sebestik.1983.Experimental elimination of the splenic function by ethyl and methyl palmitate and significance of these substances from an immunological point of view.Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch.110:917–923.
267.
Conte, A., C. Coviello, F Rantuccio, A. Scardigno, and D. Sinisi.1984.His-tological changes in rabbits after application of medicaments and cosmetic bases (III).Contact Dermatitis10:212–219.
268.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2001. Concentrations of use of Stearates. Unpublished data submitted by CTFA.
269.
Dreher, F., P. Eisner, P. L. Luisi, and P. Walde.1996.Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes.Skin Pharmacol.9:124–129.
270.
Dreher, F., P. Walde, P. Walther, and E. Wehrli.1997.Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport.J. Controlled Release45:131–140.
271.
Elder, R. L., ed. 1982a. Final report on the safety assessment of octyl palmitate, cetyl palmitate, and isopropyl palmitate. J. Am. Col. Toxicol. 1:13-35.
272.
Elder, R. L., ed. 1982b. Final report on the safety assessment of myristyl myris-tate and isopropyl myristate. J. Am. Col. Toxicol. 1:55-80.
273.
Elder, R. L., ed. 1985. Final report on the safety assessment of butyl Stearate, cetyl Stearate, isobutyl Stearate, isocetyl Stearate, isopropyl Stearate, myristyl Stearate, and octyl Stearate. J. Am. Col. Toxicol. 4:107-146.
274.
Finn, M. D., E. D. Schneiderman, and S. R. Schow.1992.Osseous regeneration in the presence of four common hemostatic agents.J. Oral Maxillofac. Surg.50:608–612.
275.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
276.
Fulton, J. E., Jr., J. E. Fulton 3rd, and S. R. Pay.1984.Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear.J. Am. Acad. Dermatol.10: 96–105.
277.
Hahn, H., U. Katzfey, O. Liesenfeld, R. H. Müller, N. Scholer, and E. Zimmermann.2000.Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages.Int. J. Pharm.196:235–239.
278.
Hansen, E., P. Liu, J. Nightingale, and J. Sclafani.1997.Effect of water on a new binary transdermal flux enhancer (Peg3-Me): In vitro evaluation using estradiol.Drug Dev. Ind. Pharm.23:9–14.
279.
Jung, S., S. Kang, J. Kim, and M. Park.1999.Skin organ culture for cutaneous irritancy screening.In Vitro Mol. Toxicol.12:77–82.
280.
Klykken, P. C, and K. L. White. Jr.1996.The adjuvancy of silicones: Dependency on compartmentalization.Curr. Top. Microbiol Immunol.210:113–121.
281.
Lazzarini, S.1982.Contact allergy to benzyl alcohol and isopropyl palmitate, ingredients of topical corticosteroid.Contact Dermatitis8:349–350.
282.
Opdyke, D. L.1981.Monographs on fragrance raw materials.Food Cosmet Toxicol.19:237–254.
283.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen. Jr., eds. 2000.International Cosmetic Ingredient Dictionary and Handbook, 8th ed., 254, 532, 722. Washington, DC: CTFA.
284.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Use concentrati on data on choleth-24 from in dustry survey. Unpublished data submitted by CTFA, April 2001. 2 pages.
285.
Dimitrijevic, D., C. Lamandin, I. F Uchegbu, A. J. Shaw, and A. T. Florence.1997.The effect of monomers and of micellar and vesicular forms of non-ionic surfactants (Solulan C24 and Solulan 16) on Caco-2 cell monolayers.J. Pharm. Pharmacol.49:611–616.
286.
Dimitrijevic, D., A. J. Shaw, and A. T. Florence.2000.Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.J. Pharm. Pharmacol.52:157–162.
287.
Drewe, J., G. Fricker, J. Vonderscher, and C. Beglinger.1993.Enterai absorption of octreotide: Absorption enhancement by polyoxyethylene-24-cholesterol ether.Br. J. Pharmacol.108:298–303.
288.
Elder, R. L., ed. 1982. Final report on the safety assessment of choleth-24. J. Am. Col. Toxicol. 1:119-126.
289.
Ennis, R. D., L. Borden, and W. A. Lee.1993.The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: A scanning electron microscopy study.Pharm. Res.7:468–475.
290.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
291.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
292.
Franz, J. M., and J. P. Vonderscher.1981.Enhancement of the intestinal absorption of ergot peptide alkaloids in the rat by micellar solutions of polyoxyethylene-24-cholesteryl ether.J. Pharm. Pharmacol.33:565–568. 'Available from the Director, Cosmetic Ingredient Review, 1101 17th Street, NW, Suite 310, Washington, DC 20036, USA.
293.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen, Jr., eds. 2002.International Cosmetic Ingredient Dictionary and Handbook, 9th ed., 328. Washington, DC: CTFA.
294.
Robinson, C. J., S. G. Shirley, and G. H. Dodd.1989.The detergent Solulan C-24 reveals properties of the olfactory adenylate cyclase system.Biochem. J.260:683–688.
295.
Tasset, C, F. Goethals, V. Preat, and M. Roland.1990.Effect of poly-oxyethyleneglycol (24) cholesterol on the solubility, toxicity, and activity of amphotericin B.Int. J. Pharm.58:41–48.
296.
Tasset, C, V. Preat, A. Bernard, and M. Roland.1992.Comparison of nephro-toxicities of different polyoxyethylene formulations of amphotericin B in rats.Antimicrob Agents Chemother.36:1525–1531.
297.
Uchegbu, I. F., J. A. Double, J. A. Turton, and A. T. Florence.1995.Distribution, metabolism, and tumoricidal activity of doxorubicin administered in sorbi—tan monostearate (Span 60) niosomes in the mouse.Pharm. Res.12:1019–1024.
298.
Uchegbu, I. F, and R. Duncan.1997.Niosomes containing (2-hydroxy-propyl)methacrylamide copolymer-doxorubicin (PK1): Effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution.Int. J. Pharm.155:7–17.
299.
Viernstein, H., B. Gottwald, and A. Wottawa. 1987. The mutagenic potential of sterol ethers. Oesterr Forschungszent Seibersdorg Report No. OEFZS-4388:1-10.
300.
Werner, U., T. Kissel, and M. Reers.1996.Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2).Pharm. Res.13:1219–1227.
301.
Agarwal, D. K., W. H. Lawrence, L. J. Nunez, and J. Autian.1985.Mutagenicity evaluation of phthalic acid esters and metabolites in Salmonella Typhimurium cultures.J. Toxicology Em/iron. Health16:61–69.
302.
Agency for Toxic Substances and Disease Registry. 1995. Toxicological profile for diethyl phthalate. NTIS Report No. PB95264214.
303.
Albro, P. W.1986.Absorption, metabolism, and excretion of di(2-ethylhexyl)phthalate by rats and mice.Em/iron. Health Perspect.65:293–298.
304.
Anderson, W. A., L. Castle, M. J. Scotter, R. C. Massey, and C. Springall.2001.A biomarker approach to measure human dietary exposure to certain phthalate diesters.Food Addit. Comtam.18:1068–1074.
305.
Api, A. M.1997.In vitro assessment of phototoxicity.In Vitro Toxicol.10:339–350.
306.
Api, A. M.2001.Toxicological profile of diethyl phthalate: A vehicle for fragrance and cosmetic ingredients.Food Chem. News.39:97–108.
307.
Bagley, D. M., J. R. Garner, G. Holland, R. W. Lewis, J.-F. Régnier, D. A. Stringer, and A. P. Walker.1996.Skin irritation: Reference chemicals data bank.Toxicol. In Vitro.10:1–6.
308.
Barber, E. D., M. Cifone, J. Rundell, R. Pryzgoda, B. D. Astill, E. Moran, A. Mulholland, E. Robinson, and B. Schneider.2000.Results of the L5178Y mouse lymphoma assay and the Balb/3T3 cell in vitro transformation assay for eight phthalate esters.J. Appl. Toxicol.20:69–80.
309.
Baskin, L. S., K. Himes, and T. Colborn.2001.Hypospadias and endocrine disruption: Is ther e a connection?Environ. Health Perspect.109:1175–1183.
310.
BASF, no date. Di-n-butyl phthalate-subacute inhalation study in Wistar rats. 20 exposures as a liquid aerosol. Unpublished data submitted by Phthalate Esters Panel, American Chemistry Council. 57 pages.
311.
BASF. 1992. Study on the oral toxicity of dibutyl phthalate in Wistar rats. Administration via the diet over 3 months. Unpublished data submitted by Phthalate Esters Panel, American Chemistry Council. 369 pages.
312.
BASF. 1999. Di-n-butyl phthalate-subacute inhalation study in Wistar rats. 20 exposures as a liquid aerosol. Unpublished data submitted by Phthalate Esters Panel, American Chemistry Council. 189 pages.
313.
Blair, R. M., H. Fang, W. S. Branham, B. S. Hass, S. L. Dial, C. L. Moland, W Tong, L. Shi, R. Perkins, and D. M. Sheehan.2000.The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands.Toxicol. Sei.45:138–153.
314.
Blount, B. C., M. J. Silva, S. P. Caudill, et al. 2000.Levels of seven urinary phthalate metabolites in a human reference population.Environ. Health Perspect.108:979–982.
315.
Bower, D. 1999. Unpublished information on hair spray particle size provided at the September 9, 1999 CIR Expert Panel meeting.
316.
Brock, J. W, S. P. Caudill, M. J. Silva, L. L. Needham, and E. D. Hilborn.2002.Phthalate monoesters levels in the urine of young children.Bull. Environ. Contam. Toxicol.68:309–314.
317.
Butala, J., M. Moore, M. Cifone, J. Bankston, and B. Astill.1996.Oncogenicity study of di(isononyl) phthalate in rats.Toxicologist.30:202.
318.
Butala, J., M. Moore, M. Cifone, J. Bankston, and B. Astill.1997.Oncogenicity study of di(isononyl) phthalate in mice.Toxicologist36:173.
319.
Castle, L., A. Mercer, J. R. Startin, and J. Gilbert.1988. Migration from plasticized films into foods 3. Migration of phthalate, sebacate, citrate and phosphate esters from films used for retail food packaging.Food Addit. Contami.5:9–20.
320.
Centers for Disease Control and Prevention. 2003. Second national report on human exposure to environmental chemicals. Available at http://www. cdc.gov/exposurereport/pdf/SecondNER.pdf
321.
Chu-Tse, W, P. Xue-Tao, C. Jun-Rong, and X. Hui-Hua.1993.A new pharmacological activity of dibutyl phthalate (dbp) on selective elimination of tumor cells from bone marrow.Leukemia Res.177:557–560.
322.
Colón, A., D. Caro, C. J. Bourdony, and O. Rosario.2000.Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development.Em/iron. Health Perspect.1089:895–900.
323.
Consumer Product testing. 1978a. Oral LD50 (rat) study no. 78-032. Unpublished data submitted by CTFA. 13 pages.
324.
Consumer Product testing. 1978b. Dermal LD50 (rat) study no. 78-033. Unpublished data submitted by CTFA. 13 pages.
325.
Consumer Product testing. 1978c. Guinea pig sensitization study no. 78-034. Unpublished data submitted by CTFA. 13 pages.
326.
Cosmetic, Toiletry, and Fragrance Administration (CTFA). 2001a. Unpublished data regarding current concentrations of cosmetic uses of Dibutyl Phthalate. January 4, 2001. 2 pages.
327.
CTFA. 2001b. Unpublished data regarding current concentrations of cosmetic uses of Dibutyl Phthalate. April 20, 2001. 2 pages.
328.
CTFA. 2001c. Unpublished data regarding current concentrations of cosmetic uses of Dimethyl and Diethyl Phthalate. October 18, 2001. 2 pages.
329.
CTFA. 2001d. Unpublished data available on the CTFA International Cosmetic Legal & Regulatory Database Global Ingredient Search.
330.
CTFA. 2002a. Unpublished data regarding physical properties of dibutyl phthalate. Submitted August 30, 2002. 3 pages.
331.
CTFA. 2002b. Unpublished data regarding average hairspray and perfume use. June 26, 2002. 3 pages.
332.
Cummings, A. M., and L. E. Gray.1987.Dibutyl Phthalate: Maternal effects versus fetotoxicity.Toxicol. Lett.39:43–50.
333.
David. R., M. Moore, M. Cifone, D. Finney, and D. Guest.1999.Chronic per-oxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery.Toxicol. Sei.50:195–205.
334.
David, R. M.2000.Exposure to phthalate esters.Environ. Health Perspect.108:A440.
335.
Dirven, H., P. H. H. Vandenbroek, A. M. M. Arends, H. H. Nordkamp, A. Delepper, P. T. Henderson, and F. J. Jongeneelen.1993.Metabolites of the plasticizer di(2-ethylhexyl)phthalate in urine samples of workers in Polyvinylchloride processing industries.Int. Arch. Occup. Environ. Health64:549–554.
336.
Duty, S. M., N. P. Singh, M. J. Silva, D. B. Barr, J. W. Brock, L. Ryan, R. F. Herrick, D. C. Christiani, and R. Hunter.2002.The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay.Environ. Health Perspect. available at http://dx.doi.Org/doi:10.1289/ehp.5756.
337.
E. I. du Pont de Nemours and Company. 1946. Possibility of dermatitis from dimethyl phthalate when used as an insect repellant. Unpublished data collected Haskell Laboratory of Industrial Toxicology and submitted by Phthalate Esters Panel, American Chemical Council. 2 pages.
338.
E. I. du Pont de Nemours and Company. 1970. Skin primary irritation and sensitization test on guinea pigs. Unpublished data collected Haskell Laboratory for Toxicology and Industrial Medicine and submitted by Phthalate Esters Panel, American Chemical Council. 2 pages.
339.
E. I. du Pont de Nemours and Company. 1974. Dimethyl phthalate. Unpublished data collected Haskell Laboratory for Toxicology and Industrial Medicine and submitted by Phthalate Esters Panel, American Chemical Council. 2 pages.
340.
Elder, R. L., ed. 1985. Final report on the safety assessment of Dibutyl Phthalate, Dimethyl Phthalate, and Diethyl Phthalate. J. Am. Col. Toxicol. 4:267-303.
341.
Elsisi, A. E., D. E. Carter, and I. G. Sipes.1989.Dermal absorption of phthalate diester in rats.Fundam. Appl. Toxic.12:70–77.
342.
Ema, M., H. Amano, T. Itami, and H. Kawasaki.1993.Teratogenic evaluation of di-n-butyl phthalate in rats.Toxicol. Lett.69:197–203.
343.
Ema, M., H. Amano, and Y. Ogawa.1994.Characterization of the developmental toxicity of di-n-butyl phthalate in rats.Toxicology86:163–174.
344.
Ema, M., A. Harazono, E. Miyawaki, and Y. Ogawa.1997a.Developmental effects of di-n-butyl phthalate after a single administration in rats.J. Appl. Toxicol.17:223–229.
345.
Ema, M., A. Harazono, E. Miyawaki, and Y Ogawa.1997b.Embryolethality following maternal exposure to dibutyl phthalate during early pregnancy in rats.Bull. Environ. Contam. Toxicol.58:636–643.
346.
Ema, M., R. Kurosaka, H. Amano, and Y Ogawa.1995a.Comparative developmental toxicity of n-butyl benzyl phthalate and di-n-butyl phthalate in rats.Arch. Environ. Contam. Toxicol.28:223–228.
347.
Ema, M., R. Kurosaka, H. Amano, and Y Ogawa.1995b.Developmental toxicity evaluation of mono-n-butyl phthalate in rats.Toxicology Lett.78:101–106.
348.
Ema, M., R. Kurosaka, A. Harazono, H. Amano, and Y Ogawa.1996.Phase specificity of developmental toxicity after oral administration of mono-n-butyl phthalate in rats.Arch. Environ. Contam. Toxicol.31:170–176.
349.
Ema, M., and E. Miyawaki.2001a.Adverse effects on development of the reproductive system in male offspring given monobutyl phthalate, a metabolite of dibutyl phthalate, during late pregnancy.Reprod. Toxicol.15:189–194.
350.
Ema, M., and E. Miyawaki.2001b.Effects of monobutyl phthalate on reproductive function in pregnant and pseudopregnant rats.Reprod. Toxicol.15:261–267.
351.
Ema, M., E. Miyawaki, and K. Kawashima.1998.Further evaluation of developmental toxicity of di-n-butyl phthalate following administration during late pregnancy in rats.Toxicol. Lett.98:87–93.
352.
Ema, M., E. Miyawaki, and K. Kawashima.2000a.Critical period for adverse effects on development of reproductive system in male offspring of rats given di-n-butyl phthalate during late pregnancy.Toxicol. Lett.Ill:271–278.
353.
Ema, M., E. Miyawaki, and K. Kawashima.2000b.Effects of dibutyl phthalate on reproductive function in pregnant and pseudopregnant rats.Reprod. Toxicol.14:13–19.
354.
Environ Corporation. 1984. Summary of the Results of Surveys of the Amount and Frequency of Use of Cosmetic Products by Women. Unpublished report submitted by CTFA. 7 pages.
355.
Environment Canada. 1994. Canadian environmental protection act priority substances list assessment report: dibutyl phthalate. NTIS Report No. PB94169059.
356.
Epstein, W. L. 1978. Human sensitization study of diethyl phthalate. Unpublished data submitted by CTFA. 4 pages.
357.
Essex Testing Clinic, Inc. 1989. Clinical safety evaluation of diethyl phthalate in repeated insult patch test, with cover letter dated 05/09/94 (sanitized). NTIS Report No. OTS0557309.
358.
Essex Testing Clinic, Inc. 1990. Final report, clinical safety evaluation of test article diethyl phthalate control (neat); repeated insult patch test with cover letter dated 05/09/94 (sanitized). NTIS Report No. OTS0557311.
359.
European Commission. 2002. The rules governing cosmetic products in the European Union. Volume 1. Cosmetics legislation-Cosmetic products. Accessed April 22, 2002. http://dg3.eudra.org/F3/home.html.
360.
Field, E. A., C. J. Price, R. S. Sleet, J. D. George, M. C. Marr, C. B. Myers, B. A. Schwetz, and R. E. Morrissey.1993.Developmental Toxicity evaluation of diethyl and dimethyl phthalate in rats.Teratology.48:33–44.
361.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
362.
Foster, P. M., M. W Cook, L. V. Thomas, D. G. Walters, and S. D. Gangolli.1983.Differences in urinary metabolic profile from di-n-butyl phthalate-treated rats and hamsters. A possible explanation for species differences in susceptibility to testicular atrophy.Drug Metab. Dispos.11:59–61.
363.
Foster, P. M. D., R. C. Cattley, and E. Mylchreest.2000.Effects of di-n-butyl phthalate (DBP) on male reproductive development in the rat: Implications for human risk assessment.Food Chem. Toxicol.38:S97–S99.
364.
Fredricsson, B., L. Möller, A. Pousette, and R. Westerholm.1993.Human sperm motility is affected by plasticizers and diesel particle extracts.Pharmacol. Toxicol.72:128–133.
365.
Fukuoka, M., T. Kobayashi, Y Zhou, and T. Hayakawa.1993.Mechanism of testicular atrophy introduced by di-n-butyl phthalate in rats. Part 4. Changes in the activity of succinate dehydrogenase and the levels of trans-ferrin and ferritin in the Sertoli and germ cells.J. Appl. Toxicol.13:241–246.
366.
Fukuoka, M., S. Nhmi, Y Zhou, T. Kobayashi, and T. Hayakawa.1996.Responsiveness of rat nonparenchymal liver cells and spleen cells to the decomposition of erythrocytes exposed to di-n-butyl phthalate and its metabolite.Biol. Pharm. Bull.19:1154–1159.
367.
Fukuoka, M., T. Tanimoto, Y. Zhou, N. Kawasaki, and A. Tanaka.1989.Mechanism of testicular atrophy by di-n-butyl phthalate in rats. Part 1.J. Appl. Toxicol.9:277–283.
368.
Fukuoka, M., Y. Zhou, A. Tanaka, I. Ikemoto, and T. Machida.1990.Mechanism of testicular atrophy induced by di-n-butyl phthalate in rats. Part 2. The effects on some testicular enzymes.J. Appl. Toxicol.10:285–293.
369.
Gall, H., A. Köhler, and R. U. Peter.1999.Anaphylactic shock reaction to dibutyl-phthalate-containing capsules.Dermatology.199:169–170.
370.
Gray, T. J. B., I. R. Rowland, P. M. D. Foster, and S. D. Gangolli.1982.Species differences in the testicular toxicity of phthalate esters.Toxicology Lett.11:141–147.
371.
Gray, L. E., J. Ostby, J. Furr, M. Price, D. N. Veeramachaneni, and L. Parks.2000.Perinatal exposure of the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat.Toxicol. Sei.58:350–365.
372.
Gray, L. E., C. Wolf, C. Lambright, et al. 1999.Administration of potentially an-tiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, ?,?'- DDE, and ketoconazole) and toxic substances (dibutyl-and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat.Toxicol. Ind. Health15:94–118.
373.
Hall, M., A. Mathews, L. Webley, and R. Harling.1999.Effects of diisononyl phthalate (DINP) on peroxisomal markers in the marmoset-DINP is not a peroxisome proliferator.J. Toxicol. Sei.24:237–244.
374.
Hansen, E., and O. Meyer.1989.No embryotoxic or teratogenic effect of dimethyl phthalate in rats after epicutaneous application.Pharmacol. Toxicol.64:237–238.
375.
Harris, C. A., P. Henttu, M. G. Parker, and J. P. Sumpter.1997.The estro-genic activity of phthalate estersinvitro. Environ. Health Perspect.105:802–811.
376.
Harrison Research Laboratories. 1998. Repeated insult patch test (RIPT) on a nail enamel. Unpublished data submitted by CTFA. 13 pages.
377.
Hill Top Research, Inc. 1968. Primary irritation patch test on 3239K. Unpublished data submitted by CTFA. 13 pages.
378.
Hill Top Research, Inc. 1971. Repeated insult patch test of group number 69, A-40-DIETPH. Unpublished data submitted by CTFA. 11 pages.
379.
Hill Top Research, Inc. 1998. Evaluation of phototoxicity in humans. HTR project no. 101649. Unpublished data submitted by CTFA. 56 pages.
380.
Hill Top Research, Inc. 1999. Evaluation of phototoxicity in humans. HTR project no. 100688. Unpublished data submitted by CTFA. 62 pages.
381.
Hill Top Research, Ltd. 1997a. Evaluation of human photoallergy by repeated insult patch test. Project no. 97-4182-74. Unpublished data submitted by CTFA. 58 pages.
382.
Hill Top Research, Ltd. 1997b. Evaluation of human photoallergy by repeated insult patch test. Project no. 97-4193-74. Unpublished data submitted by CTFA. 84 pages.
383.
Hoppin, J. A., J. W. Brock, B. J. Davis, and D. D. Baird.2002.Reproducibility of urinary phthalate metabolites in first morning urine samples.Environ. Health Perspect.110:515–518.
384.
Houlihan, J., C. Brody, and B. Schwan. 2002. Not too pretty. Phthalates, beauty products & the FDA. Unplublished report released by Environmental Working Group, Coming Clean, and Health Care Without Harm. Available at http://www.nottoopretty.org
385.
Imajima, T, T. Shono, O. Zakaria, and S. Suita.1997.Prenatal phthalate causes cryptorchidism postnatally by inducing transabdominal ascent of the testes in fetal rats.J. Pediatr. Surg.32:18–21.
386.
Inveresk Research International. 1990. 2 weeks dermal dose range finding study in rats. Unpublished data submitted by CTFA. 652 pages.
387.
Ivy Research Laboratories. 1973. The primary irritation potential of one fragrance material in six different vehicle formulations. Unpublished data submitted by CTFA. 5 pages.
388.
Ivy Research Laboratories. 1984. The determination of the contact-sensitizing potential of four materials by means of the maximization study. Unpublished data submitted by CTFA. 4 pages.
389.
Jackson Research Associates. 2002. Analysis of the Subungual Penetration of 100% Dibutyl Phthalate (DBP) in Human Fingernails. Unpublished report submitted by the American Beauty Association, 10-25-02.
390.
Japanese Plasticizer Industrial Association. 1997. Evaluation of estrogen activity of phthalate esters by receptor-binding test (Study no. 6L471). Unpublished data submitted by Phthalate Esters Panel, American Chemistry Council. 59 pages.
391.
Japanese Plasticizer Industrial Association. 1998. Evaluation of estrogen activity and mechanism of action of DBP and DEHP by in vivo assay using rats (Study no.: 7L432). Unpublished data submitted by Phthalate Esters Panel, American Chemistry Council. 27 pages.
392.
Jensen, P. A., and O'Brien, D.1993.Industrial Hygiene. In Aerosol measurement, principles techniques and applications, ed. K. Willeke and P. A. Baron. New York: John Wiley and Sons.
393.
Jones, H. B., D. A. Garside, R. Liu, and J. C. Roberts.1993.The influence of phthalate esters on Leydig cell structure and function in vitro and in vivo.Exp. Molecul. Pathol.58:179–193.
394.
Jury, H. H., T. R. Zacharewski, and G. L. Hammond.2000.Interaction between human plasma sex hormone-binding globulin and xenobiotic ligands.J. Steroid Biochem. Mol. Biol.75:167–176.
395.
Kageyama, K., Y Onoyama, T. Nakajima, S. Otani, I. Yano, H. Hotta, I. Matsui-Yuasa, H. Kogawa, and N. Miwa.1994.DNA synthesis inhibition and trans-membrane permeation into tumor cells by various dialkyl phthalates upon hyperthermia.Anticancer Res.14:2769–2772.
396.
Kanerva, L., R. Jolanki, K. Alanko, and T. Estlander.1999.Patch-test reactions to plastic and glue allergens.Acta. Derm. Venereal.79:296–300.
397.
Kanerva, L., R. Jolanki, and T. Esterlander.1997.Allergic and irritant patch test reactions to plastic and glue allergens.Contact Dermatitis.37:301–302.
398.
Karmin, M. A., and G. H. Mayor.1991.Diethyl phthalate: A perspective. J.Clin. Pharmacol.31:484–489.
399.
Kavlock, R., K. Boekelheide, R. Chapín, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams, and T. Zacharewski.2002.NTP Center for the Evaluation of Risks to Human Reproduction: Phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate.Reprod. Toxicol.16:489–527.
400.
Khaliq, M. A., M. S. Alam, and S. P. Srivastava.1992.Implications of physico-chemical factors on the migration of phthalate esters from tubing commonly used for oral/nasal feeding.Bull Environ Toxicol.48:572–578.
401.
Kim, S. H., S. S. Kim, O. Kwon, K. H. Sohn, et al. 2002.Effects of dibutyl phthalate and monobutyl phthalate on cytotoxicity and differentiation in cultured rat embryonic limb bud cells; protection by antioxidants.Toxicol. Environ. Health.65:461–472.
402.
Kleinsasser, N. H., E. R. Kastenbauer, H. Weissacher, R. K. Muezenrieder, and U. A. Harréus.2000.Phthalates demonstrate genotoxicity on human mucosa of the upper aerodigestive tract.Environ. Mol. Mutagen.35:9–12.
403.
Kluwe, W. M.1982.Overview of phthalate ester phamacokinetics in mammalian species.Environ. Health Perspect.45:3–10.
404.
Kohn, M. C, F Parham, S. A. Masten, C. J. Portier, M. D. Shelby, J. W. Brock, and L. L. Needham.2000.Human exposure estimates for phthalates.Environ. Health Perspect.108:A440–A442.
405.
Koo, J. W, F Parham, M. C. Kohn, S. A. Masten, J. W Brock, L. L. Needham, and C. J. Portier.2002.The association between biomarker based exposure estimates for phthalates and demographic factors in a human reference population.Environ. Health Perspect.110:405–410.
406.
Kozombo, W J., R. Kroll, and R. J. Rubin.1982.Assessment of the mutagenicity of phthalate esters.Environ. Health Perspect.45:103–109.
407.
Kurata, Y, F Kidachi, M. Yokoyama, N. Toyota, M. Tsuchitani, and M. Katoh.1998.Subchronic toxicity of di(2-ethylhexyl) phthalate in common marmosets: Lack of peroxisomal proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia.Toxicol. Sei.42:49–56.
408.
Lamb, J. C, R. E. Chapín, J. Teague, A. D. Lawton, and J. R. Reel.1987.Reproductive effects of four phthalic acid esters in the mouse.Toxicol. Appl. Pharmacol.88:255–269.
409.
Lamb, J. C, J. Reel, and A. D. Lawton.1997a.Diethylphthalate.Em/iron. Health Perspect.105:245–246.
410.
Lamb, J. C, J. Reel, and A. D. Lawton.1997b.Di-n-butylphthalate, mice.Environ. Health Perspect.105:247–248.
411.
Leberco Laboratories. 1963. Rabbit eye irritation study of 12.5% diethyl phtha-late. Unpublished data submitted by CTFA. 5 pages.
412.
Lington, A., M. Bird, R. Plutnick, W. Stubblefield, and R. Scala.1997.Chronic toxicity and carcinogenic evaluation of di-isononylphthalate in rats.Fundam. Appl. Toxicol.36:79–89.
413.
Lisheng, W., W. Chutse, R Xuetao, et al. 1996a.Dibutyl phthalate purged autol-ogous bone marrow transplant in the treatment of leukemia.Leukemia Rese.20:343–348.
414.
Lisheng, W., W. Chutse, P. Xuetao, X. Li, C. Jurong, and H. Fuchu.1996b.Purging effect of dibutyl phthalate on leukemic cells associated with apoptosis.Leukemia Res.20:989–992.
415.
Liss, G. M., P. W. Albro, R. W. Hartle, and W. T. Stringer.1985.Urine phthalate determinations as an index of occupational exposure to phthalic anhydride and di(2-ethylhexyl)phthalate.Scand. J. Work Environ. Health.11:381–387.
416.
Lovekamp, T. N., and B. J. Davis.2001.Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estrodiol production in cultured rat granulosa cells.Toxicol. Appl. Pharmacol.172:217–224.
417.
Lygre, H., E. Solheim, and N. R. Gjerdet.1995.Leaching from denture base materialsin vitro. Acta Odontol. Scand.53:75–80.
418.
McKee, R. H.2000.The role of inhibition of gap junction intercellular communication in rodent liver tumor induction by phthalates: Review of data on selected phthalates and their potential relevance to man.Regula. Toxicol. Pharmacol.32:51–55.
419.
Melnick, R. L., and C. M. Schiller.1985.Effect of phthalate esters on energy coupling and succinate oxidation in rat liver mitochondria.Toxicology34:13–27.
420.
Milligan, S. R., A. V. Balasubramanian, and J. C. Kalita.1998a.Relative potency of xenobiotic estrogens in an active in vivo mammalian assay.Environ. Health Perspect.106:23–26.
421.
Milligan, S. R., O. Khan, and M. Nash.1998b.Competitive binding of xenobiotic oestrogens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma.Gen. Comp. Endocrinol.112:89–95.
422.
Ministry of Health, Labor and Welfare. 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumgaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
423.
Ministry of Health, Labor and Welfare. 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chôme, Kasumgaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
424.
Mint, A., S. A. M. Hotchkiss, and J. Caldwell.1994.Percutaneous absorption of diethyl phthalate through rat and human skinin vitro. Toxicol. In Vitro.8:251–256.
425.
Monsanto Europe. No date. Study to evaluate the effect of monobutyl phthalate on uterine growth in immature female rats after oral administration. Unpub lished data submitted by Phthalate Esters Panel, American Chemistry Council. 16 pages.
426.
Moura, C, M. Dias, and T. Vale.1994.Contact dermatitis in painters, polishers and varnishers.Contact Dermatitis.31:51–52.
427.
Murakami, K., K. Nishiyama, and T. Higuti.1986a.Mitochondria effect of orally administered dibutyl phthalate in rats.Jpn. J. Hyg.41:769–774.
428.
Murakami, K., K. N ishiyama, and T. Higuti.1986b.Toxicity of dibutyl phthalate and its metabolites in rats.Jap. J. Hyg.41:775–781.
429.
Murature, D. A., S. Y. Tang, G. Steinhardt, and R. C. Dougherty.1987.Phthalate esters and semen quality parameters.Biomed. Environ. Mass Spectrom.14:473–477.
430.
Mylchreest, E., R. C. Cattley, and P. M. D. Foster.1998.Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: An androgenic mechanism?Toxicol. Sei.43:47–60.
431.
Mylchreest, E., M. Sar, R. C. Cattley, and P. M. D. Foster.1999.Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide.Toxicol. Appl. Pharmacol.156:81–95.
432.
Mylchreest, E., M. Sar, D. G. Wallace, and P. M. Foster.2002.Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-buytl) phthalate.Reprod. Toxicol.16:19–28.
433.
Mylchreest, E., D. G. Wallace, R. C. Cattley, and P. M. D. Foster.2000.Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-butyl) phthalate during late gestation.Toxicol. Sei.55:143–151.
434.
Nail Manufacturers Council (NMC). 2001. Letter from NMC including ingredient use product type and concentration survey. Unpublished data submitted by NMC of May 7, 2001. 4 pages.
435.
National Toxicology Program (NTP). 1991. Final report: On the reproductive toxicity of di-n-butyl phthalate (CAS No. 84-72-2) in Sprague-Dawley rats. NTIS Report No. PB92111996.
436.
NTP. 1995a. NTP technical report on toxicity studies of dibutyl phthalate (CAS No. 84-74-2) administered in feed to F34 4/N rats and B6C3F1 mice. NTIS Report No. PB95232427.
437.
NTP. 1995b. Toxicology and carconigenesis studies of diethylphthalate in F344/n rats and B6C3F1 mice with dermal initiation/promotion study of di-ethylphth alate and dimethylphthalate in male Swiss (CD-I) mice. Unpublished data submitted by Phthalate Esters Panel, American Chemistry Council. 278 pages.
438.
Netherlands Organization for Applied Scientific Research and National Institute of Public health and the Environment. 2001. Risk assessment, dibutylphtha-late. Unpublished data submitted by CTFA. 183 pages.
439.
Ohtani, H., I. Miura, and Y. Ichikawa.2000.Effects of dibutyl phthalate as an environmental endocrine disruptor on gona dal sex differentiation of genetic males of the frog Rana rugosa.Environ. Health Perspect.108:1189–1193.
440.
Ow, R. K. K. and S. Amrith.1997.Ocular prosthetics: Use of a tissue conditioner material to modify a stock ocular prosthesis.J. Prosthet. Dentistry.78:218–222.
441.
Paganet, G., F Campi, K. Varani, A. Piffanelli, G. Giovannini, and P. A. Borea.2000.Endocrine-distrupting agents on healthy human tissues.Pharmacol. Toxicol.86:24–29.
442.
Page, B. D., and G. M. Lacroix.1992.Studies into the transfer and migration of phthalate esters from aluminum foil-paper laminates to butter and margerine.Food Add. Contami.9:197–212.
443.
Payan, J. P., J. P. Marty, J. P. Fabry, D. Beydon, I. Boudry, E. Ferrari, F Canel, M. C. Grandclaude, and C. M. Vincent.2001.In vivo and in vitro percutaneous absorption of [14C]di-n-butylphthalate in rat.Drug Metab. Distrib.29:843–854.
444.
Peakall, D. B.1975.Phthalate esters: occurrence and biological effects.Residue Rev.54:1–41.
445.
Pfordt, J., and E. Bruns-Weller. 1999. Phthalate esters as a group of environmental chemicals with an endocrine disruption potential. Lower Saxony Ministry of Food, Agriculture and Forestry: Hamburg. Unpublished data submitted by the Phthalate Esters Panel, American Chemistry Council. 53 pages.
446.
Phthalate Esters Panel, American Chemistry Council. 1982a. Toxicity tests of dibutyl phthalate, dibutyl isophthalate, and dibutyl terephthalate. Unpublished data submitted by the Phthalate Esters Panel, American Chemistry Council. 5 pages.
447.
Phthalate Esters Panel, American Chemistry Council. 1982b. 28-day subacute percutaneous toxicity SL: VE-1005-20, SR: TGSE 1037, P75-006. Unpublished data submitted by the Phthalate Esters Panel, American Chemistry Council. 10 pages.
448.
Phthalate Esters Panel, American Chemistry Council. 1999. Di-n-butylphthalate (DBP). Unpublished data submitted by the Phthalate Esters Panel, American Chemistry Council. 42 pages.
449.
Plasterer, M. R., W. S. Bradshaw, G. M. Booth, M. W. Carter, R. L. Schüler, and B. D. Hardin.1985.Developmental toxicity of nine selected compounds following prenatal exposure in the mouse: Napthalene, p-nitrophenol, sodium selenate, dimethyl phthalate, ethylenethiourea, and four glycol ether derivatives.J. Toxicol. Environ. Health15:25–38.
450.
Proctor & Gamble Co. 1984. Teratogenicity study of E-2426.01 (diethyl phthalate) by dermal application to rabbits with cover letter dated 05/02/94. NTIS Report No. OTS0572465.
451.
Pugh, G., J. Isenberg, L. Kamendulis, L. Clare, W. Brown, A. Lington, D. Ackley, J. Smith, and J. Klaunig.2000.Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys.Toxicol Sei.56:181–188.
452.
Research Triangle Institute. 1995. The toxicokinetics and metabolism of di-n-butyl phthalate. Unpublished data submitted by CTFA. 58 pages.
453.
Research Institute for Fragrance Materials (RIFM). 1984. Acute dermal irritation study. RIFM 1795. Unpublished data submitted by CTFA. 13 pages.
454.
RIFM. 1984. Acute dermal irritation study. RIFM 3099. Unpublished data submitted by CTFA. 13 pages.
455.
Saillenfait, A. M., J. P. Payan, J. P. Fabry, et al. 1998.Assessment of the developmental toxicity, metabolism, and placental transfer of di-n-butyl phthalate administered to pregnant rats.Toxicol. Sei.45:212–224.
456.
Saillenfaint, A. M., I. Langonné, and B. Leheup.2001.Effects of mono-n-butyl phthalate on the development of rat embryos : in vivo and in vitro observations.Pharmacol. Toxicol.89:104–112.
457.
Schreck, C. E.1991.Permethrin and dimethyl phthalate as tent fabric treatments againstAedes aegypti. J. Am. Mosquito Control Assoc.7:533–535.
458.
Sciences International, Inc. 1995. Toxicological profile for diethyl phthalate. Unpublished data submitted by CTFA on August 30, 2002. 3 pages.
459.
Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP). 2002. Opinion of the scientific committee on cosmetic products and non-food products intended for consumers concerning diethyl phthalate. Unpublished data submitted by CTFA. 36 pages.
460.
Scott, R. C, P. H. Dugard, J. D. Ramsey, and C. Rhodes.1987.In vitro absorption of some o-phthalate diesters through human and rat skin.Environ. Health Perspect.74:223–227.
461.
Selene, C. H., J. Chou, J. Holler, and C. De Rosa.1998.Minimal risk levels (MRLs) for hazardous substances.J. Clean Technol. Environ. Toxicol. Occup. Med.7:1–24.
462.
Shultz, V. D., S. Phillips, M. Sar, P. M. D. Foster, and K. W. Gaido.2001.Altered gene profiles in fetal rats after in utero exposure to di(n-butyl) phthalate.Toxicol. Sei.64:233–242.
463.
Small, L. D., E. O. Dillingham, and J. Autian. 1973. Tissue distribution and excretion of diethyl phthalate following percutaneous administration to female albino rats. Unpublished data submitted by CTFA. 23 pages.
464.
Sonde, V., A. D'souza, R. Tarapore, L. Pereira, M. P. Khare, P. Sinkar, S. Krishnan, and C. V. Rao.2000.Simultaneous administration of diethylphth alate and ethyl alcohol and its toxicity in male Sprague-Dawley rats.Toxicology.147:23–31.
465.
Srivastava, S., G. B. Singh, S. P. Srivastava, and P. K. Seth.1990a.Testicular toxicity of di-n-butyl phthalate in adult rats: Effect on marker enzymes of spermatogenesis.Ind. J. Exp. Biol.28:67–70.
466.
Srivastava, S. P., S. Srivastava, D. K. Saxena, S. V. Chandra, and P. K. Seth.1990b.Testicular effects of di-n-butyl phthalate (DBP): Biochemical and histopatho-logical alterations.Arch. Toxicol.64:148–152.
467.
Tarvainen, K.1995.Analysis of patients with allergic patch test reactions to a plastics and glues series.Contact Dermatitis32:346–351.
468.
Tavares, I. A., and N. D. Vine.1985.Phthalic acid esters inhibit arachido-nate metabolism by rat peritoneal leucocytes.J. Pharm. Pharmacol.37:67–68.
469.
Tokunaga, H., Y. Ching, T. Uchino, and M. Ando.2001. Studies of diethyl phthalate on in vitro percutaneous permeation.J. Soc. Cosmet. Chem. Jpn.35:312–316.
470.
Unilever. 1999. Diethyl phthalate: assessment for oestrogenic potentia 1. Unpublished data submitted by CTFA. 126 pages.
471.
US Environmental Protection Agency. 1994a. Final report, clinical safety evaluation of test article diethyl phthalate control (neat); repeated insult patch test, with cover letter dated 05/09/94 (sanitized). NTIS No. OTS0557311.
472.
US Environmental Protection Agency. 1994b. Final report, clinical safety evaluation of test article diethyl phthalate in repeated insult patch test, with cover letter dated 05/09/94 (sanitized). NTIS No. OTS0557309.
473.
Van Beek. L. 1974. Primary skin irritation and eye irritation tests with a perfume concentrate. Unpublished data submitted by CTFA. 9 pages.
474.
Waliszewski, St. M., and G. A. Szymczynski.1989.Determination of phthalate esters in human semen.Andrologia229:69–73.
475.
Walseth, F and O. G. Nilsen.1984.Phthalate esters: II. Effects of inhaled dibutyl phthalate on cytochrome P-450 mediated metabolism in rat liver and lung.Arch. Toxicol.55:132–136.
476.
Walseth, F, and O. G. Nilsen.1986.Phthalate esters: Effects of orally administered dibutylphthalate on cytoch rome P-450 mediated metabolism in rat liver and lung.Acta Pharmacol. Toxicol.59:263–269.
477.
White, R. D., D. L. Earnest, and D. E. Carter.1983.The effect of intestinal esterase inhibition on the in vivo absorption and toxicity of di-n-butyl phthalate.Food Chem. Toxicol.21:99–101.
478.
Wilkinson, S. M., and M. H. Bech.1992.Allergic contact dermatitis from dibutyl phthalate, propylgallate and hydrocortisone in Timodine .Contact Dermatitis27:197.
479.
Williams, D. T, and B. J. Blanchfield.1975.The retention, distribution, excretion, and metabolism of dibutyl phthalate-7-14C in the rat.J. Agrie. Food Chem.23:854–858.
480.
Wine, R. N., L. H. Li, L. H. Barnes, D. K. Gulati, and R. E. Chapín.1997.Reproductive toxicity of di-n-butylphthalate in a continuous breeding protocol in Sprague-Dawley rats.Environ. Health Perspect.105:102–107.
481.
Zacharewski, T. R., M. D. Meek, J. H. demons, Z. F Wu., M. R. Fieldon, and J. B. Mathews.1998.Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.Toxicol. Sei.46:282–293.
482.
Zhou, Y., M. Fukuoka, and A. Tanaka.1990.Mechanism of testicular atrophy induced by di-n-butyl phthalate in rats. Part 3. Changes in the activity of some enzymes in the Sertoli and germ cells, and in the levels of metal ions.J. Appl. Toxicol.10:447–453.
483.
CTFA. 2003. Concentrations of use-dimethicone copolyols. Unpublished data submitted by CTFA on February 6, 2003.
484.
DiSapio, A. J. and M. S. Starch.1981.New silicone emulsifier technology.Cosmet. Toiletries96:55–57.
485.
Elder, R. L.1982.Final report on the safety assessment of dimethicone copolyol.J. Am. Col. Toxicol.1:33–54.
486.
FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
487.
National Industrial Chemical Notification and Assessment Scheme (NICNAS). 1997. Full Public Report: Abmil EM90. Unpublished data available at the URL http://www.nicnas.gov.au/publications/CAR/new/NA/NAFULLR/ NA0400FR/NA460FR.pdf
488.
Pepe, R. L., J. A. Wenninger, and G. N. McEwen, Jr. eds. 2002.International cosmetic ingredient dictionary and handbook, 9th ed.Washington, DC: Cosmetic, Toiletry, and Fragrance Association.
489.
Starch, M., and C. De Vries.1986.Dimethicone copolyol compounds and their contribution to diminish irritating effects on the rabbit eye.Parfuem. Kosmet.67:148, 151–152, 154.
490.
Wendel, S. R., and A. J. DiSapio.1983.Organofunctional silicones for personal care applcations.Cosmet. Toiletries98:103–106.
491.
Yahagi, K.1992.Silicones as conditioning agents in shampoos.J. Soc. Cosmet. Chem.43:275–284.
492.
Astill, B. D., R. Gingell, D. Guest, et al. 1996.Oncogenicity Testing of 2-Ethylhexanol in Fischer 344 Rats and B6 C3F1 Mice.Fundam. Appl. Toxicol.31:29–41.
493.
Bell, F. R1983.Effect of the plasticizer di(2-ethylhexyl) adipate (dioctyladipate, DOA) on lipid metabolism in the rat: I. Inhibition of cholesterolgenesis and modification of phospholipid synthesis.Lipids18:211–215.
494.
Bell, F. P.1984.Di(2-ethylhexyl)adipate (DEHA): effect on plasma lipids and hepatic cholesterolgenesis in the rat.Bull. Environ. Contam. Toxicol.32:20–26.
495.
Bergman, K., and L. Albanus.1987.Di-(2-ethylhexyl)adipate: Absorption, au-toradiographic distribution and elimination in mice and rats.Food Chem. Toxicol.25:309–316.
496.
Bower, D. 1999. Unpublished information on hair spray particle sizes provided at the September 9, 1999 CIR Expert Panel meeting.
497.
British Industrial Biological Research Association. 1985. Rat liver and lipid effects of representative phthalate esters. NTIS Report No. OTS0509538.
498.
Busser M. T., and W. K. Lutz.1987.Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters.Carcinogenesis8:1433–1437.
499.
Chemical Manufacturer Association. 1989. A study of the hepatic effects of di-(2-ethylhexyl)adipate in the mouse and rat with appendices and cover letter dated 11/17/89. NTIS Report No. OTS0000731. Available from Director, Cosmetic Ingredient Review, 1101 17th Street NW, Suite 310, Washington, DC 20036, USA.
500.
Cornu, M. C, Y. Keith, C. R. Elcombe, and J. C. Lhuguenot.1988.In Vivo and In Vitro Metabolism of Di-(2-ethylhexyl) Adipate, a Peroxisome Proliferator, in the Rat.Arch. Toxicol. Suppl. 12 Target Organ. Toxic. Process.265–268.
501.
Cornu, M. C, J. C. Lhuguenot, A. M. Brady, R. Moore, and C. R. Elcombe.1992.Identification of the proximate peroxisome prolif erator(s) derived from di (2-ethylhexyl) adipate and species differences in response.Biochem. Pharmacol.43:2129–2134.
502.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2003. Unpublished data regarding current concentrations of cosmetic uses of Diethylhexyl Adipate and Diisopropyl Adipate.
503.
Dalgaard, M., H. Ulla, A. M. Vinggaard, et al. 2003.Di(2-ethylhexyl)adipate (DEHA) induced developmental toxicity but not antiandrogenic effects in pre-and postnatally exposed Wistar rats.Reprod. Toxicol.17:163–170.
504.
Divincenzo, G. D., W. H. Donish, K. R. Mueller, M. L. Hamilton, and E. D. Barber.1983.Mutagenicity testing of urine from rats dosed with 2-ethylhexanol derived plasticizers.Em/iron, mutagen.5:471.
505.
Dirven, H. A., R H. van den Broek, J. G. Peters, J. Noordhoek, and F. J. Jongeneelen.1992.Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.Biochem. Pharmacol.43:2621–2629.
506.
Eastman Kodak Co. 1984. Bacterial mutagenicity testing of urine fromrats dosed with 2-ethylhexanol derived plasticizers. NTIS Report No. OTS0206391.
507.
Eastman Kodak Co. 1992. Submission summary: Synopsis of teratology study in rats (final report) using di(2-ethylhexyl)adipate with cover letter dated 091391. NTIS Report No. OTS0533689-1.
508.
Elder, R. L., ed. 1984. Final report on the safety assessment of dioctyl adipate and diisopropyl adipate. J. Am. Col. Toxicol. 2:101-130.
509.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
510.
Gupta, B. N., and A. K. Mathur.1985.Effect of dermal application of a skin barrier cream on skin enzymes in rabbits and guinea-pigs.Biol. Membrane11:157–160.
511.
Gupta, B. N., R. Shanker, P. N. Viswanath, A. K. Mathur, L. Shukla, and A. Singh.1987.Safety evaluation of a barrier cream.Contact Dermatitis17:10–12.
512.
International Agency for Research on Cancer (IARC). 2000. Di(2-ethylhexyl) adipate entry. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 77:149-175.
513.
Jensen P. A., and D. Obrien.1993.Industrial Hygiene. In Aerosol measurement. Principles techniques and applications, ed. K. Will eke and P. A. Baron, 538–540. New York: John Wiley and Sons.
514.
Katch, H., S. Nakajima, Y Kawashima, H. Kozuka, and M. Uchiyama.1984.Induction of rat hepatic long-chain acyl-CoA hydrolases by various peroxisome proliferators.Biochem. Pharmacol.33:1081–1085.
515.
Kawashima, Y, N. Hanioka, M. Matsumura, and H. Kozuka.1983a.Induction of microsomal stearoyl-CoA desaturation by the administration of various peroxisome proliferators.Biochim. Biophys. Acta752:259–264.
516.
Kawashima, Y, S. Nakagawa, Y Tachibana, and H. Kozuka.1983b.Effects of peroxisome proliferators on fatty acid-binding protein in rat liver.Biochim. Biophys. Acta754:21–27.
517.
Keith, Y, M. C. Cornu, P. M. Canning, J. Foster, J. C. Lhuguenot, and C. R. Elcombe.1992.Peroxisome proliferation due to di(2-ethylhexyl) adipate, 2-ethylhexanol and 2-ethylhexanoic acid.Arch. Toxicol.66:321–326.
518.
Kluwe, W M.1986.Carcinogenic potential of phthalic acid esters and related compounds: Structure-activity relationships.Environ. Health Perspect.65:271–278.
519.
Kluwe, W M., J. E. Huff, H. B. Matthews, R. Irwin, and J. K. Haseman.1985.Comparative chronic toxicities and carcinogenic potentials of 2-ethylhexyl-containing compounds in rats and mice.Carcinogenesis6:1577–1583.
520.
Kolmar Research Center. 1984. Toxicological examination of di-a-ethyl-hexyl-adipate (wickenol 158). NTIS Report No. OTS0000286-1.
521.
Korhonen, A., K. Hemminki, and H. Vainio.1983.Embryotoxic effects of phthalic acid derivatives, phosphates and aromatic oils used in the manufacturing of rubber on three day chicken embryos.Drug Chem. Toxicol.6:191–207.
522.
Lake, B. G., R. J. Price, M. E. Cunninghame, and D. G. Walters.1997.Comparison of the effects of di-(2-ethylhexyl)adipate on hepatic peroxisome proliferation and cell replication in the rat and mouse.Toxicology123:217–226.
523.
Litton Bionetics, Inc. 1984. Evaluation of di-2-ethylhexyl-adipate in the in vitro transformation of balb/3t3 cells assay. NTIS Report No. OTS0000286-0.
524.
Litton Bionetics, Inc. 1989. Mutagenicity evaluation of di-2-ethyl hexyl adipate in the Ames Salmoneila/microsome plate test (final report) with attachments, cover sheet and letter dated 06/06/89. NTIS Report No. OTS0520392.
525.
Litton Bionetics, Inc. 2000. Evaluation of di-2-ethylhexyl-adipate in the in vitro transformation of balb/3t3 cells assay addendum to the final report of September 1982. Contract no. Pe-140-mut-lb. NTIS Report No. OTS0508486.
526.
Loftus, N. J., W. J. Laird, G. T. Steel, M. F Wilks, and B. H. Woollen.1993.Metabolism and pharmacokinetics of deuterium-labelled di-2-(ethylhexyl) adipate(DEHA) in humans.Food Chem. Toxicol.31:609–614.
527.
Loftus, N. J., B. H. Woollen, G. T. Steel, M. F Wilks, and L. Castle.1994.An assessment of the dietary uptake of di-2-(ethylhexyl)adipate (DEHA) in a limited population study.Food Chem. Toxicol.32:1–5.
528.
Microbiological Assc. 1984. Submission of unpublished balb/3t3 cell transformation assays on Di-2-ethylhexyl adipate with attached reports. NTIS Report No. 0000286-0.
529.
National Toxicology Program (NTP) 1984. Carcinogenesis bioassay of di(2-ethylhexyl) adipate (cas no. 103-23-l)F344 rats and B6C3fl mice (feed study). NTIS Report No. OTS0000286-0.
530.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen, Jr., eds. 2002.International Cosmetic Ingredient Dictionary and Handbook, 8th ed., vol. 1. Washington, DC: CTFA.
531.
Registry of Toxic Effects of Chemical Substances (RTECS). 1997. Diisopropyl Adipate entry. RTECS database. Bethesda, MD: National Library of Medicine.
532.
Registry of Toxic Effects of Chemical Substances (RTECS). 1999. Diethylhexyl Adipate entry. RTECS database. Bethesda, MD: National Library of Medicine.
533.
Reisenbichler, H., and P. M. Eckl.1993.Genotoxic effects of selected peroxisome proliferators.Mutat. Res.286:135–144.
534.
Rhodes, C, T. Soames, M. D. Stonard, M. G. Simpson, A. J. Vernall, and C. R. Elcombe.1984.The absence of testicular atrophy and in vivo and in vitro effects on hepatocyte morphology and peroxisomal enzyme activities in male rats following the administration of several alkanols.Toxicol. Lett.21:103–109.
535.
Takagi, A., K. Sai, T. Umemura, R. Hasegawa, and Y. Kurokawa.1990.Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate.Jpn. J. Cancer Res.81:213–215.
536.
Takahashi, K., H. Sakano, N. Numata, S. Kuroda, and N. Mizuno.2002.Effect of fatty acid diesters on permeation of anti-inflammatory drugs through rat skin.Drug Dev. Ind. Pharm.28:1285–1294.
537.
Takahashi, K., T. Suzuki, H. Sakano, and N. Mizuno.1995.Effect of vehicles on diclofenac permeation across excised rat skin.Biol. Pharm. Bull.18:571–575.
538.
Tomaszewski, K. E., D. K. Agarwal, and R. L. Melnick.1986.In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.Carcinogenesis7:1871–1876.
539.
von Daniken, A., W K. Lutz, R. Jackh, and C. Schlatter.1984.Investigation of the potential for binding of Di(2-ethylhexyl)phthalate (DEHP) and Di(2-ethylhexyl)adipate (DEHA) to liver DNA in vivo.Toxicol. Appl. Pharmacol.73:373–387.
540.
Yanagita, T, M. Satoh, H. Nomura, N. Enomot, and M. Sugano.1987.Alteration of hepatic phospholipids in rats and mice by feeding di-(2-ethylhexyl)adipate and di-(2-ethylhexyl)phthalate.Lipids22:572–577.
541.
Zeiger, E., S. Haworth, K. Mortelmans, and W. Speck.1985.Mutagenicity testing of di(2-ethylhexyl)phthalate and related chemicals inSalmonella. Environ. Mutagen.7:213–232.
542.
Bogdanov, S., V. Kilchenmann, and A. Imdorf.1998.Agaricide residues in some bee products.J. Apicul. Res.37:57–67.
543.
Brusick, D.1976.Mutagenic evaluation of compound FDA 75-43, MX8006-44-8 candelilla wax, L. F. refined. Project No. 2468, Litton Bionetics, Inc. (Cited in FAO and WHO, 1993.)
544.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2003. Unpublished data regarding current concentrations of cosmetic uses of Euphorbia Cerífera (Candelilla) Wax, Copernica Cerífera (Carnauba) Wax, Rhus Succedanea Fruit Wax, and Beeswax.
545.
Elder, R. L., ed. 1984. Final report on the safety assessment of Candelilla Wax, Carnauba Wax, Japan Wax, and Beeswax. J. Am. Col. Toxicol. 3:1-41.
546.
FAO and WHO. 1993a. Beeswax. WHO food additive series. Pages 230-234.
547.
FAO and WHO. 1993b. Candelilla wax. WHO food additives series. Pages 235-243.
548.
FASEB. 1975. Evaluation of the health aspects of beeswax (yellow or white) as a food ingredient. Federation of American Societies for Experimental Biology. Prepared for FDA. Contract No. FDA 223-75-2004. Unpublished report. (Cited in FAO and WHO, 1993a.)
549.
FASEB. 1981. Evaluation of the health aspects of candelilla wax as a food ingredient. Federaton of American Societies for Experimental Biology. Prepared for FDA, Contract No. FDA 223-78-210. Unpublished report. (Cited in FAO and WHO, 1993b.)
550.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients FDA Database. Washington, DC: FDA.
551.
Garcia, M., M. D. del Pozo, J. Diez, D. Munoz, and L. F. de Corres.1995.Allergic contact dermatitis from a beeswax nipple-protective.Contact Dermatitis33:440–441.
552.
Harrisson, J. W E. 1946. Product No. 12, type III GRS. Rubber and candelilla wax. Report No. 36731. LaWall and Harrisson, Consultants, Unpublished report. (Cited in FAO and WHO, 1993b.)
553.
Harrisson, J. W E. 1948. Product No. 16, 50/50 mixture candelilla wax and haveatex (Styrene and Butadiene) Polymer N-1017. Report 38222. LaWall and Harrisson, Consultants. Unpublished report. (Cited in FAO and WHO, 1993b.)
554.
Harrisson, J. W. E. 1953. Long-term safety studies. Resume of studies on young dogs and albino rats. LaWall and Harrisson, Consultants. Unpublished report. (Cited in FAO and WHO, 1993b.)
555.
Hodge, H. C. 1973. A critical review at the 1) Feeding studies of candelilla wax incorporated in gum base, 2) together with studies of the possible carcinogenic potential by other routes of administration. University of California, San Francisco. (Cited in FAO and WHO, 1993b.)
556.
Lucente, P., M. Cavalli, C. Vezzani, C. Orlandi, and C. Vincenzi.1996.Contact cheilitis due to beeswax.Contact Dermatitis35:258.
557.
Mortelmans, K. E., and S. L. Eckford. 1979. Microbial mutagenesis testing of substances compound report: F76-048, candelilla wax. Final Report, Project No. LSU-6909. SRI International. (Cited in FAO and WHO, 1993b.)
558.
Nakamura, T.1985.Contact dermatitis to Rhus succedanea.Contact Dermatitis12:279.
559.
Privai, M. J., V. F. Simmon, and K. E. Mortelmans.1991.Bacterial mutagenicity testing of 49 food ingredients gives very few positive results.Mutat. Res.260:321–329.
560.
Rivera, R. F, J. O. Moffett, and R. L. Cox.1987.Menthol residues in honey beeswax and honey bees.Am. Bee J.127:850.
561.
Rowland, I. R., K. R. Butterworth, I. F. Gaunt, P. Grasso, and S. D. Gangolli.1982.Short-term toxicity study of carnauba (Copernica cerífera) wax in rats.Food Chem. Toxicol.20:467–472.
562.
Valsecchi, R., and T. Cainelli.1984.Dermatits from propolis.Contact Dermatitis11:317.
563.
Van Ketel, W G., and D. P. Bruynzeel.1992.Occupational dermatitis in an accordion repairer.Contact Dermatitis27:186.
564.
American Conference of Governmental Industrial Hygienists (ACGIH). 2000. 2000 TLSs and BEIs. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH: ACGIH.
565.
Avis, S. P., and J. T. Archibald.1994.Asphyxiai suicide by propane inhalation and plastic bag suffocation.J. Forensic Sei.39:253–256.
566.
Bowen, S. E., J. Daniel, and R. L. Balster.1999.Deaths associated with inhalant abuse in Virginia from 1987 to 1996.Drug Alcohol Dépendance.53:239–245.
567.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Concentration of use-isobutane, isopentane, propane, and butane. Unpublished data submitted by CTFA on February 15, 2002.
568.
Elder, R. L.1982.Final report of the safety assessment of isobutane, isopentane, n-butane and propane.J. Am. Col. Toxicol.1:127–142.
569.
Food and Drug Administration (FDA). 1976. Cosmetic product formulation data. FDA database. Washington, DC: FDA.
570.
FDA. 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
571.
Hartop, P. J., T. L. Cook, and M. G. Adams.Simulated consumer exposure to dimethyl ether and propane/butane in hairsprays.Inti. J. Cosmet. Sei.13:161–167.
572.
McLennan, J. J., A. Sekula-Perlman, M. B. Lippstone, and R. T. Callery.Propane-associated autoerotic fatalities. Am. J. Forensic Med. Pathol.19:381–386.
573.
American Pertoleum Institute. 1984. Thirteen week inhalation toxicity study of C4/C5 hydrocarbon blends in rats with 2 cover letters dated 10/30/84 and 11/08/84. NTIS Report No. OTS0000332-1.
574.
Rohrig, T. P.1997.Sudden death due to butane inhalation.Am. J. Forensic Med. Pathol.18:299–302.
575.
Siegel, E., and S. Wason.1990.Sudden death caused by inhalation of butane and propane.N. Engl. J. Med.232:1838.
576.
Stewart, R. D., A. A. Hermann, E. D. Baretta, H. V. Forster, J. J. Sikora, P. E. Newton, and R. J. Soto.1977.Acute and repetitive human exposure to isobu—tane.Scand. J. Environ. Health3:234–243.
577.
Stewart, R. D., P. E. Newton, E. D. Baretta, A. A. Hermann, H. V. Forster, and R. J. Soto.1978.Physiological response to aerosol propellants.Environ. Health Perspect.26:275–285.
578.
Aungst, B. J.1989.Structure-effect studies of fatty acid isomers as skin penetration enhancers and skin irritants.Pharm. Res.6:244–247.
579.
Bagley, D. M., J. R. Gardner, G. Holland, R. W. Lewis, J. F. Régnier, D. A. Stringer, and A. P. Walker.1996.Skin irritation: Reference chemicals data bank.Toxicol. In Vitro10:1–16.
580.
Bagley, D. M., J. R. Gardner, G. Holland, R. W. Lewis, H. Vrijhof, and A. P. Walker.1999.Eye irritation: Updated reference chemicals databank.Toxicol. In Vitro13:505–510.
581.
Chollet, J. L., E. S. Goebl, C. S. Moeckly, and K. R. Phares.1997.The effect of temperature on the solubility of imiquimod in isostearic acid.Pharmaceut. Res.14:S483.
582.
Chollet, J. L., M. J. Jozwiakowski, K. R. Phares, M. J. Reiter, P. J. Roddy, H. J. Shultz, Q. V. Ta, and M. A. Tomai.1999.Development of a topically active imiquimod formulation.Pharm. Dev. Technol.4:35–43.
583.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Concentration of use of Isostearic Acid in cosmetic products. Unpublished data submitted by CTFA.
584.
Elder, R. L., ed. 1983. Final report on the Safety Assessment of Isostearic Acid. J. Am. Col. Toxicol. 1:1-23.
585.
Elmaleh, D. R., E. Livini, S. Levy, D. Varnum, H. W Strauss, and G. L. Brownell.1983.Comparison of 11C and 14C-labeled fatty acids and their beta-methyl analogs.Int. J. Nucl. Med. Biol.10:181–187.
586.
Fentem, J. H., G. E. B. Archer, M. Balls, P. A. Bontham, R. D. Curren, L. K. Earl, D. J. Esdaile, H.-G. Holzhutter, and M. Liebsch.1998.The ECVAM International Validation Study on in vitro tests for skin corrosivity. 2. Results and evaluation by management team.Toxicol. In Vitro12:483–524.
587.
FDA. 2002. Cosmetic product formulation data. FDA database. Washington, DC: FDA. Kawaji, T, and M. Yamaji. 2001. Oily patches for external use containing di-clofenac sodium. US Patent 6262121.
588.
Kubota, K., T. Takahashi, T. Fujiwara, S. Yamada, T. Sato, R. Kubota, R. Iwata, K. Ishiwata, T. Ido, and T. Matsuzawa.1991.Possibility for tumor detection with fatty acid analogs.Int. J. Rad. Appl. Instrum. B18:191–195.
589.
Nadathur, S. R., J. R. Carney, S. J. Gould, and A. T. Bakalinsky.1996.Palmitic acid is the major fatty acid responsible for significant anti-N-methyl-N-nitro-N-nitroguanidine (MNNG) activity in yogurt.Mutat. Res.359:179–189.
590.
Roehl, E. L., P. J. Sakers, and H. M. Brand.1989.Isostearic acid and its derivatives as new raw materials in cosmetics.Parfuem. Kosmet.70:140–144.
591.
Roehl, E. L., P. J. Sakers, and H. M. Brand.1990.Isostearic acid and isosteric acid derivatives.Cosmet Toiletries105:79–87.
592.
Suhaimi, H., F B. Ahmad, and S. E. Friberg.1995.Curcumin in a model skin lotion formulation.J. Pharm. Sei.84:376–380.
593.
Suzuki, K., K. Nagao, J. Tokunaga, N. Katayama, and M. Uyeda.1996.Inhibition of DNA methyltransferase by microbial inhibitors and fatty acids.J. Enzyme Inhib.10:271–280.
594.
Takahashi, K., T. Suzuki, H. Sakano, and N. Mizuno.1995.Effect of vehicles on diclofenac permeation across excised rat skin.Biol. Pharmaceu. Bull.18:571–575.
595.
Whitehouse, M. W1982.Rat polyarthritis: Induction with adjuvants constituted with mycobacteria (and oils) from the environment.J. Rheumatol.9:494–501.
596.
Worth, A. P., and M. T. D. Cronin.2001.The use of pH measurements to predict the potential of chemicals to cause acute dermal and ocular toxicity.Toxicology169:119–131.
597.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2001. Concentration of Use-Laneth-10 Acetate, Laneth-9 Acetate, Laneth-5, Laneth-16, and Laneth-25. Unpublished data submitted by CTFA on December 11, 2001.
598.
Elder, R. L.1982.Final report on the Safety Assessment of Laneth-10 Acetate Group.J. Am. Col. Toxicol.1:1–23.
599.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
600.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen, Jr., eds. 2000.International cosmetic ingredient dictionary and handbook, 8th ed., vol. 1., 132. Washington, DC: CTFA.
601.
Aungst, B. J., and N. J. Rogers.1988.Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and bucea insulin delivery.Pharm. Res.5:305–308.
602.
Bakale, G., and R. D. McCreary.1992.Response to the ke test to NCI-screened chemicals: II. Genotoxic carcinogens and non-genotoxic non-carcinogens.Carcinogenesis13:1437–1445.
603.
Beissert, S., D. Presser, A. Rutter, D. Metze, T. A. Luger, and T. Schwarz.1999.Embolia cutis medicamentosa (Nicolau syndrome) after intra-articular injection.Hautarzt50:214–216.
604.
Benea, G., R. Galeotti, S. Tartari, and P. Mannella.1988.Percutaneous therapy of primary varicocele. 6 years' experience.Radiol. Med.76:458–465.
605.
Banque de Données Automatisée sur les Médicaments (BIAM). 2002. Donnez-nous votre avis. Lauromacrogol 400. http://www.biam2.org/www/ Subl333.html
606.
Bergh, M., L. P. Shao, G. Hagelthorn, et al. 1998.Contact allergens from surfactants. Atmospheric oxidation of polyoxyethylene alcohols, formation of ethoxylated aldehydes, and their allergenic activity.J. Pharm. Sei.87:276–282.
607.
Brand, N., G. Mailhot, and M. Boite.2000.The interaction “light, Fe(III)” as a tool for pollutant removal in aqueous solution: Degradation of alcohol ethoxylates.Chemosphere40:395–401.
608.
Carlin, M. C, and J. L. Ratz.1987.Treatment of telangiectasia: Comparison of sclerosing agents.J. Dermatol. Surg. Oncol.13:1181–1184.
609.
Cook, L., and B. Ternai.1988.Deleterious effect of Brij 35 on alkyl 2-pyrones and other hydrophobic inhibitors of human sputum and leucocyte elastase.Biochem. Int.17:637–646.
610.
Cosmetic Physicians Society of Australasia. 2002. Sclerotherapy for veins. The technique of sclerotherapy for treating veins. http://www.cosmeticphysicians. org.au/Sclerotherapy.htm
611.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Use concentration data on laureth-4 and laureth-23 from industry survey. Unpublished data submitted by CTFA, June 26, 2002. 2 pages.
612.
Donovan, M. D., G. L. Flynn, and G. L. Amidon.1990.The molecular weight dependence of nasal absorption: The effect of absorption enhancers.Pharm. Res.7:808–815.
613.
Elder R. L., ed. 1983. Final report on the safety assessment of laureths-4 and-23. J. Am. Col. Toxicol. 2:1-15.
614.
Feied, C. F, J. J. Jackson, T. S. Bren, et al. 1994.Allergic reactions to polidocanol for vein sclerosis. Two case reports.J. Dermatol. Surg. Oncol.20:466–468.
615.
Food and Drug Administration (FDA). 1992. Import alert IA6649. Automatic detention of polidocanol, also known as aetoxisclerol 0.5% and aethoxysklerol injection 1% and 3%. http://www.fda.gov/ora/fiars/oraJmportJa6649.html
616.
FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
617.
Foureman, P., J. M. Mason, R. Valencia, and S. Zimmering.1994.Chemical mutagenesis testing in Drosophila: X. Results of 70 coded chemicals tested for the National Toxicology Program.Environ. Mol. Mutagen.23:208–227.
618.
Frosch, P. J., and A. Schulze-Dirks.1989.Contact allergy caused by polidocanol (thesit).Hautarzt40:146–149.
619.
Frullini, A., and A. Cavezzi.2002.Sclerosing foam in the treatment of varicose veins and telangiectases: History and analysis of safety and complications.Dermatol. Surg.28:11–15.
620.
Gallo, R., M. Basso, S. Voltolini, and M. Guarrera.2001.Allergic contact dermatitis from laureth-9 and polyquaternium-7 in a skin-care product.Contact Dermatitis45:356–357.
621.
Georgiev, M.1993.Postsclerotherapy hyperpigmentations. Chromated glycerin as a screen for patients at risk (a retrospective study).J. Dermatol. Surg. Oncol.19:649–652.
622.
Geukens, J., E. Rabe, and T. Bieber.1999.Embolia cutis medicamentosa of the foot after sclerotherapy.Eur. J. Dermatol.9:132–133.
623.
Goldman, M. P.2002.Treatment of varicose and telangiectatic leg veins : Double-blind prospective comparative trial between aethoxyskerol and sotradecol.Dermatol. Surg.28:52–55.
624.
Goossens, A., M. H. Beck, E. Haneke, et al. 1999.Adverse cutaneous reactions to cosmetic allergens.Contact Dermatitis40:112–113.
625.
Guex, J. J.1993.Indications for the sclerosing agent polidocanol (aetoxisclerol dexo, aethoxisklerol kreussler).J. Dermatol. Surg. Oncol.19:959–961.
626.
Hamann, K., P. S. Skov, and C. Avnstorp.1981.Aethoxysklerol. A histamine liberator?Ugeskr. Laeger.143:822–823.
627.
Hayakawa, E., A. Yamamoto, Y. Shoji, and V. H. Lee.1989.Effect of sodium glycocholate and polyoxyethylene-9-lauryl ether on the hydrolysis of varying concentrations of insulin in the nasal homogenates of the albino rabbit.Life Sei.45:167–174.
628.
Ikeda, T., K. Ninomiya, K. Sugi, et al. 1993.An experimental study on transcoro-nary chemical ablation: Comparison of ventricular tachyarrhythmias induced by chemical ablation according to different chemical materials. Kokyu To Junkan41:459–462.
629.
Imperiali, G., V. Terruzzi, D. Spotti, and G. Minoli.1986.Heart failure as a side effect of polidocanol given for oesophageal variceal sclerosis.Endoscopy18:207.
630.
Institut Fresnius. 2002. Polidocanol. http://enius.de/schadstoffe/polidocanol. html
631.
Jaganathan, L., and R. Boopathy.1998.Interaction of Triton X-100 with acyl pocket of butyrylcholinesterase: Effect on esterase activity and inhibitor sensitivity of the enzyme.Indian J. Biochem. Biophys.35:142–147.
632.
Jain, R., S. Bandhu, S. Sawhney, and R. Mittal.2002.Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.J. Clin. Ultrasound30:416–423.
633.
James, M. P., and H. Grech.2002.Subclinical, primary antiphospholipid syndrome unmasked by sclerotherapy.Br. J. Dermatol.146:527–528.
634.
Kerr, D. J., T. E. Wheldon, J. G. Russell, et al. 1987.The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systems.Eur. J. Cancer Clin. Oncol.23:1315–1322.
635.
Kimura, M., and A. Kawada.2000.Follicular contact dermatitis due to polyoxyethylene laurylether.J. Am. Acad. Dermatol.42:879–880.
636.
Kojima, H., A. Hanamura, S. Miyamoto, A. Sato, H. Konishi, and I. Yoshimura.1995.Evaluation of seven alternative assays on the main ingredients in cosmetics as predictors of Draize eye irritation scores.Toxicology In Vitro9:333–340.
637.
Li, G. L., R. van der Geest, L. Chanet, et al. 2002.In vitro iontophoresis across human stratum corneum. Structure-transport relationship of penetration enhancement.J. Control Release84:49–57.
638.
Loveday, K. S., B. E. Anderson, M. A. Resnick, and E. Zeiger.1990.Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. 5. Results with 46 chemicals.Environ. Mol. Mutagen.16:272–303.
639.
Macias Rodriguez, M. A., M. J. Soria de la Cruz, M. Iglesias Arrabal, and L. Martin Herrera.1992.Esophageal carcinoma after the endoscopie sclerotherapy of varices.Rev. Esp. Enferm. Dig.82:43–46.
640.
Matthews, E. J., J. W. Spalding, and R. W. Tennant.1993.Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity rodent bioassays.Environ. Health Perspect.101(Suppl. 2):347–482.
641.
Meissner, K., and B. Jirikowski.1993.Stomach wall slough and ulcer perforation following endoscopie injection hemostasis with polidocanol.Endoscopy25:185–187.
642.
Merenciano Cortina, F J., W. Rafie Mazketli, M. Amat Cecilia, and P. Romero Perez.2001.Sclerotherapy of hydrocele and cord cyst with polidocanol. Efficiency study.Acta Urol. Esp.25:704–709.
643.
Metz, K. A., J. Erhard, E. Gross, and K. Donhuijsen.1986.Effect of various sclerosing drugs on the rat esophagus. Z.Gastroenterol.24:605–611.
644.
Ministry of Health, Labor and Welfare (MHLW). June 2001. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restri ctedlist]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
645.
Myhr, B. C, and W J. Caspary.1991.Chemical mutagenesis at the thymi-dine kinase locus in L5178Y mouse lymphoma cells: Results for 31 coded compounds in the National Toxicology Program.Em/iron. Mol. Mutagen.18:51–83.
646.
National Toxicology Program (NTP). 2002a. Ethoxylated dodecyl alcohol (9002-92-0). http://ntp-server.niehs.nih.gov
647.
NTP. 2002b. Carcinogenicity study on ethoxylated dodecyl alcohol. Personal communication with NTP's Central Data Management, December 4.
648.
Nishida, R., R. Inoue, Y. Takimoto, and T. Kita.1999.A sclérosant with astringent properties developed in China for oesophageal varices: Comparison with ethanolamine oléate and polidocanol.J. Gastroenterol. Hepatol.14:481–488.
649.
Noppeney, T, A. Scheldt, and I. Kurth.2001.Indications and technique for sclerotherapy of varicose veins.Zentralbl. Chir.126:546–550.
650.
Norris, M. J., M. C. Carlin, and J. L. Ratz.1989.Treatment of essential telang-iectasia: Effects of increasing concentrations of polidocanol.J. Am. Acad. Dermatol.20:643–649.
651.
Oexle, B., J. Weirich, K. Haverkampf, and H. Antoni.1988.Effects of polidocanol as a constituent of a venous sclerosing agent on cardiac electrical activity. Studies on the isolated perfused heart and pa pillary muscle of the guinea pig and on the isolated sinus node of the rabbit.Arzneimuttekfirschung38:1578–1582.
652.
Olesch B.1952.Neuere Erkenntisse zur Pharmakokinetik von polidocanol (aethoxysklerol).Arzneimittelforsche2:109.
653.
Olivares, J. L., G. Rodriguez, J. A. Fernandez, and M. A. de Gregorio.2001.Jugular venous malformation in an 8-year-old boy: Treatment with endovas-cular sclerotherapy.Eur. J. Pediatr.160:392–394.
654.
Orikasa, K.1989.Studies on the damage of the cultured endothelial cells and K-562 cells by sclérosants (ethanolamine oléate, Aethoxysklerol and absolute ethanol) used in the treatment of esophageal varices.Nippon Shokakibyo Gakkai Zasshi86:2365–2372.
655.
Ormeci, N., I. Soykan, M. Palabiyikoglu, et al. 2002.A new therapeutic approach for treatment of hydatid cysts of the spleen.Dig. Dis. Sei.47:2037–2044.
656.
Pepe, R. C, J. A. Wenninger, and G. N. Jr. McEwen, eds. 2002.International cosmetic ingredient dictionary and handbook.9th ed., 878–879, 882. Washington, DC: CTFA.
657.
Potzi, R., P. Ferenci, and A. Gangl.1991.Endoscopie sclerotherapy of esophageal varices during pregnancy-case report.Z. Gastroenterol.29:246–247.
658.
Procter & Gamble Company. 1984. Initial submission: Letter from Procter & Gamble Company to USEPA submitting information on alkylethoxylates enclosed study with attachments. NTIS Report No. OTS0543795.
659.
Pundzius, J., and M. Jievaltas.1998.Experimental studies of injection agents for peptic ulcer bleeding endoscopie control.Int. Surg.83:280–282.
660.
Registry of Toxic Effects of Chemical Substances (RTECS). 2002. Laureth-4 entry. RTECS database. Columbus, OH: Scientific and Technical Information Network (STN) International.
661.
Shelby, M. D., G. L. Erexson, G. J. Hook, and R. R. Tice.1993.Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals.Environ. Mol. Mutagen.21:160–179.
662.
Shirai, H.1999.Experimental study of intraarterial injection of polidocanol as an embolie agent.Nippon Igaku Hoshasen Gakkai Zasshi59:853–859.
663.
Strieker, B. H., J. A. van Oijen, C. Kroon, and A. H. Ovink.1990.Anaphylaxis following use of polidocanol. Wed.Tijdschr. Geneeskd.134:240–242.
664.
Suzuki, S., H. Atai, and F. Y. Hatakeyama.1989.Mutagenicity test on Polidocanol.Jitchuken Zenrinsho Kenkyuho15:1–9.
665.
Suzuki, M., M. Machida, K. Adachi, et al. 2000.Histopathological study of the effects of a single intratracheal instillation of surface active agents on lung in rats.J. Toxicol. Sei.25:49–55.
666.
Svensson, A.1988.Allergic contact dermatitis to laureth-4.Contact Dermatitis18:113–114.
667.
Tang, J., N. Esmon, I. Ferian, and A. Fesmire.1981.The enhancement of strep-tokinase activation of plasminogen by nonionic detergents and by serum albumin.Thromb. Res.24:359–365.
668.
Tennant, R. W., B. H. Margolin, M. D. Shelby, et al. 1987.Prediction of chemical carcinogenicity in rodents from in-vitro genetic toxicity assays.Science236:933–941.
669.
Trenkwalder, P., and H. Lydtin.1994.Ischaemic neurological deficit after sclerotherapy.Lancet343:794.
670.
Utter, W., J. Geier, and T. Fuchs.2000.Contact allergy to polidocanol.J. Allergy Clin. Immunol.106:1203–1204.
671.
Van der Pias, J. P., J. C. Lambers, J. W Van Wersch, and P. J. Koehler.1994.Reversible ischaemic neurological deficit after sclerotherapy of varicose veins.Lancet343:428.
672.
Vian, L., J. Vincent, J. Maurin, I. Fabre, J. Giroux, and J.P Cano.1995.Comparison of three in vitro cytotoxicity assays for estimating surfactant ocular irritation.Toxicol. In Vitro9:185–190.
673.
Weiss, R. A., and M. A. Weiss.1990.Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: Hypertonie saline vs. polidocanol.J. Dermatol. Surg. Oncol.16:800–804.
674.
Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, K. Mortelmans, and W Speck.1987.Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals.Environ. Mol. Mutagen.9(Suppl. 9): 1–110.
675.
Zhou, M., and M. D. Donovan.1996.Recovery of the nasal mucosa following laureth 9 induced damage.Int. J. Pharm.130:93–102.
676.
Zipper, S. G.2000.Peroneal nerve damage after varicose vein sclerotherapy with ethoxysclerol. Single case description with malpractice relevant questions.Versicherungsmedizin52:185–187.
677.
Bechgaard, E.1985.Acnegenicity Testing in Rabbits. An Objective Quantification Method.Acta Derm. Venereol.65:282–286.
678.
Blevins, R. D., and D. E. Taylor.1982.Mutagenicity screening of twenty-five cosmetic ingredients with the Salmonella/microsome test.J. Environ. Sei. Health A17:214–239.
679.
Campbell, R. L., and R. D. Bruce.1981.Comparative dermatoxicology. I. Direct comparison of rabbit and human primary skin irritation responses to isopropyl myristate.Toxicol. Appl. Pharmacol.59:555–563.
680.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Concentration of use of Myristyl and Isopropyl Myristate. Unpublished data submitted by CTFA.
681.
Elder, R. L., ed. 1982. Final Report on the Safety Assessment of Myristyl Myristate and Isopropyl Myristate. J. Am. Col. Toxicol. 1:55-80.
682.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
683.
Fulton, J. E., and S. R. Pay.1984.Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear.J. Am. Acad. Dermatol.10:96–105.
684.
Guillot, J. P., M. C. Martini, and J. Y. Giauffret.1977.Safety evaluation of cosmetic raw materials.J. Soc. Cosmet. Chem.28:377–393.
685.
Komatsu, H., K. Asaba, and M. Suzuki.1979.Some biochemical effects of isopropyl myristate and squalane on rabbit skin.J. Soc. Cosmet. Chem.30:263–278.
686.
Motoyoshi, K.1983.Enhanced comedone formation in rabbitear skin by squa-lene and oleic acid peroxides.Br. J. Dermatol.109:191–198. “Available from the Director, Cosmetic Ingredient Review, 1101 17th Street NW, Suite 310, Washington, DC 20036, USA.
687.
Pepe, R. C, J. A. Wenninger, G. N. McEwen, Jr. eds. 2002.International cosmetic ingredient dictionary and handbook, 9th ed., vols. 1-4. Washington, DC: CTFA.
688.
Suzuki, M., K. Asaba, H. Komatsu, and M. Mochizuka.1978.Autoradiographic study on percutaneous absorption of several oils useful for cosmetics.J. Soc. Cosmet. Chem.29:265–282.
689.
Tucker, S. B., S. A. Flannigan, M. Dunbar, and R. B. Drotman.1986.Development of an objective comedogenicity assay.Arch. Dermatol.122:660–665.
690.
Benedetto, G. D., M. Pierangeli, A. Scalise, and A. Bertani.2002.Paraffin oil injection in the body: An obsolete and destructive prodecure.Ann. Plastic Surg.49:391–396.
691.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2003. Concentrations of use-mineral waxes. Unpublished data submitted by CTFA on January 21, 2003. 6 pages.
692.
Elder, R. L.1984.Final report on the safety assessment of fossil and synthetic waxes.J. Am. Col. Toxicol.3:43–99.
693.
Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA. Heimbach, J. T, A. R. Bodor, J. S. Douglas, et al. 2002. Dietary exposures to mineral hydrocarbons from food-use applications in the United States. Food Chem. Toxicol. 40:555-571. Hintschich, C. R., C. K. Beyer-Machule, and F. H. Stefani. 1995. Paraffinoma of the periorbit-a challenge for the oculoplastic surgeon. Ophthal. Plastic Reconstr. Surg. 11:39-44. Joint FAO/WHO Expert Committee on Food Additives (JECFA). 1993. Micro-crystalline wax and paraffin wax. WHO Food Addit. Ser. 30:253-260. JECFA. 1996. Mineral oils (food grade), paraffin waxes and microcrystalline waxes. WHO Food Addi. Ser. 35:193-206.
694.
Pepe, R. C., J. A. Wenninger, and G. N. McEwen, Jr.2002.International cosmetic ingredient dictionary and handbook.9th ed.Washington, DC: CTFA.
695.
Smith, J. H., A. K. Mallett, A. J. Preston, et al. 1996.Ninety-day feeding study in Fischer-344 rats of highly refined petroleum-derived food-grade white oils and waxes.Toxicol. Pathol.24:214–230.
696.
Vigneswaran, W T., and S. S. Ramasastry.1996.Paraffin plombage of the chest revisited. Ann.Thorac. Surg.62:1837–1839.
697.
Witschel, H., and K. Geiger.1994.Paraffin induced sclerosing lipogranuloma of eyelids and anterior orbit following endonasal sinus surgery.Br. J. Ophthamol.78:61–65.
698.
Barany, E., M. Lindberg, and M. Loden.2000.Unexpected skin barrier influence from nonionic emulsifiers.Int. J. Pharm.195:189–195.
699.
Bryan, A. J., R. Kaur, G. Robinson, N. W. Thomas, and C. G. Wilson.1980.Histological and physiological studies on the intestine of the rat exposed to solutions of Mvri 52 and PEG 2000.Int. J. Pharm.7:145–156.
700.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Use concentration data on peg Stearates from industry survey. Unpublished data submitted by CTFA, September 13, 2002. 5 pages.
701.
Cutler, R. R., P. Wilson, and F V. Clarke.1987.The effect of polyoxyethylene Stearate (POES) on the growth of mycobacteria in radiometric 7H12 Middle-brook TB medium.Tubercle.68:209–220.
702.
Dahlgren, C, and K. E. Magnusson.1980.Modulation of polymorphonuclear leukocyte locomotion by synthetic amphiphiles.Scand. J. Infect. Dis. Suppl.24:44–47.
703.
Dahlgren, C, I. Rundqvist, O. Stendahl, and K. E. Magnusson.1980.Modulation of polymorphonuclear leukocyte locomotion by synthetic amphiphiles : Effect of saturated fatty acid esters (C2-C18) of poly(ethyleneglycol) 6000.Cell Biophys.2:253–267.
704.
Elder, R. L., ed. 1983. Final report on the safety assessment of PEG-2,-6,-8,-12,-20,-32,-40,-50,-100, and-150 Stearates. J. Am. Col. Toxicol. 2:17-34.
705.
Gowan, W. G., F Tio, K. Lamp, C. Gowan, and S. Stavchansky.1986.The effects of Tween 80 MYRJ-52 and polyethylene glycol 8000 on the rate of pentobarbital disappearance cumulative water flux and histological changes in the rat small intestine.Int. J. Pharm.29:169–176.
706.
Hachiya, N.1987.Evaluation of chemical genotoxicity by a series of short-term tests.Akita. Igaku.14:269–292.
707.
Ismail, S., A. A. Mohamed, and M. G. Abd El-Mohsen.1989.Modifying effects of polyoxyethylene Stearates on the rate of acid-catalyzed hydrolysis of acetylsalicyclic acid.Bull. Pharm. Sei.12:52–67.
708.
Ivanchenko, O. B., O. N. Finskaya, A. N. Fattakhova, I. M. Skipina, and IE. Cherepneva.1992.Assessment of genotoxicity of non-ionogenic surfactants.Biol. Nauki.10:75–80.
709.
Kaur, R., D. J. W. Grant, and T. Eaves.1980.Comparison of polyethylene glycol and polyoxyethylene Stearate as excipients for solid dispersion systems of griseofulvin and tolbutamide. Part 1. Phase equilibria. Part 2. Dissolution and solubility studies.J. Pharm. Sei.69:1317–1326.
710.
Kilbanov, A. L., K. Maruyama, V. P Torchilin, and L. Huang.1990.Ampipathic polyethyleneglycols effectively prolong the circulation time of liposomes.FEBS Lett.268:235–237.
711.
Kobayashi, I.1989. The screening test for mutagenesis of surfactants, detergents and fluorescent whitening agents.Gosei Senzai Kenkyukaishi12:19–28.
712.
Lee, M. H., C. D. Kim, and H. J. Ahn.1994.Evaluation of surfactant cytotoxicity potential by neutral red uptake assay, MTT assay and cell protein assay.Korean J. Toxicol.10:215–220.
713.
Lewis, R. W., J. C. McCall, P. A. Botham, and R. Trebilcock.1994.A comparison of two cytotoxicity tests for predicting the ocular irritancy of surfactants.Toxicol. In Vitro8:867–869.
714.
Margarit, M. V., I. C. Rodriguez, and A. Cerezo.1992.Myrj 51 as a suppository excipient in fluence on pharmaceutical availability and bioavailability of sodium valproate.Int. J. Pharm.81:67–73.
715.
Miller, M. A., L. Thibert, F Desjardins, S. H. Siddiqi, and A. Dascal.1996.Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene Stearate present in the BACTEC pyrazinamide susceptibility test.J. Clin. Mi-crobiol.34:84–86.
716.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen Jr., eds. 2002.International cosmetic ingredient dictionary and handbook, 9th ed., 1201–1207. Washington, DC: CTFA.
717.
Pienaar, E. W., N. P. Kriek, B. Boneschans, and H. A. Koelman.1994.Adverse effects of polyethylene glycol and phenytoin on the rectal mucosa of the rat.Drug Dev. Ind. Pharm.20:1493–1502.
718.
Realini, L., P. Van Der Stufyt, K. De Ridder, B. Hirschel, and F. Portaels.1997.Inhibitory effects of polyoxyethylene Stearate, PANTA, and neutral pH on (R) growth of Mycobacterium genavense in BACTEC primary cultures.J. Clin. Microbiol.35:2791–2794.
719.
Salminen, S., and E. Salminen.1987.Urinary excretion of orally administered oxalic acid in MYRJ-45-treated NMRI mice.Toxicol. Lett.37:91–94.
720.
Satoh, S., Y. Horiguchi, K. Ito, N. Nambu, and T. Nagai.1985.Irritative effects of suppository bases on the rectal membranes in rabbits.Arch. Pract. Pharm.45:298–303.
721.
Shen, W.-W, A. G. Danti, and F N. Bruscato.1976.Effect of nonionic surfactants on percutaneous absorption of salicylic acid and sodium salicylate in the presence of dimethyl sulfoxide.J. Pharm. Sei.65:1780–1783.
722.
Tassett, C, V. Preat, A. Bernard, and M. Roland.1992.Comparison of nephro-toxicities of different polyoxyethylene formulations of amphotericin B in rats.Antimicrob. Agent Chemother.36:1525–1531.
723.
Tassett, C, V. Preat, and M. Roland.1991.The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B.J. Pharm. Pharmacol.43:297–302.
724.
Tatsumi, H., and H. Ritsuko.1991.A study on the relation between the result of guinea-pig skin irritation test and human patch test with cosmetic ingredients.Hifu33:31–38.
725.
Uraizee, S. A., A. M. McPhillips, A. A. Sakr, and W A. Ritschel.1999.Evaluation of absorption enhancers and enzyme inhibitors for the protection of human insulin: screening study.Pharm. Ind.61:259–262.
726.
CTFA. 2002. Product use concentration information for Polyamino Sugar Condensate; memorandum dated January 22. Unpublished data.
727.
Baker, C. G., R. D. Berg, and E. S. Curtis.1987.Formulating with NMF (normal moisturizing factor).Drug Cosmet. Ind.140:32–39.
728.
Elder, R. L., ed., 1982. Final report on the safety assessment of Polyamino Sugar Condensate. J. Am. Col. Toxicol. 1:25-32.
729.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
730.
Peterson, R. V., et al. 1986.Athymic nude mouse grafted with human skin as a model for evaluating the safety and effectiveness of radiolabeled cosmetic ingredients.J. Soc. Cosmet. Chem.37:249–265.
731.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen. Jr., eds. 2000.International Cosmetic Ingredient Dictionary and Handbook, 8th ed., 1114–1115. Washington, DC: CTFA.
732.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Product use concentration information for Polybutene. Unpublished data submitted by CTFA. Available from the Director, Cosmetic Ingredient Review, 1101 17th Street NW, Suite 310, Washington, DC 20036.
733.
Elder, R. L. ed. 1982. Final report on the safety assessment of Polybutene. J. Am. Col. Toxicol. 1:103-118.
734.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
735.
Skyberg, K., V. Skaug, B., Gylseth, J. R. Pedersen, and O. H. Iversen.1990.Subacute inhalation toxicity of mineral oils, C15-C20 alkylbenzenes, and polybutene in male rats.Environ. Res.53:48–61.
736.
Wenninger, J. A., R. C. Canterbery, and G. N. McEwen, Jr., eds. 2000.International Cosmetic Ingredient Dictionary and Handbook, 8th ed., 1114–1115. Washington, DC: CTFA.
737.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2001. Product use concentration information for Polybutene. Unpublished data submitted by CTFA.
738.
Elder, R. L., ed. 1983. Final report on the safety assessment of Polyquaternium-11. J. Am. Col. Toxicol. 2:161-178.
739.
Food and Drug Administration (FDA). 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
740.
Bower, D. 1999. Unpublished information on hair spray particle size provided at the September 9, 1999, CIR Expert Panel meeting.
741.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Ingredient use data-potassium cocoyl hydrolyzed collagen. Unpublished data submitted by CTFA.
742.
Elder, R. L. 1983. Final report on the safety assessment of potassium-coco-hydrolyzed animal protein and triethanolamine-coco-hydrolyzed animal protein. J. Am. Col. Toxicol. 2:75-86.
743.
FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
744.
Jensen, P. A., and D. O'Brien.1993.Industrial Hygiene. In ed. K. Willeke, and P. A. Baron, 538–540. Aerosol measurement. Principles techniques and applications, New York: John Wiley and Sons.
745.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen, Jr., eds. 2002.International Cosmetic Ingredient Dictionary and Handbook, 9th ed., vol. 2, 1336, 1689. Washington, DC: CTFA.
746.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Ingredient use data-potassium cocoyl hydrolyzed collagen. Unpublished data submitted by CTFA.
747.
Elder, R. L. ed. 1983. Final report on the safety assessment of Propylene Glycol Stearate and Propylene Glycol Stearate Self-Emulsifying. J. Am. Col. Toxicol. 2:101-124.
748.
Fulton, J. E., and S. R. Pay.1984.Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear.J. Am. Acad. Dermatol.10:96–105.
749.
Pepe, R. C, J. A. Wenninger, and G. N. McEwen, Jr. eds. 2002.International Cosmetic Ingredient Dictionary and Handbook, 9th ed., vol l-4, 1418. Washington, DC: CTFA.
750.
Archuleta, M. M.1995.Aqueous foam toxicology evaluation and hazard review.Albuquerque, NM: Sandia National Labs.
751.
Bahl, M. K.1985.ESCA studies on the skin lipid removal by solvents and surfactants.J. Soc. Cosmet. Chem.36:287–296.
752.
Bernhofer, L. P., M. Seiberg, and K. M. Martin.1999.The influence of the response of skin equivalent systems to topically applied consumer products by epithelial-mesenchymal interactions.Toxicol In Vitro13:219–229.
753.
Bower, D. 1999. Unpublished information on hair spray particle size provided at the September 9, 1999, CIR Expert Panel meeting.
754.
Charbonnier, V., B. M. Morrison, Jr., M. Paye, and H. I. Maibach.2000.An open assay model to induce subclinical non-erythematous irritation.Contact Dermatitis.42:207–211.
755.
Charbonnier, V., B. M. Morrison, Jr., Paye, M., and Maibach, H. 1.2001. Subclinical, non-erythematous irritation with an open assay model (washing): sodium lauryl sulfate (SLS) versus sodium laureth sulfate (SLES)Food Chem. Toxicol.39:279–286.
756.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Ingredient use data. Unpublished data submitted by CTFA.
757.
Dillarstone, A., and M. Paye.1993.Antagonism in concentrated surfactant system.Contact Dermatitis28:198.
758.
Elder, R. L. ed. 1982. Final Report on the Safety Assessment Sodium Laureth Sulfate and Ammonium Laureth Sulfate. J. Am. Col. Toxicol. 2:1-34.
759.
Food and Drug Administration (FDA). 2002. Cosmetic product formulation data. FDA database. Washington, DC: FDA.
760.
Gettings, S. D., R. A. Lordo, P. I. Feder, and K. L. Hintze.1998.A comparison of Low Volume, Draize and in vitro eye irritation data. III. Surfactant-based formulations.Food Chem. Toxicol.36:209–231.
761.
Jensen, P. A., and D. O'Brien.1993.Industrial Hygiene. In ed. Willeke K. and P. A. Baron, 538–540. Aerosol measurement. Principles techniques and applications, New York: John Wiley and Sons.
762.
Koyama, K., Y. Kasuya, K. Koyama, and Goto, K.1997.Nitric oxide-mediated vasorelaxation induced by sodium polyoxyethylene laurylether sulfate.Toxicol. Appl. Pharm.145:294–300.
763.
Osgood, T. B., J. L. Ubels, G. A. Smith, and C. E. Dick.1990.Evaluation of ocular irritancy of hair care products.J. Toxicol. Cutan. Ocul. Toxicol.9:37–51.
764.
Stern, M., M. Klausner, R. Alvarado, K. Renskers, and M. Dickens.1998.Evaluation of the EpiOcular(tm) Tissue Model as an alternative to the Draize eye irritation test.Toxicol. In Vitro12:455–461.
765.
Tachón, P., K. Cotovio, K. G. Dossou, and M. Prunieras.1989.Assessment of surfactant cytotoxicity: Comparison with Draize eye test.Int. J. Cosmet. Sei.11:233–243.
766.
Tani, N., S. Kinoshita, Y. Okamoto, M. Kotani, H. Itagaki, N. Murakami, S. Sugiura, M. Usami, K. Kato, H. Kojima, T. Ohno, K. Saijo, M. Kato, M. Hayashi, and Y. Ohno.1999.Interlaboratory validation of the in vitro eye irritation tests for cosmetic ingredients (8) evaluation of cytotoxicity tests on SIRC cells.Toxicol. In Vitro13:175–187.
767.
Tavss, E. A., E. Eigen, and A. M. Klingman.1985.Anionic surfactants.J. Soc. Cosmet.36:251–254.
768.
Waldman, B. A.1982.Analysis of 1,4-dioxane in ethoxylated compounds by gas chromatography/mass spectrometry using selected ion monitoring.J. Soc. Cosmet. Chem.33:19–25.
769.
Wenninger, J. A., and G. N. McEwen, Jr., eds. 2002.International Cosmetic Ingredient Dictionary and Handbook, 9th ed., vol. l-4, 101, 1569. Washington, DC: CTFA.
770.
Abdul-Hussain, S., and D. Acosta.1994.In vitro model to evaluate the cyto-toxicity of two groups of surfactant mixtures with rat keratinocyte cultures.Toxic. Subs. J.13:1–14.
771.
Abidi T. R, C. A. Faaland, D. D. Scala, L. D. Rhein, and J. D. Laskin.1989.Ethoxylated alcohol (Neodol-12) and other surfactants in the assay of protein kinase C.Biochim. Biophys. Acta992:362–368.
772.
Aiba, S., A. Terunuma, H. Manóme, and H. Tagami.1997.Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules.Eur. J. Immunol.27:3031–3038.
773.
Agner, T.1990.Susceptibility of atopic dermatitis patients to irritant dermatitis cause by sodium lauryl sulphate.Acta Derm. Venerol.71:296–300.
774.
Agner, T., and J. Serup.1988.Contact thermography for assessment of skin damage due to experimental irritants.Acta Derm. Venerol.68:192–195.
775.
Agner, T., and J. Serup.1989.Skin reactions to irritants assessed by non-invasive bioengineering methods.Contact Dermatitis20:352–359.
776.
Agner, T., and J. Serup.1990.Sodium lauryl sulphate for irritant patch testing-A dose-response study using bioengineering methods for determination of skin irritation.J. Invest. Dermatol.95:543–547.
777.
Agner, T., and J. Serup.1993.Time course of occlusive effects on skin evaluated by measurement of transepidermal water loss (TEWL): Including patch tests with sodium lauryl sulphate and water.Contact Dermatitis28:6–9.
778.
Agner, T, J. Serup, V. Handlos, and W. Batsberg.1989.Different skin irritation abilities of different qualities of sodium lauryl sulphate.Contact Dermatitis21:184–188.
779.
Ahlfors, E. E., and A. Larsson.1988.Chemically induced inflammation in ratoral mucosa.Scand. J. Dent. Res.96:428–434.
780.
Aiba, S., and S. I. Katz.1990.Phenotypic and functional characteristics of in vivoactivated Langerhans cells.J. Immunol.145:2791–2796.
781.
Allen, M. H., S. H. Wakeline, D. Holloway, S. Lisby, I. Baadsgaard, J. N. Barker, and J. P. McFadden.2000.Association of TFNA gene polymorphism at position-308 with susceptibility to irritant contact dermatitis.Immunogen-esis51: 201–205.
782.
Allenby, C. E, D. A. Basketter, A. Dickens, E. G. Barnes, and H. C. Brough.1993.An arm immersion model of compromised skin: (I). Influence on irritation reactions.Contact Dermatitis28:84–88.
783.
American Cancer Society (ACS). 1998a. Debunking the myth. Article dated 09/23/1998.
Anavkar, A. S., and C. V. Natraj.1989.An in vitro method for evaluation of the irritancy of anionic surfactants.J. Am. Oil. Chem. Soc.66:1386–1389.
786.
Anderberg, E. K., and P. Artursson.1993.Epithelial transport of drugs in cell culture. VIII: Effect of sodium dodecyl sulfate on cell membranes and tight junction permeability in human intestinal epithelial (Caco-2) cells.J. Pharm. Sei.82:392–398.
787.
Anderson, C, C. Svensson, F. Sjögren, T. Andersson, and K. Wârdell.1995.Human in vivo microdialysis technique can be used to measure cytokines in contact reactions.Curr. Probl. Dermatol.23:121–130.
788.
Anderson, C, K. Sundberg, and O. Froth.1986.Animal model for assessment of skin irritancy.Contact Dermatitiss15:143–151.
789.
Anonymous. 2002. Poisonous Shampoo?: Shampoo containing “SLS” is a cancer hazard-Fiction! http://www.truthorfiction.com/rumors/shampoo.htm
790.
Arechabala, B., C. Coiffard, P. Rivalland, L. J. M. Coiffard, and Y. de Roeck-Holtzhauer.1999.Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutralred test, MTT assay and LDH release. J.Appl. Toxicol.19:163–165.
791.
Ariyoshi, T, H. Hasegawa, Y. Nanri, and K. Arizono.1990.Profile of hemopro-teins and heme-metabolizing enzymes in rats treated with surfactants.Bull. Environ. Contam. Toxicol.44:369–376.
792.
Baert, J. H., R. J. Veys, and K. Ampe.1996.The effect of sodium lauryl sulfate on the expression of cytokeratin mRNA in hamster cheek pouch epithelium. J.Oral. Pathol. Med.25:497–501.
793.
Baert, J. H., R. J. Veys, K. Ampe, and J. A. De Boever, 1996.The effect of sodium lauryl sulphate and triclosan in hamster cheek pouch mucosa.Int. J. Exp. Pathol.77:73–78.
794.
Bangha, E., U. Hinnen, and P. Eisner, 1996.Irritancy testing in occupational dermatology: Comparison between two quick tests and the acute irritation induced by sodium lauryl sulphate.Acta Dermato-Venerol.76:450–452.
795.
Bárány, E., M. Lindberg, and M. Lodén.1999.Biophysical characterization of skin damage and recovery after exposure to different surfactants.Contact Dermatitis40:98–103.
796.
Basketter, D., L. Blaikie, and F Reynolds.1996.The impact of atopic status on a predictive human test of skin irritation potential.Contact Dermatitis35:33–39.
797.
Basketter, D. A., M. Chamberlain, H. A. Griffiths, M. Rowson, E. Whittle, and M. York.1997.The classification of skin irritants by human patch test.Food Chem. Toxicol.35:845–852.
798.
Basketter, D. A., and H. A. Griffiths.1993.A study of the relationship between susceptibility to skin stinging and skin irritation.Contact Dermatitis29:185–188.
799.
Basketter, D. A., J. A. Miettinen, and A. Lahti.1998.Acute irritant reactivity to sodium lauryl sulfate in atopies and non-atopies.Contact Dermatitis38:253–257.
800.
Basketter, D. A., E. W Scholes, and I. Kimber.1994.The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test.Food Chem. Toxicol.32:543–547.
801.
Basketter, D. A., E. Whittle, H. A. Griffiths, and M. York.1994.The identification and classification of skin irritation hazard by a human patch test.Food Chem. Toxicol.32:769–775.
802.
Begoan, P. 2001. Myth busting, http://www.cosmeticscop.com/skinfacts/ mythbusting.htm#sodium.
803.
Benoit, J., M. Cormier, and J. Wepierre.1988.Comparative effects of four surfactants on growth, contraction, and adhesion of cultured human fibroblasts.Cell. Biol. Toxicol.4:111–122.
804.
Berardesca, E., G. P. Vignoli, F Distante, P. Brizzi, and G. Rabbiosi.1995.Effects of water temperature on surfactant-induced skin irritation.Contact. Dermatitis32:83–87.
805.
Berardesca, E., D. Fideli, P. Gabba, M. Cespa, G. Rabbiosi, and H. I. Maibach.1990.Ranking of surfactant skin irritancy in vivo in man using the plastic occlusion stress test (POST).Contact Dermatitis23:1–5.
806.
Bergtresser, P. R., and W. H. Eaglestein.1973.Irritation by hydrophillic ointment under occlusion.Arch. Dermatol.108:218–219.
807.
Berry, M., and D. L. Easty.1993.Isolated human and rabbit eye: Models of corneal toxicity.Toxicol. In Vitro7:461–464.
808.
Biochemical Research Lab. 2000. Toxicological properties of several commercially available surfa ctants, with cover letter dated 04/10/00 (sanitized). NTIS Report No. OTS0574051.
809.
Blakemore, W. M., J. E. Rule, and M. C. Bowman.1979.Trace analysis of two detergents in blood from guinea pigs after immersion in aqueous baths.Toxicol. Lett. (Amsterdam)3:127–136.
810.
Blanken, R., M. J. T. van Vilsteren, R. A. Tupker, and P. J. Coenraads.1989.Effect of mineral oil and linoleic-acid-containing emulsions on the skin vapour loss of sodium-lauryl-sulphate-induced irritant skin reactions.Contact Der-matits20:93–97.
811.
Bloom, E., M. Sznitowska, J. R. Polansky, and H. I. Maibach.1993.In vitro tests for irritants: Qualitative differences in biological properties.In Vitro Toxicol.6:171–185.
812.
Booman, K. A., T. M. Cascieri, J. Demetrulias, A. Driedger, J. F Griffith, G. T. Grochoski, B. Kong, W C. Mc Cormick, H. North-Root, M. G. Rozen, and R. I. Sedlak.1988.In vitro methods for estimating eyeirritancy of cleaning products phase I: Preliminary assessment.J. Toxicol.7:173–185.
813.
Brand, C. U., and L. R. Braathen.1996.Investigation of skin-derived lymph: An approach to get insight into the skin immune system.Dermatology193:283–288.
814.
Brand, C. U., Hunziker, T., and L. R. Braathen.1992.Studies on human skin lymph containing Langerhans cells from sodium lauryl sulphate contact dermatitis. J.Invest. Dermatol.99:109S–110S.
815.
Brasch, J., D. Becker, and I. Effendy.1999.Reproducibility of irritant patch test reactions to sodiuml auryl sulfate in a double-blind placebo-controlled randomized study using clinical scoring.Contact Dermatitis41:150–155.
816.
Butler, N. J., G. R. Langley, and J. Winwood.1992.A cell suspension agar diffusion test using Neutral Red release to assess the relative irritancy potential of cosmetic ingredients and formulations.Int. J. Cosmet. Sei.15:33–42.
817.
Chung, J. H., H. C. Eun, S. Y. Jung, and K. H. Cho.1993.A comparative study of cytotoxicity of skin irritants between cultured human, oral and skin keratinocytes.J. Invest. Dermatol.101:430.
818.
Cohen, C, G. Dossou, A. Rougi er, and R. Rouget.1990.Measurement of inflammatory mediators produced by human keratinocytes in-vitro a predictive assessment of cutaneous irritation.Toxicol. In Vitro5:407–410.
819.
Conrads, A., and H. Zahn.1987.A study of the interaction of sodium dodecyl sulphate with the proteins of human heel stratum corneum.Int. J. Cosmet. Sei.9:29–46.
820.
Cooper, A., J. Fentem, and M. Balls.1994.Inhibition of intercellular communication: An in vitro assay for detecting potential tumour promoters.Toxicol. In Vitro8:535–537.
821.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Concentration of Use-Sodium Lauryl Sulfate and Ammonium Lauryl Sulfate. Unpublished data. 3 pages.
822.
Cruchley, A. T., A. O'Regan, and D. M. Williams.1992.Sodium lauryl sulphate increased human mucosal permeability.J. Dent. Res.71:693. Abstract.
823.
Cua, A. B., K.-R Wilhelm, and H. I. Maibach.1990.Cutaneous sodium lauryl sulfate irritation potential: Age and regional variability.Brit. J. Dermatol.123:607–613.
824.
Cumberbatch, M., R. J. Dearman, and I. Kimber.1998.Interleukin la required for Langerhans cell migration provoked in mice by the skin irritant sodium lauryl sulphate.Hum. Exp. Toxicol.17:497.
825.
Cumberbatch, M., R. C. Scott, D. A. Basketter, E. W Scholes, J. Hilton, R. J. Dearman, and I. Kimber.1993.Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation.Toxicol.77:181–191.
826.
Dahl, M. V., and M. J. Roering.1984.Sodium lauryl sulfate irritant patch tests. III. Evaporation of aqueous vehicle influences inflammatory response.J. Am. Acad Dermatol.11:477–479.
827.
Dahl, M. Y, F Pass, and R. J. Trancik.1984.Sodium lauryl sulfate irritant patch tests. II. Variations of test responses among subjects and comparison to variations of allergic responses elicited by Toxicodendron extract.J. Am. Acad Dermatol.11:474–477.
828.
de Brugerolle de Fraissinette, A., V. Picarles, S. Chibout, M. Kolopp, J. Medina, P. Burtin, M. E. Ebelin, S. Osborne, F K. Myer, A. Spake, M. Rosdy, B. De Wever, E. A. Ettlin, and A. Cordier.1999.Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles.Cell Biol. Toxicol.15:121–135.
829.
DeLeo, V. A., D. Hanson, S. Scheide, B. J. Kong, and S. DeSalva.1989.The effect of surfactants on metabolism of chloine phospholipids in human epidermal keratinocytes in culture.J. Toxicol. Cutan. Ocul. Toxicol.8:227–240.
830.
de Vries, I. J. M., E. G. Langeveld-Wildschut, F C. van Reijsen, I. C. Bihari, C. A. Bruijnzeel-Koomen, and T. Thepen.1997.Nonspecific T-cell homing during inflammation in atopic dermatitis: Expression of cutaneous lymphocyte-associated antigen and integrin a? skin-infiltrating T cells.J. Allergy Clin. Immunol.100:694–701.
831.
Dickson, F M., J. N. Lawrence, and D. J. Benford.1993.Surfactant-induced cytotoxicity in cultures of human keratinocytes and a commercially available cell line (3T3).Toxicol. In Vitro7:381–384.
832.
Dickson, F M., J. N. Lawrence, and D. J. Benford.1994.Cytotoxicity of 12 chemicals of known human and animal skin irritation potential in human keratinocyte cultures.Toxicol. In Vitro8:661–663.
833.
Dierickx, P. J.1989.Cytotoxicity testing of 114 compounds by the determination of the protein content in HEP G2 cell cultures.Toxicol. In Vitro3:189–193.
834.
Dihoom, M., G. S. Mahmoud, and O. H. Sudani.1996.An outbreak of hand dermatitis among workers using sodium lauryl sulfate for skin cleansing.Contact. Dermatitis34:366–367.
835.
Di Nardo, A., K. Sugino, P. Wertz, J. Ademóla, and H. I. Maibach.1996.Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: A correlation study between ceramides and in vivo parameters of irritation.Contact Dermatitic35:86–91.
Effendy, I., and H. I. Maibach.1995.Surfactants and experimental irritant contact dermatitis.Contact. Dermatitis33:217–225.
838.
Eichhorn, U., R. Klöcking, H. Schweizer, and H.-P. Klöcking.1987.Cell membrane toxicity detected with the chromium-51 release test.Mech. Models Toxicol.11:334–337.
839.
Elder, R. L., ed. 1983. Final report on the safety assessment of sodium lauryl sulfate and ammonium lauryl sulfate. J. Am. Col. Toxicol. 2:127-181.
840.
Eisner, P., and G. Burg.1993.Irritant reactivity is a better risk marker for nickel sensitivity than atopy. Acia.Dermato-Venerol.73:214–216.
841.
Eisner, P., D. Wilhelm, and H. I. Maibach.1990.Multiple parameter assessment of vulvar irritant contact dermatitis.Contact Dermatitis23:20–26.
842.
P. Eisner, D. Wilhelm, and H. I. Maibach. 1991. Effect of low-concentration sodium lauryl sulfate on human vulvar and forearm skin: Age-related differences. J. Reprod. Med. 36:77-81.
843.
Emilson, A., M. Lindberg, and B. Forslind.1993.The temperature effect on in vitro penetration of sodium lauryl sulfate and nickel chloride through human skin.Acta Derm. Venerol.73:203–207.
844.
Emilson, A., M. Lindberg, and A. Scheynius.1998.Differential epidermal expression of the invariant chain in allergic and irritant contact dermatitis.Acta Derm. Venerol.78:402–407.
845.
Etter, J.-C. L., and A. Wildhaber.1985.Biopharmaceutical test of ocular irritation in the mouse.Food Chem. Toxicol.23:321–324.
846.
Eun, H. C, J. H. Chung, S. Y. Jung, K. H. Cho, and K. H. Kim.1994.A comparative study of the cytotoxicity of skin irritants on cultured human oral and skin keratinocytes.Br. J. Dermatol.130:24–28.
847.
Farm, G.1998.Repeated open application tests (ROAT) in patients allergic to colophony evaluated visually and with bioengineering techniques.Acta Derm. Venerol.78:130–135.
848.
Ferguson, T. M., and C. Prottey.1976.Effect of surfactants upon mammalian cells in vitro.Food Cosmet. Toxiol.14:431–434.
849.
Fisher, G. J., J. Esmann, C. E. Griffiths, H. S. Talwar, E. A. Duell, C. Hammerberg, J. T. Elder, L. J. Finkel, G. D. Karabin, B. J. Nickoloff, K. D. Cooper, and J. J. Voorhees.1991.Cellular, immunologie and biochemical characterization of topical retinoic acid-treated human skin. J.Invest. Dermatol.96:699–707.
850.
Fisher, G. J., A. Tavakkol, C. E. Griffiths, J. T. Elder, Q. Y Zhang, L. Finkel, D. Danielpour, A. B. Glick, H. Higley, and L. Ellingsworth.1992.Differential modulation of transforming growth factor-beta 1 expression and mucinde-position by retinoic acid and sodium lauryl sulfate in human skin.J. Invest. Dermatol.98:102–108.
851.
Fitzpatrick, M. J., I. K. Berezesky, and B. F Trump.1991.Evaluation of toxicity of model xenobiotics in-vitro utilizing JB6 cells.J. Cell. Biol.115:21A.
852.
Flanagan, S. A., M. H. Smolensky, R. Harrist, R. L. Brown, V. K. Menon, and J. P. McGovern.1984.Scapular reactivity to contact irritants: Application-time and area variations.Chronobiologia11:93–108.
853.
Flower, C, B. J. Phillips, and D. Anderson.1987.Investigation of surface-activity as a possible mechanism of clastogenic action of mono-2-ethyl-hexylphtalate.Mutagenesis2:304. Abstract.
854.
FDA. 1981. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
855.
FDA. 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
856.
Food and Drug Research Labs (FDRL). 1979a. Initial submission: Primary skin irritation study with ammonium lauryl sulfate in rabbits with cover letter dated 051592. NTIS Report No. OTS0539899.
857.
FDRL. 1979b. Initial submission: Eye irritation test with ammonium lauryl sulfate in rabbits with cover letter dated 051592. NTIS Report No. OTS0539909.
858.
FDRL. 1985a. Initial submission: Primary dermal irritation study of 15% active solution of sodium lauryl sulfate in New Zealand White rabbits (final report) with attachments and letter dated 11/22/91. NTIS Report No. OTS0534770.
859.
FDRL. 1985b. Initial submission: Primary dermal irritation study of 15% active solution of ammonium lauryl sulfate in New Zealand White rabbits (final report; with attachments and letter dated 03/13/92). NTIS Report No. OTS0536168.
860.
Forsey, R. J., H. Shahidulluh, C. Sands, E. McVittie, R. D. Aldridge, J. A. A. Hunter, and S. E. M. Howie.1998.Epidermal Langerhans cell apoptosis is induced in vivo by nonanoic acid but not by sodium lauryl substrate.Br. J. Dermatol.139:453–461.
861.
Freeman, S., and H. Maibach.1988.Study of irritant contact dermatitis by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry.J. Am. Acad. Dermatol.19:496–502.
862.
Fröndin, T., and C. Anderson.1987.Multiple parameter assessment of skin irritancy.Contact. Dermatitis17:92–99.
863.
Frosch, P. J., and B. M. Czarnetzki.1987.Surfactants cause in-vitro chemotaxis and chemokinesis of human neutrophils.J. Invest. Dermatol.88:52S–55S.
864.
Frosch, P. J., A. Schulze-Dirks, M. Hoffman, I. Axthelm, and A. Kurte.1993a.Efficacy of skin barrier creams. (I). The repetitive irritation test (RIT) in the guinea pig.Contact Dermatits28:94–100.
865.
Frosch, P. J., A. Schulze-Dirks, M. Hoffman, and I. Axthelm.1993b.Efficacy of skin barrier creams. (II). Ineffectiveness of a popular “skin protector” against various irritants in the repetitive irritation test in the guinea pig.Contact. Dermatitis29:74–77.
866.
Frosch, P. J., and C. Wissing.1982.Cutaneous sensitivity to ultraviolet light and chemical irritants.Arch. Dermatol. Res.272:269–278.
867.
Fuchs, J., and L. Packer.1999.Antioxidant protection from solar-simulated radiation-induced suppression of contact hypersensitivity to the recall antigen nickel sulfate in human skin.Free Radie. Biol. Med.27:422–427.
868.
Fullerton, A., U. Broby-Johansen, and T. Agner.1994.Sodium lauryl sulphate in an in vitro model using human skin.Contact. Dermatitis30:222–225.
869.
Fulmer, A. W, and G. J. Kramer.1986.Stratum corneumlipid abnormalities in surfactant-induced dry scaly skin.J. Invest. Dermatol.86:598–602.
870.
Gatto, H., J. Viac, M. Charveron, and D. Schmitt.1992.Study of immune-associated antigens (IL-1 and ICAM-1) in normal keratin ocytes treated by sodium lauryl sulphate.Arch. Dermatol. Res.284:186–188.
871.
Gehring, W.1990.Effects of irritants in atopic dermatitis.Contact Dermatitis22:292–293.
872.
Gibson, W. T, and M. E. Teall.1983.Interactions of C12 surfactants with the skin: Changes in enzymes and visible and histological features of rat skin treated with sodium lauryl sulphate.Food Chem. Toxicol.21:587–594.
873.
Goh, C. L.1988.A comparison of the effect of UVB and sodium lauryl sulphate on the skin water vapour loss.Ann. Acad. Med. Singapore17:495–497.
874.
Gollhausen, R., and A. M. Kligman.1985.Effects of pressure on contact dermatitis.Am. J. Ind. Med.8:323–328.
875.
Grant, R. L., and D. Acosta.1996.Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells.Fundam. Appl. Toxicol.33:71–82.
876.
Grant, R. L., C. Yao, D. Gabaldon, and D. Acosta.1992.Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues : I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies.Toxicology76:153–176.
877.
Green, K., R. E. Johnson, J. K. Chapman, E. Nelson, and L. Cheeks.1989.Preservative effects on the healing rate of rabbit corneal epithelium.Lens. Eye Toxic. Res.6:37–41.
878.
Gräsjo, A., A. Leijon-Kuligowski, H. Törma, G. M. Roomans, and M. Lindberg.1996.Different pathways in irritant contact eczema? Early differences in the epidermal elemental content and expression of cytokines after application of 2 different irritants.Contact. Dermatitis35:355–360.
879.
Griffith, J. F, G. A. Nixon, R. D. Bruce, P. J. Reer, and E. A. Bannan.1980.Dose-response studies in the albino rabbit eye as a basis for selecting optimum testing conditions for predicting hazard to the human eye.Toxicol. Appl. Pharmacol.55:501–513.
880.
Griffiths, H. A., K.-P Wilhelm, M. K. Robinson, X. M. Wang, J. M. McFadden, M. Work, and D. A. Basketter.1997.Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard.Food Chem. Toxicol.35:255–260.
881.
Grunewald, A. M., M. Gloor, W. Gehring, and P. Kleesz.1995.Damage to the skin by repetitive washing.Contact. Dermatitis32:225–232.
882.
Guironnet, G., C. Dalbiez-Gauthier, F. Rousset, D. Schmitt, and J. Peguet-Navarro.2000.In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells.Toxicol. In Vitro14:517–522.
883.
Gülden, M.1993.In vitro toxicity screening using cultured rat skeletal muscle cells: I. Surfactants and mitochondrial poisons.Toxicol. In Vitro7:25–34.
884.
Gupta, B. N., C. Agarwal, and A. Singh.1987.Effect of sodium lauryl sulfate on rat and liver kidney enzymes an in-vitro study.Bull. Environ. Contam. Toxicol.39:425–433.
885.
Hall-Manning, T. J., G. H. Holland, G. Rennie, P. Réveil, J. Hines, M. D. Barratt, and D. A. Basketter.1998.Skin irritation potential of mixed surfactant systems.Food Chem. Toxicol.36:233–238.
886.
Hasegawa, Y, T. Irkura, and D.-I. Mizuno.1970.Screening test for the prevention of métastases produced by Ehrlich carcinoma cells.Chem. Pharm. Bull.18:810–814.
887.
Haskell Laboratories. 1984. Initial submission: Approximate lethal concentrations by inhalation of sodium lauryl sulfate and sodium dodecylbenzene sul-fonate with cover letter dated 090292. NTIS Report No. OTS0546357.
888.
Held, E., and T. Agner.1999.Comparison between 2 test models in evaluation the effect of a moisturizer on irritated human skin.Contact Dermatitis40:261–268.
889.
Herlofson, B. B., and P. Barkvoll.1996.Oral mucosal desquamation caused by two toothpaste detergents in an experimental model.Eur. J. Oral Sei.104:21–26.
890.
Hinnen, U., P. Eisner, and G. Burg.1995.Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate.Contact Dermatitis33:236–239.
891.
Hoefakker, S., M. Caubo, E. H. van't Erve, M. J. Roggeveen, W J. A. Boersma, T. van Joost, W. R. F Notten, and E. Claassen.1995.In vivo cytokine profiles in allergic and irritant contact dermatitis.Contact. Dermatitis33:258–266.
892.
Hoh, A., K. Mai er, and R. M. Dreher.1987.Multilayered keratinocyte culture used for in vitro toxicology.Mol. Toxicol.1:537–546.
893.
Howett, M. K., E. B. Neely, N. D. Christensen, B. Wigdahl, F. C. Krebs, D. Malamud, S. D. Patrick, M. D. Pickel, P. A. Welsh, C. A. Reed, M. G. Ward, L. R. Budgeon, and J. W Kreiden1999.A broad-spectrum microbiocide with virucidal activity against sexually transmitted viruses.Antimicrob. Agents Chemother.43:314–321.
894.
Hunziker, T, C. U. Brand, A. Kapp, E. R. Waelti, and L. R. Braathen.1992.Increased levels of inflammatory cytokines in human skin lymph derived from sodium lauryl sulphate-induced contact dermatitis.Br. J. Dermatol.127:254–257.
895.
Hunziker T, C. U. Brand, A. Limat, and L. R. Braathen.1993.Alloactivating and antigen-presenting capacities of human skin lymph cells derived from sodium lauryl sulfate-induced contact dermatitis.Eur. J. Dermatol.3:137–140.
896.
Igarashi, H.1986.With which component of the bovine isolated cornea does sodium lauryl sulfate react to produce opacity?Toxicol. Lett.32:249–254.
897.
Ikarashi, Y., Y. Tsukamoto, T. Tsuchiya, and A. Nakamura.1993.Influence of irritants on lymph node cell proliferation and the detection of contact sensitivity to metal salts in the murine local lymph node assay.Contact. Dermatitis29:128–132.
898.
Ikarashi, Y, T. Tsuchiya, and A. Nakamura.1993.A sensitive mouse lymph node assay with two application phases for detection of contact allergens.Arch. Toxicol.67:629–636.
899.
Ingram, A. J., and P. Grasso.1975.Patch testing in the rabbit using a modified human patch test method: Application of histological and visual assessment.Br. J. Dermatol.92:131–142.
900.
Jain, P. T., M. J. Fitzpatrick, P. C. Phelps, I. K. Berezesky, and B. F. Trump.1992.Studies of skin toxicity in vitro: Dose-response studies on JB6 cells.Toxicol. Pathol.20:394–404.
901.
Janik, F, and H. U. Wolf.1992.The Ca+2-transport-ATPase of human ery-throcytes as an in vitro toxicity test system-acute effects of some chlorinated compounds.J. Appl. Toxicol.12:351–358.
902.
Johnson, O. H., S. Casey, M. K. Doletz, K. E. McCaleb, A. M. Miller, P. A. Papa, L. B. Swett, M. A. Valentini, and C. T. Helmes.1984.A study of biocides for the selection of candidates for carcinogen bioassay.J. Environ. Sei. Health19:1–25.
903.
Judge, M. R., H. A. Griffiths, D. A. Basketter, I. R. White, R. J. G. Rycroft, and J. P. McFadden.1996.Variation in response of human skin to irritant challenge.Contact Dermatitis34:115–117.
904.
Junghans, V., C. Gutgesell, T. Jung, and C. Neumann.1998.Epidermal cytokines IL-lbeta, TNF-alpha, and IL-12 in patients with atopic dermatitis: Response to application of house dust mite antigens.J. Invest. Dermatol.111:1184–1188.
905.
Kacani, L., M. Ferencik, F Devinsky, J. Most, and M. P. Dierrich.1994.Im-munomodulatory effect of sodium dodecyl sulfate on human neutrophils and the human promyelocytic HL-60 line.Eur. J. Pharmacol.270:285–289.
906.
Kawachi, T, T. Komatsu, T. Kada, M. Ishidate, M. Sasaki, T. Sugiyama, and Y Tazima.1980.Results of recent studies on the relevance of various short-term screening tests in Japan. In: The predictive value of short-term screening tests in carcinogenicity evaluation.Appl. Methods Oncol.3:253–267'.
907.
Kawai, K., M. Nakagawa, J. Kawai, and K. Kawai.1992.Evaluation of ski irritancy of sodium lauryl sulphate: A comparative study between the replica method and visual evaluation.Contact Dermatitis27:174–181.
908.
Kemp, R. B., R. W J. Meredith, and S. H. Gamble.1985.Toxicity of commercial products on cells in suspension culture a possible screen for the Draize eye irritation test.Food Chem. Toxicol.23:267–270.
909.
Kennah, H. E., S. Hignet, P. E. Laux, J. D. Dorko, and C. S. Barrow.1989.An objective procedure for quantitating eye irritation based upon changes of corneal thickness.Fundam. Appl. Toxicol.12:258–268.
910.
Kligman, A. M., and L. H. Kligman.1998.A hairless mouse model for assessing the chronic toxicity of topically applied chemicals.Food Chem. Toxicol.36:867–878.
911.
Kobiler, D., S. Lustig, Y. Gozes, D. Ben-Nathan, and Y. Akov.1989.Sodium doedecylsulphate induces a breach in the blood-brain barrier and enables a West Nile Virus to penetrate into mouse brain.Brain Res.496:314–316.
912.
Kojima, H., A. Hanamura, S. Miyamoto, A. Sato, H. Konishi, and I. Yoshimura.1995.Evaluation of seven alternative assays on the main ingredients in cosmetics as predictors of Draize eye irritation scores.Toxicol. In Vitro9:333–340.
913.
Kolde, G., and J. Knop.1987.Different cellular reaction patterns of epidermal Langerhans cells after application of contact sensitizing, toxic, and toi erogenic compounds. A comparative ultrastructural and morphometric time-course analysis.J. Invest. Dermatol.89:19–23.
914.
Kondo, S., S. Pastore, G. M. Shivji, R. C. McKenzie, and D. N. Sauder.1994.Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin.Lymphokine Cytokine Res.13:367–375.
915.
Körting, H. C, T. Herzinger, A. Haringer, M. Kerscher, T. Angerpointer, and H. I. Maibach.1994.Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HaCaT cells, and 3T3 mouse fibroblasts: Correlation with in vivo data from a soap chamber assay.J. Dermatol. Sei.7:119–129.
916.
Krasteva, M., J. Peguet-Navarro, C. Moulon, P. Courtellemont, G. Redziniak, and D. Schmitt.1996.In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells-a screening predictive assay for contact sensitizers.Clin. Exp. Allergy26:563–570.
917.
Krebs, F C, S. R. Miller, D. Malamud, M. K. Howett, and B. Wigdahl.1999.Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C3 IG, or an alkyl sulfate, sodium dodecyl sulfate.Antiviral Res.43:157–173.
918.
Lammintausta, K., H. I. Maibach, and D. Wilson.1988.Susceptibility to cumulative and acute irritant dermatitis an experimental approach in human volunteers.Contact. Dermatitis19:84–90.
919.
Larsen, C. G., T. Ternowitz, F G. Larsen, C. Zachariae, and K. Thestrup-Pedersen.1989.ETAF-interleukin-1 and epidermal lymphocyte chemotac-tic factor in epidermis overlying an irritant patch test.Contact. Dermatitis20:335–340.
920.
Lawrence, J. N., and D. J. Benford.1995.Comparison of tumour promoter-induced prostaglandin E2 release in human and rat keratinocytes.Carinogen-esis16:1247–1251.
921.
Lawrence J. N., F M. Dickson, and D. J. Benford.1997.Skin irritant-induced cytotoxicity and prostaglandin E12 release in human skin keratinocyte cultures.Toxicol. In Vitro11:627–631.
922.
Lawrence, J. N., S. Starkey, F M. Dickson, and D. J. Benford.1996.Use of human and rat keratinocyte cultures to assess skin irritation potential.Toxicol. In Vitro10:331–340.
923.
Lawrence, R. S., M. H. Groom, D. M. Ackroyd, and W E. Parish.1985.The chorioallantoic membrane in irritation testing.Food Chem. Toxicol.24:497–502.
924.
Le, M., S. Cals, J. Schalkwijk, and P. van der Valk.1996.An immunohistochem-ical study on mild skin irritation by a single application of a low-molarity sodium dodecyl sulfate solution: Keys to prevention of irritant contact dermatitis.Curr. Probl. Dermatol.25:67–77'.
925.
Le, M., J. Schalkwijk, G. Sigenthaler, P. C. M. van de Kerkhof, J. H. Veerkamp, and P. G. M. vander Valk.1996.Changes in keratin ocyte differentiation following mild irritation by sodium dodecyl sulphate.Arch. Dermatol. Res.288:684–690.
926.
Lee, C. H., Y Kawasaki, and H. I. Maibach.1994.Effect of surfactant mixtures on irritant contact dermatitis potential in man: Sodium lauroyl glutamate and sodium lauryl sulfate.Contact. Dermatitis30:205–209.
927.
Lee, C. H., and H. I. Maibach.1995.The sodium lauryl sulfate model: An overview.Contact. Dermatitis33:1–7.
928.
Lee, C. H., and H. I. Maibach.1994.Study of cumulative irritant contact dermatitis in man utilizing open application on subclinically irritated skin.Contact. Dermatitis30:271–275.
929.
Lee, J. Y, I. Effendy, and H. I. Maibach.1997.Acute irritant contact dermatitis: Recovery time in man.Contact. Dermatitis36:285–290.
930.
Li, L.-F, V. C. Fiedler, and R. Kumar.1997a.Protein kinase C isoform levels in normal and sodium dodecyl sulphate-irritated mouse skin.Br. J. Dermatol.139:11–15.
931.
Li, L.-F, V. C. Fiedler, and R. Kumar.1997b.Mouse skin protein kinase C iso-forms in irritant and allergic contact dermatitis.J. Invest. Dermatol.108:621. Abstract.
932.
Li, L.-F, V. C. Fiedler, and R. Kumar.1998.Down-regulation of protein kinase C isoforms in irritant contact dermatitis.Contact. Dermatitis38:319–324.
933.
Lindberg, M., G. Farm, and A. Scheynius.1991.Differential effects of sodium lauryl sulphate and non-anoic acid on the expression of CD la and ICAM-1 in human epidermis.Acta Derm. Venereol.71:384–388.
934.
Lindberg, M., and T. G. Grundin.1987.Elemental changes in guinea-pig epidermis in the hyperplastic response to irritant stimuli.Br. J. Dermatol.116:477–484.
935.
Lisby, S., O. Baadsgaard, K. D. Cooper, and G. L. Vejlsgaard.1989.Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: Relevance for skin cancer?J. Invest. Dermatol.92:842–847.
936.
Lisby, S., K. M. Müller, C. V. Jongeneel, J.-H. Saurat, and C. Hauser.1995.Nickel and skin irritants up-regulate tumor necrosis factor-a mRNA in ker-atinocytes by different by potentially synergistic mechanisms.Int. Immunol.7:343–352.
937.
Lodén, M.1990.The simultaneous penetration of water and sodiumlauryl sulfate through isolated human skin.J. Soc. Cosmet. Chem.41:227–233.
938.
Löffler, H., and I. Effendy.1997.Crescendo reactions to sodium lauryl sulfate and retinoic acid in irritant patch tests.Contact. Dermatitis37:47–48. Abstract.
939.
Loveless, S. E., G. S. Ladies, G. F. Gerberick, C. A. Ryan, D. A. Basketter, E. W. Scholes, R. V. House, J. Hilton, R. J. Dearman, and I. Kimber.1996.Further evaluation of the local lymph mode assay in the final phase of an international collaborative trial.Toxicology108:141–152.
940.
Luster, M. I., J. L. Wilmer, D. R. Germolec, J. Spalding, T. Yosihda, K. Gaido, P. P. Simenova, F. G. Burleson, and A. Bruccoleri.1995.Role of keratinocyte-derived cytokines in chemical toxicology.Toxicol. Lett.82/83:471–476.
941.
Machida, M., K. Sano, M. Arakawa, M. Hayashi, and S. Awazu.1994.Effects of surfactants and protease inhibitors on nasal absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.Biol. Pharm. Bull.17:1375–1378.
942.
Manetz, T. S., D. A. Pettit, and B. J. Meade.2001.The determination of draining lymph node cell cytokine mRNA levels in BALA/c mice following dermal sodium lauryl sulfate, dinitrofluorobenzene, and toluene diisocyanate exposure.Toxicol. Appl. Pharmacol.171:174–183.
943.
Marinovich, M., E. Tragni, A. Corsini, and C. L. Galli.1990.Quantification of in vitro cytotoxicity of surfactants : Correlation with their eye irritation potential.J. Toxicol. Cutan. O cul. Toxicol.9:169–178.
944.
Marks, R., and T. Kingston.1985.Acute skin toxicity reactions in man tests and mechanisms.Food Chem. Toxicol.23:155–164.
945.
Mathur, A. K., B. N. Gupta, A. Singh, S. Singh, and R. Shanker.1993.Renal toxicity of nickel, sodium lauryl sulphate and their combination after dermal application in guinea pigs.Biomed. Environ. Sei.6:231–236.
946.
Mathur, A. K., C. Agarwal, A. Singh, and B. N. Gupta.1988.Effect of sodium lauryl sulphate and nickel alone and in combination on the skin of guinea pigs.Toxicol. Lett.42:249–256.
947.
Mathur, A. K., B. N. Gupta, A. Singh, S. Singh, S. Narang, and R. Shanker.1992.Cutaneous toxicity of sodium lauryl sulphate, nickel, and their combination in guinea pigs: Biochemical and histopathological observations.Bull. Environ. Contam. Toxicol.49:871–878.
948.
Mathur, A. K., B. N. Gupta, A. Singh, S. Singh, R. Shanker, and S. Narang.1991.Hepato-toxicity of nickel, sodiumlauryl sulphate and their combination after repeated dermal application in guinea pigs.J. Environm. Sei. Health A Environ. Eng.A26T333–1343.
949.
McFadden, J. P., S. H. Wakelin, and D. A. Basketter.1998.Acute irritation thresholds in subjects with Type I-Type VI skin.Contact. Dermatitis38:147–149.
950.
McGregor, D. B., A. Brown, P. Cattanach, I. Edwards, D. McBride, and W. J. Caspary.1986.Results of L-5178Y mouse lymphoma cell mutagenesis experiments with coded compounds.Toxicol. Lett. (Amsterdam)31:213. Abstract.
951.
McGregor, D. B., A. Brown, P. Cattanach, I. Edwards, D. McBride, C. Riach, and W. J. Caspary.1988.Responses of the L5178Y tk+/tk-mouse lymphoma cell forward mutation assay III. 72 coded chemicals.Environ. Mol. Mutagen.12:85–154.
952.
McLelland, J., S. Shuster, and J. N. S. Matthews.1991.'Irritants' increase the response to an allergen in allergic contact dermatitis.Arch. Dermatol.127:1016–1019.
953.
Meeks, R. G., D. Zaharevitz, and R. F Chen.1981.Membrane effects of retinoids: Possible correlation with toxicity.Arch. Biochem. Biophys.207:141–147.
954.
Mikulowska, A.1990.Reactive changes in the Langerhans' cells of human skin cause by occlusion with water and sodium lauryl sulfate.Acta Derm. Venerol.70:468–473.
955.
Mikulowska, A., and A. Andersson.1996.Sodium lauryl sulfate effect on the density of epidermal Langerhans cells. Evaluation of different test models.Contact. Dermatitis34:397–401.
956.
Miura, Y.1987.Effects of in-vivo administration of detergents on the hepatic microsomal cytoch rome P-450 system in rat.J. Appl. Toxicol.7:213–217.
957.
Miura, Y, H. Hisaki, B. Fukushima, T. Nagai, and T. Ikeda.1989.Detergent induced changes in serum lipid composition in rats.Lipids24:915–918.
958.
Mohamadzadeh, M., M. Müller, T. Hultsch, A. Enk, J. Saloga, and J. Knop.1994.Enhanced expression of IL-8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers, tolerogens and irritants.Exp. Dermatol.3:298–303.
959.
Montserret, R., M. J. McLesih, A. Böckmann, C. Geourjon, and F. Penin.2000.Involvement of electrostatic interactions in the mechanism of peptide folding induced by sodium dodecyl sulfate binding.Biochemistry39:8362–8373.
960.
Mortelmans, K., S. Haworth, T. Lawlor, W. Speck, B. Tainer, and E. Zeiger.1986.Salmonella mutagenicity testing of 270 chemicals.Environ. Mutagen.8:1–119.
961.
Muir, C. K.1987.Surfactant-induced opacity of bovine isolated cornea: An epithelial phenomenon.Toxicol. Lett.38:51–54.
962.
Müller-Decker, K., T. Heinzelmann, G. Fürstenberger, A. Kecskes, W.-D. Lehmann, and F Marks.1998.Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants.Toxicol. Appl. Pharmacol.153:59–67.
963.
Newby, C. S., R. M. Barr, M. W. Greaves, and A. I. Mallet.2000.Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate.J. Invest. Dermatol.115:292–298.
964.
Nordlind, K., and J. Thyberg.1986.In-vitro effects of sodium lauryl sulfate on DNA synthesis and fine structure of human thymocytes.Int. Arch. Allergy Appl. Immunol.81:165–169.
965.
North-Root, H., F Yackovich, J. Demtrulias, M. Gacula, Jr., and J. E. Heinze.1985.Prediction of the eye irritation potential of shampoos using the in-vitro SIRC cell toxicity test.Food Chem. Toxicol.23:271–274.
966.
Oba, K., and R. Takei.1992.Carcinogenic mutagenic-genetic toxicity and ter-atogenic properties. In Surfactant science series, vol. 43, Anionic surfactants: Biochemistry, toxicology, dermatology, 2nd ed., ed. C. Gloxhuber, K. Kuenstler, 331–409. New York: Marcel Dekker, Inc.
967.
Ollmar, S., and L. Emtestam.1992.Electrical impedence applied to non-invasive detection of irritation in skin.Contact. Dermatitis27:37–42.
968.
Osborne, R., and M. A. Perkins.1990.In-vitro irritation testing with human skin cell cultures.Toxicol. In Vitro.5:563–568.
969.
Osborne, R., M. A. Perkins, and C. Hudson.1990a.Evaluation of surfactant-induced toxicity in cultured human skin cells.Invest. Dermatol.94:562. Abstract.
970.
Osborne, R., M. A. Perkins, and C. Hudson.1990b.Evaluation of surfactant-induced toxicity in cultured human skin cells.Clin. Res.38:616A.
971.
O'Neill, C. A., R. A. Günther, G. J. Jesmok, and S. N. Giri.1991.Effects of recombinant human interleukin-2 and excipient infusion on plasma levels of prostaglandins and thromboxane B2 in sheep.Lymphokine Cytokine Res.10:207–212.
972.
Palacio, S., D. Schmitt, and J. Vivac.1997.Contact allergens and sodium lauryl sulfate upregulate vascular endothelial growth factor in normal keratinocytes.Br. J. Dermatol137:540–544.
973.
Pasche-Koo, F, A. Arechalde, J.-F Arrighi, and C. Häuser.1995.Effect of N- acetylcysteine, an inhibitor of tumor necrosis factor, in irritant contact dermatitis in the human.Curr. Probl. Dermatol.23:198–206.
974.
Patil, S. M., P. Singh, and H. I. Maibach.1994.Cumulative irritancy in man to sodium lauryl sulfate: The overlap method phenomenon.Int. J. Pharmaceut.110:147–154.
975.
Patil, S. M., P. Singh, K. Sarasour, and H. I. Maibach.1995.Quantification of sodium lauryl sulfate penetration into the skin and underlying tissues after topical application-pharmacological and toxicological implications.J. Pharm. Sei.84:1240–1244.
976.
Patterson, S. E., J. V. Williams, and J. G. Marks, Jr.1999.Prevention of sodium lauryl sulfate irritant contact dermatitis by Pro-Q aerosol foam skin protectant. J.Am. Acad. Dermatol.40:783–785.
977.
Phillips, B. J., D. Anderson, and S. D. Gangolli.1986.Environ. Health Perspect.65:263–266.
978.
Pichowski, J. S., M. Cumberbatch, Dearman, D. A. Basketter, and I. Kimber.2000.Investigation of induced ch anges ininterleukin lbeta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing.Toxicol. In Vitro14:351–360.
979.
Pinnagoda, J., R. A. Tupker, P. J. Coenraads, and J. P. Nater.1989.Prediction of susceptability to an irritant response by transepidermal water loss.Contact. Dermatitis20:341–346.
980.
Ponec, M., and J. Kempenaar.1995.Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants.Skin. Pharmacol.8:49–59.
981.
Potokar, M. S.1992.Acute subacute and chronic toxicity data on anionics. In Surfactant science series, vol. 43, Anionic surfactants: Biochemistry, toxicology, dermatology, 2nd ed., ed. C. Gloxhuber and K. Kuenstler, 81–116. New York: Marcel Dekker, Inc.
982.
Prinsen, M. K., T. Romijn, and Snoeig, N. J.1997.Skin sensitization testing: The relevance of rechallenge and pretreatment with sodium lauryl sulfate in guinea pig maximization test.Food Chem. Toxicol.35:923–926.
983.
Product Safety Labs. 1980a. Initial submission: Letter from Rhone-Poulenc Inc submitting two skin corrosion studies with sodium lauryl sulfate in rabbits. NTIS Report No. OTS0539861.
984.
Product Safety Labs. 1980b. Initial submission: Modified eye irritation study with sodium lauryl sulfate in rabbits with cover letter dated 051592. NTIS Report No. OTS0539896.
985.
Product Safety Labs. 1980c. Initial submission: Letter from Rhone-Poulenc Inc submitting two corrosion studies with ammonium lauryl sulfate in rabbits. NTIS Report No. OTS0539864.
986.
Product Safety Labs. 1980d. Initial submission: DOT skin corrosion and primary skin irritation studies with sodium lauryl sulfate in rabbits with cover letter dated 051592. NTIS Report No. OTS0539901.
987.
Rees, P., J. Watson, R. H. Cumming, J. Liddell, and P. Turner.1996.Effects of heat shock on Gram negative bacteria: Use of lysis by sodium dode-cyl sulphate as a probe for the integrity of DNA.Bioseparation6:125–132.
988.
Rheins, L. S., M. A. Harén, and E. V. Buehler.1993.Alterations in the cutaneous immune response following topical application of sodium lauryl sulfate and Kathon CG.J. Toxicol. Cutan. Ocul. Toxicol.12:249–259.
989.
Rheins, L. D., F. A. Simion, R. L. Hill, R. H. Cagan, J. Mattai, and H. I. Maibach.1990.Human cutaneous response to a mixed surfactant system: Role of solution phenomena in controlling surfactant irritation.Dermatológica180:18–23.
990.
Rivalland, P., L. Coiffard, and Y. De Roeck-Holtzhauer.1994.Determination of the cytotoxicity of sodium lauryl sulfate on reconstituted skin.Cell. Biol. Toxicol.10:436.
991.
Robinson, M. K.1999.Population differences in skin structure and physiology and the susceptibility to irritant and allergic dermatitis: Implication for skin safety testing and risk assessment.Contact. Dermatitis41:65–79.
992.
Robinson, M. K., M. A. Perkins, and D. A. Basketter.1998.Application of a 4-h human patch test method for comparative and investigative assessment of skin irritation.Contact. Dermatitis38:194–202.
993.
Roguet, R., K. G. Dossou, and A. Rougier.1992.Use of in vitro skin recombinants to evaluate cutaneous toxicity: A preliminary study.J. Toxicol.11:305–315.
994.
Rougier, A.1995.Examples of the use of cell cultures in skin irritancy assessment.Curr. Probl. Dermatol.22:214–230.
995.
Rougier, A., M. Cottin, O. De Silva, P. Catroux, R. Rouget, and K. G. Doosou.1994.The use of in vitro methods in the ocular irritation a ssessment of cosmetic products.Toxicol. In Vitro8:893–905.
996.
Rowe, T. C, D. Grabowski, and R. Ganapathi.2001.Isolation of covalent enzyme-DNA complexes.Methods Mol. Biol.95:129–135.
997.
Ryan, C. A., and G. F. Gerberick.1999.Cytokine mRNA expression in human epidermis after patch treatment with rhus and sodium lauryl sulfate.Am. J. Contact. Dermatitis10:127–135.
998.
Santa Maria, A., J. M. Pozuelo, A. Lopez, and F. Sanz.1996.Toxicity of potential irritants in mammalian cells in vitro.Ecotoxicol. Environ. Safety34:56–58.
999.
Scaife, M. C.1985.An in-vitro cytotoxicity test to predict the ocular irritation potential of detergents and detergent products.Food Chem. Toxicol.23:253–258.
1000.
Schneider, A. I., K. Maier-Reif, and T. Graeve.1997.The use of an in vitro cornea for predicting molecular and cellular toxicity.In Vitro Toxicol.10:309–318.
1001.
Seidenarsi, S.1994.Echographic evaluation with image analysis of irritant reactions induced by nonanoic acid and hydrochloric acid.Contact. Dermatitis31:146–150.
1002.
Seidenari, S., and B. Belletti.1994.Instrumental evaluation of subclinical irritation induced by sodium lauryl sulfate.Contact. Dermatitis30:175.
1003.
Seidenari, S., B. Belletti, and M. E. Schiavi.1996.Skin reactivity to sodium lauryl sulfate in patients with respiratory atopy.J. Am. Acad. Dermatol.35:47–52.
1004.
Seidenarsi, S., and A. Di Nardo.1992.B scanning evaluation of irritant reactions with binary transformation and image analysis.Acta Derm. Venerol. Suppl.175:9–13.
1005.
Serup, J., and B. Staberg.1987.Ultrasound for assessment of allergic and irritant patch test reactions.Contact. Dermatitis17:80–84.
1006.
Shadduck, J. A., J. Everitt, and P. Bay. 1985. Use of in-vitro cytotoxicity to rank ocular irritation of six surfactants. In Alternative methods in toxicology, vol. 3, In vitro toxicology, ed. A. M. Goldberg, 641-650.
1007.
Shopis, C, and B. Eng.1985.Rapid cytotoxicity testing using a semi-automated protein determination on cultured cells.Toxicol. Lett.26:1–8.
1008.
Sladowski, D. T, S. J. Steer, L. Moore, A. Willshaw, R. H. Clothier, and M. Balls.1994.The complement activation assay: The test for immediate phototoxicity.Toxicol. In Vitro8:513–515.
1009.
Spoo, J. W., R. A. Rogers, and N. A. Monteiro-Riviere.1992.Effects of formaldehyde, DMSO, benzoyl peroxide, and sodium lauryl sulfate on isolated perfused porcine skin.In Vitro Toxicol.5:251–260.
1010.
Stephens, T. J., and P. R. Bergstresser.1985.Fundamental concepts in photoim-munology and photoallergy.J. Toxicol. Cutan. Ocul. Toxicol.4:193–218.
1011.
Steven, F. S., M. M. Griffin, M. Anees, and E. W. Benbow.1992.Observations on the conformational changes in the structure of a cell surface protease, followed by its ability to be recognized by competitive and noncompetitive inhibitors.J. Enzyme Inhib.6:251–258.
1012.
Stolz, R., U. Hinnen, and P. Eisner.1997.An evaluation of the relationship between 'atopic skin' and skin irritability in metalworker trainees.Contact. Dermatitis36:281–284. New York: Mary Ann Liebert, Inc.
1013.
Stringer, C. P., R. Hicks, and P. A. Botham.1991.The expression of MHC Class II (la) antigens on mouse keratinocytes following epicutaneous application of contact sensitizers and irritants.Br. J. Dermatol.125:521–528.
1014.
Tachón, P., J. Cotovio, K. G. Dossou, and M. Prunieras.1989.Assessment of surfactant cytotoxicity: Comparison with the Draize eye test.Int. J. Cosmet. Sei.11:233–243.
1015.
Tausch, I., Bielfeldt, A. Hildebrand, and J. Gassmüller.1996.Validation of a modified Duhring Chamber Test (DCT) as a repeated patch test for the assessment of the irritant potential of topical preparations.Parfume Kosmet.77:28–31
1016.
Tavss, E. A., E. Eigen, and A. M. Kligman.1988.Anionic detergent-induced skin irritation and anionic detergent-induced pH rise of bovine serum albumin.J. Soc. Cosmet. Chem.39:267–272.
1017.
Thyrum, P. T, and B. Jirgensons.1980.Interactions between tumor-promoting agents and histones studied by circular dichromism.Cancer. Biochem. Bio-phys.5:7–13.
1018.
Treffel, P., and B. Gabard.1996.Measurement of sodium lauryl sulfate-induced skin irritation.Acta Derm. Venereal.76:341–343.
1019.
Tupker, R. A., E. E. Bunte, V. Fidler, J. W Wiechers, and P. J. Coenraads.1999.Irritancy ranking of anionic detergents using one-time occlusive, repeated occlusive and repeated open tests.Contact. Dermatitis40:316–322.
1020.
Tupker, R. A., P.-J. Coenraads, J. Pinnagoda, and J. P. Nater.1989.Baseline transepidermal waterloss (TEWL) as a prediction of susceptability to sodium lauryl sulphate.Contact. Dermatitis20:265–269.
1021.
Tupker, R. A., J. Pinnagoda, P.-J. Coenraads, and J. P. Nater.1989.The influence of repeated exposure to surfactants on the human skin as determined by transepidermal water loss and visual scoring.Contact. Dermatitis20:108–114.
1022.
Tupker, R. A., J. Pinnagoda, and J. P. Nater.1990.The transient effect of sodium lauryl sulfate on the epidermal barrier assessed by transepidermal water loss: Inter-individual variation.Acta Derm. Venerol.70:1–5.
1023.
Tuschl, H., R. Kovac, and E. Weber.2001.The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals.Toxicol. In Vitro14:541–549.
1024.
Ulfgren, A. K., L. Klareskog, and M. Lindberg.2000.An imrnunohistochemical analysis of cytokine expression in allergic and irritant contact dermatitis.Acta Derm. Venerol.80:167–170.
1025.
Van Der Valk, P. G. M., and H. I. Maibach.1989.Post-application occlusion substantially increases the irritant response of the skin to repeated short-term sodium lauryl sulfate (SLS) exposure.Contact. Dermatitis21:335–338.
1026.
van de Sandt, J. J. M., T. T. Bos, and A. A. J. J. L. Rutten.1995.Epidermal cell proliferation and terminal differentiation in skin organ culture after topical exposure to sodium dodecyl sulphate.In Vitro Cell. Dev. Biol. Anim.31:761–766.
1027.
Van Duijnhoven-Avontuur, W. M. G., J. A. C. Alkemade, J. Schalkwijk, P. D. Mier, and P. G. M. Van der Valk.1994.The inflammatory and proliferative response of normal skin in a model for acute chemical injury: Ornithine decarboxylase induction as a common feature in various models for acute skin injury.Br. J. Dermatol.130:725–730.
1028.
Van Neste, D.1990.In vivo evaluation of unbound water accumulation in stratum corneum: The influence of acute skin irritation induced by sodium lauryl sulfate.Dermatológica181:197–201.
1029.
Van Neste, D., and B. De Brouwer.1992.Monitoring of skin response to sodium lauryl sulphate: Clinical scores versus bioengineering methods.Contact. Dermatitis27:151–156.
1030.
Van Neste, D., G. Mahmoud, and M. Masmoudi.1987.Experimental induction of rough dermatitic skin in humans.Contact. Dermatitis16:27–33.
1031.
Villeponteau, B.1989.Characterization of a topoisomerase-like activity at specific hypersensitive sites in the Drosophila histone gene cluster.Biochem. Biophys. Res. Commun.162:232–237.
1032.
Vinardell, M. P., and M. Macián.1994.Comparative study of the HET-CAM test and the Draize eye test for assessment of irritancy potential.Toxicol. In Vitro8:467–470.
1033.
von den Driesch, P., M. Fartasch, A. Hüner, and M. Ponec.1995.Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: Effect of sodium dodecyl sulphate.Arch. Dermatol. Res.287:249–253.
1034.
Wahlberg, J. E., and H. I. Maibach.1981.Sterile cutaneous pustles: A manifestation of primary irritancy?: Identification of contact pustologens.J. Invest. Dermatol.76:381–383.
1035.
Wahlberg, J. E., K. Wrangsjö, and A. Hietasalo.1985.Skin irritancy from nonanoic acid.Contact. Dermatitis13:266–269.
1036.
Walker, A. P.1985.A more realistic animal technique for predicting human eye response.Food Chem. Toxicol.23:175–178.
1037.
Ward, R. K., A. W Hubbard, H. Sulley, M. J. Garle, and R. H. Clotheir.1998.Human keratinocyte cultures in an in vitro approach for the assessment of surfactant-induced irritation.Toxicol. In Vitro ?2?63-?3.
1038.
Watson, R. E. B., N. M. Craven, S. Kang, C. J. P. Jones, C. M. Kielty, and C. E. M. Griffiths.2001.A short-term screening protocol, using fibriilin-1 as a reporter molecule, for photoaging repair agents.J. Invest. Dermatol.116:672–678.
1039.
Welzel, J., C. Metker, H. H. Wolff, and K.-P Wilhelm.1998.SLS-irritated human skin shows no correlation between degree of proliferation and TEWL increase.Arch. Dermatol. Res.290:615–620.
1040.
Wilhelm, K.-P, G. Freitag, and H. H. Wolff.1994.Surfactant-induced skin irritation and skin repair. Evaluation of the acute human irritation model by noninvasive techniques.J. Am. Acad. Dermatol.30:944–949.
1041.
Wilhelm, K.-P, and H. I. Maibach.1990.Susceptibility to irritant contact dermatitis induced by sodium lauryl sulfate.J. Am. Acad. Dermatol23:122–124.
1042.
Wilhelm, K.-P, J. C. Saunders, H. I. Maibach.1990.Increased stratum corneum turnover induced by subclinical irritant dermatitis.Br. J. Dermatol.122:793–798.
1043.
Willis, C. M., C. J. M. Stephens, and J. D. Wilkinson.1988a.Experimentally-in duced irritant contact dermatitis: Determination of optimum irritant concentrations.Contact. Dermatitis18:20–24.
1044.
Willis, C. M., C. J. M. Stephens, and J. D. Wilkinson.1988b.Assessment of erythema in irritant contact dermatitis.Contact. Dermatitis18:138–142.
1045.
Willis, C. M., C. J. M. Stephens, and J. D. Wilkinson.1989.Epidermal damage induced by irritants in man: A light and electron microscopic study.J. Invest. Dermatol.93:695–699.
1046.
Willis, C. M., C. J. M. Stephens, J. D. Wilkinson.1990a.Differential effects of structurally unrelated chemical irritants on the density and morphology of epidermal CD1+ cells.J. of Invest. Dermatol.95:711–716.
1047.
Willis, C. M., C. J. M. Stephens, J. D. Wilkinson.1990b.Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants.J. Invest. Dermatol.101:364–370.
1048.
Willis, C. M., C. J. M. Stephens, and J. D. Wilkinson.1992.Differential effects of structurally unrelated chemical irritants on the density of proliferating keratinocytes in 48 h patch test reactions.J. Invest. Dermatol.99:449–453.
1049.
Willshaw, A., L. J. Moore, and M. Balls.1994.In vitro alternatives for the detection of photoirritant chemicals: The EEC trial.Toxicol. In Vitro8:723–735.
1050.
Wilmer, J. L., F G. Burleson, F Kayama, J. Kanno, and M. I. Luster.1994.Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J.Invest. Dermatol.102:915–922.
1051.
Wollina, U., V Fuenfstueck, C. Hipler, and B. Knopf.1988.Alterations of epidermal lectin binding sites in acute contact dermatitis.Contact. Dermatitis19:109–115.
1052.
Xu, G., H. M. Leibich, R. Lehmann, and S. Müller-Hagedorn.2001.Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.Methods Mol. Biol.162:459–474.
1053.
Yang, E. K., H. H. Yoon, D. H. Lee, and J. K. Park.2000.Assessment of toxic potential of industrial chemicals using a cultured human bioartificial skin model: Production of interleukin la and hydroxyeicosatetraenoic acids.Skin Pharmacol. Appl. Skin Physiol.13:246–257.
1054.
York, M., D. A. Basketter, J. A. Cuthbert, and L. Neilson.1995.Skin irritation testing in man for hazard assessment-evaluation of four patch systems.Hum. Exp. Toxciol.14:729–734.
1055.
Younger Laboratories. 1974. Initial submission: Dermal toxicity study of dodecyl sodium sulfate in rabbits with cover letter dated 08 /13/ 92. NTIS Report No. OTS0555175.
1056.
Zehnder, S., R. Mark, S. Manning, A. Sakr, J. L. Lichtin, and K. L. Gabriel.1992.Human in vivo method for assessing reduction of the irritation potential of sodium lauryl sulfate by mild surfactants : Validation with an ether carboxylate with two different degrees of ethoxylation.J. Soc. Cosmet. Chem.43:313–330.
1057.
Zhitkovich, A., and M. Costa.1992.A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo.Carcinogenesis13:1485–1489.
1058.
Zhou, J., R. Mark, T. Stoudemayer, A. Sakr, J. L. Lichthin, and K. L. Gabriel.1991.The value of multiple instrumental and clinical methods, repeated patch applications, and daily evaluations for assessing stratum corneum changes induced by surfactants.J. Soc. Cosmet. Chem.42:105–128.
1059.
Beisson, F., N. Ferte, S. Bruley, R. Voultoury, R. Verger, and V. Arrondel.2001.Oil-bodies as substrates for lipolytic enzymes.Biochim. Biophys. Acta1531:47–58.
1060.
Bonhomme, L., G. Fredj, J. L. Grossiord, A. M. Szekely, C. Jasmin, et al. 1993.Formulation of all-trans-retinoic acid gel for topical treatment of epidemic Kaposi sarcoma lesions.J. Pharm. Clin.12:77–80.
1061.
Brosig, J., and S. Clemens.1997.[Echographic diagnosis of efferent lacrimal ducts with contrast media.]Klin. Monatsbl. Augenheilkd.210:27–32.
1062.
Cicinelli, E., F Savino, I. Cagnazzo, R Scorcia, and P. Galantino.1992.Progesterone administration by nasal spray in menopausal women: Comparison between two different spray formulations.Gynecol. Endocrinol.6:247–251.
1063.
Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Ingredient Use Data-Prunus Amygdalus Dulcís (Sweet Almond) Oil and Prunus Amygdalus Dulcís (Sweet Almond) Seed Meal. Unpublished data submitted by CTFA dated September 13, 2002. 2 pages.
1064.
Davis, P. A., and C. K. Iwahashi.2001.Whole almonds and almond fractions reduce aberrant crypt foci in a rat model of colon carcinogenesis.Cancer. Lett.165:27–33.
1065.
Elder, R. L. ed. 1983. Final report on the safety assessment of sweet almond oil ' and almond meal. J. Am. Col. Toxicol. 2:85-99.
1066.
Guillet, G., and M. H. Guillet.2000[Percutaneous sensitization to almond oil in infancy and study of ointments in 27 children with food allergy]Allergy Immunol. (Paris)32:309–311.
1067.
Guillot, J. P., J. Y. Giauffret, and M. C. Martini.1979.A study of skin and eye irritation in the rabbit eye due to different sources of some cosmetic raw materials. Pat II.Int. J. Cosmet. Sei.1:27–57.
1068.
Hammer, K. A., C. F Carson, and T. V. Riley.1999.Antimicrobial activity of essential oils and other plant extracts.J. Appl. Microbiol.86:985–990.
1069.
Hyson, D. A., B. O. Schneeman, and P. A. Davis.2002.Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J.Nutr.132:703–707.
1070.
Ishidate, M., Y. Takizawa, Y Sakabe, M. Ishizaki, D. Watanabe, M. Täte, and K. Takemoto.1988.Results of mutagenicity screening of food additives (part 9).Tokishikoroji Foramu (Toxicol. Forum)11:663–669.
1071.
Iskander, F Y1993.Determination of seventeen elements in edible oils and margarine by instrumental neutron activation analysis.J. Am. Oil. Chem. Soc.70:803–805.
1072.
Jumma, M., and B. W. Müller.1998.Effect of oil components and homogeniziation conditions on the physiochemical properties and stability of parenteral fat emulsions.Int. J. Pharmacol.163:81–89.
1073.
Marti-Mestres, G., H. Mailols, V. Van Sam, B. Guillot, et al. 1994.Study of the hydration and occlusive power in vivo and in vitro of lipophillic excipients and of their oil-phase emulsions.Int. J. Cosmet. Sei.16:161–170.
1074.
Messiha, F S.1990.Effect of almond and anis oils on mouse liver alcohol de-hydrogenase, aldehyde dehydrogenase and heart liver lactate dehydrogenase isoenzymes.Toxicol. Lett.54:183–188.
1075.
Niinimaki, A., K. Reijula, T. Pirila, A-M. Koistinen.1993.Papain-inducedallergic rhinoconjunctivitis in a cosmetologist.J. Allerg. Clin. Immunol.92:492–493.
1076.
Opdyke, D. L. J.1979.Monographs on fragrance raw materials. Almond Oil Sweet.Food Cosmet. Toxicol.17:709.
1077.
Patkar, K. L., C. M. Usha, H. S. Shetty, N. Paster, and J. Lacey.1993.Effect of spice essential oils on growth and aflatoxin B1 production by Aspergillus flavus.Lett. Appl. Microbiol.17:49–51.
1078.
Ruiz Del Castillo, M. L., M. Herraiz, and G. P. Blanch.2000.Determination of the enantiomeric of gamma-lactones in edible oils by on-line coupled high performance liquid chromatography and gas chromatography.J. Agrie. Food Chem.48:1186–1190.
1079.
Sanchez, A., D. A. Rubano, G. W. Shavilk, P. Fagenstrom, U. D. Register, and R. W. Hubbard.1988.Separate effects of dietary protein and fat on serum cholesterol levels: Another view of amino acid content of proteins.Arch. Latinoam Nutr.38:239–250.
1080.
Spiller, G. A., D. J. Jenkins, L. N. Cragen, J. E. Gates, O. Bosello, K. Berra, C. Rudd, M. Stevenson, and R. Superko.1992.Effect of diet high in monoun-saturated fat from almonds on plasma and cholesterol and lipoproteins.J. Am. Col. Nutr.11:126–130.
1081.
Thomas, P., A. Boussuges, M. Gainnier, V Quenee, S. Donati, M. L. Ayem, A. Barthélémy, and J. M. Sainty.1998.[Fat embolism after intrapenile injection of sweet almond oil.]Rev. Mai. Respir.15:307–308. 27 Available from Director, Cosmetic Ingredient Review, 1101 17th Street NW, Suite 310, Washington, DC 20036, USA.
1082.
Van Hoogmoed, L. M., D. W. Agnew, M. Whitcomb, D. W. Hyde, M. H. MacDonald, and J. R. Snyder.2002.Ultrasonographic and histologie evaluation of medial and middle patellar ligaments in exercised horses following injections with ethanolamine oléate and 2% iodine in almond oil.Am. J. Vet. Res.63:738–743.
1083.
Weber, L. F.1937.External causes of dermatitis. A list of irritants.Arch. Der-matol. Syphilo.35:129–179.